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ABSTRACT
Fast atom bombardment mass spectrometry (FABHS) was employea to verify
the DNA sequence of intracellular (non-glycosylated) and extracellular
(glycosylated) invertase from the yeast SaccharolDyces cererisiae, and to
locate points of N-glycosylation in the extracellula~ fo~m of this enzyme.
Collision induced dissociation (CID) mass spectra were acquired with a
tandem high resolution mass spectrometer of E.B.(cc]E28} configuration (where
£1 and E1 are the electric sectors of the first and second high resolution
mass spectrometers in tandem, 8. and BJ are the magnetic sectors, and [ee] 1s
th~ collision cell) In this technique, a precurso~ Ion Is selected by the
first mass spectrometer (BIB.), fragmentation Is induced by collision with a
neutral gas in the collision cell «(cc), and the masses of the resulting
fragment ions are determinen by the the second mass spectrometer (EJB2).
Thus, peptide ion fragmentations were studied in a detail not previously
possible; three as yet unreported fragmentation processes were characterized.
The structural information contalr.ed within such spectra was ascertained,
and computer programs aiding the interpretation of eIn mass spectra of
peptides of unknown sequence were written.
The use of tandem mass spectrometry in the sequencing of proteins vas
demonstrated by the deter.lnation of the primary structures of three bacterial
thioredoxlns (small proteins of molecular weight 11,500) isolated from
Chlorobium thiosullatophiJum, Chromalium rinosum, and Rhodospirillum ,.ubrum,
and a mammalian thioredoxin isolated from rabbit bone marrow. Bnzymatic
digests and high perforaance liquid chromatography were used to obtain
peptides, which were detected by FABMS and their sequences determined from
their CIO mass spectra.
Thesis Supervisor: Dr. Klaus Biemann
Title: Professor of Chemistry
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Section I
Introduction
I.I Mass Spectrometry of Peptides and Proteins
Since the introduction of fast atom bombardment (PAS) 1n 1981 (1) as
a means of 1,onizing large polar molecules, mass spectrometry has become
an increasingly important method for the analysis of pept1des. P~lor to
the emergence of FAB mass spectrometry, tedious sample and time consuming
derivGtl~ations were required for the introduction of these very polar
nonvolatile molecules into the mass spectrometer via a gas chromatograph
or a direct insertion prcbe (2-3)& The most abundant ions found 1n FAB
mass spectra of peptides are due to the protonated molecules <H+8)+ in
the case of positive ion FABMS or the deprotonated molecules (M-8)- for
negative 10n FABHS, thus allowing for the molecular weight determination
of the peptidese Since the sensitivity for positive ion FABHS of
peptides Is better than that for negative ion FABHS, the former te~hnique
is used throughout the work described here.
This ability to determine peptide molecular weights has &s one of
its major applications, the verification and correction of protein
primary structures as determined either by Bdman degradation (4) or from
DNA seqyences (5-7). The basic idea is to compare observed molecular
weights of peptides derived from specific cleavages of the gene product,
with the values predicted from the DNA sequences. A similar application
of PABMS is in the confirmation of the structure of proteins produced
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from recombinant DNA technology, ~here it is important to quickly
determine if a gene product is the sam~ as the wild type protein (7-9)~
This, naturally, is of significance for the biotechnology 1.ndustry where,
at least for patent purposes, it 1s important to know what has been
produced. This methodology can also be employed for the detection of
post translational modifications, where the observed molecular weight of a
modified peptide differs from the predicted molecular weight by the mass
of the modification (10-14). An example, utilizing this technique for
the determination of the location of N-glycosylation sites in an
extracellular Jeast invertase 1s presented In Section II of this thesis.
Although the molecular weight of a peptide can be readily determined
from the mass of the ("+8)+ ion, the high stability of this Ion precludes
the formation of significantly abundant sequence specific fragment ions.
Despite this, there have been a number of reports correlating FABMS
peptide fragments with the known peptide sequence <3,15-17); there are
far fewer instances where a FABMS spectrum has been used to deduce the
sequence of an unknown peptide (3,16,18-19). The difficulty with this
approach is that relatively large amounts of pure (single component)
pept1des are required to obtain a spectrum that exhibits sufficiently
abundant fragment Ions.
A technique that overcomes these limitations, tandem mass
spectrometry (or HS/MS> , involves the selection of a precursor ion,
followed by excitation through collision or other energetic processes,
and mass analysis of the resulting fragment ions. In the summer of 1985
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a JEOL HIll0llI0 mass spectrometer consisting of two Nier-Johnson double
focussing instruments in tandem was installed at HIT, thus allowing for
what we have termed high performance tandem mass spectrometry (HPTHS).
Use of the term HPTMS is meant to imply a type of HS/MS where both the
selection of the precursor ion and the mass analysis of the daughter ions
can be carried out at unit mass resolution on fairly large molecules (up
to mass 3000). It Is not meant to imply that further improvements are
unlikely or that other types of mass spectrometers, such as Fourier
transform ion cyclotron resonance or quadrupole instruments, are "low
performance", although ~~ of yet only four-sector instruments (two
electric and two magnetic sectors) such as the 8X110/110 have met these
conditions. Tandem mass spectrometry, part~cularly HPTHS, has several
advantages over normal FABHS in that fragmentation 1s enhanced, and the
resulting spectra are simplified, being devoid of the matrix related
ions, lJe isotope peaks, and other ions not resulting from fragmentation
of the selected precursor ion. Thus, "SIMS is applicable to the analysis
of mixtures where one precursor ion after the other can be mass selected
and collls1onally activated.
For the sequencing of peptides and proteins, tandem mass
spectrometry has some distinct advantages over conventional methods.
Although DNA sequencing is nova routine procedure (20-21), it cannot
provide any information concerning post translational modifications. The
same largely holds true for Edman sequencing, where a modified amino acid
will appear as a blank in an Bdman cycle, or the PTH-amino acid will have
an unusual retention time. Furthermore, Edman sequencing fails
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completely on N-termlnally blocked peptides. Edman degradation also
requires complete separation of peptldes, which Is time consuming and may
lead to a poor recovery of purified peptides. Although its best not to
have very complex mixtures of peptides for "SIMS, there is no need to
carry out extensive purification efforts. This 1s not to suggest that
the conventional methods should be abandoned, rather that tandem mass
spectrometric sequencing 1s a complementary technique.
What follows are short discussions of various topics - FAD,
collisional activation, and 11nk£~ scans for double focusing mass
spectrometers - that are relevant to the contents of this thesis, an
overview of the instrumentation and methods employed, and applications of
these methods. In Section II the first such application deals with the
confirmation of the amino acid sequences of both intracellular and
extracellular invertases, as predicted from the published DNA sequence,
and the location of the attachment of carbohydrate chains to asparagines
in the extracellular form of this enzyme. Studies on the fragmentation
of collisionally activated protonated peptides were made possible with
the installation of the JBOL BXIIO/IIO tandem mass spectrometer (Section
III). In particular, three previously unreported ion types were
characterized, two of which allow for the differentiation of the isomeric
amino acids leucine and isoleucine. Chemically stable positive charges,
or highly basic moieties, were found to have a significant effect on the
types of fragment ions observed in colilsionally activated derivatized
peptides. Baving defined the types of fragment ions observed, Section IV
describes tvo computer programs that aid in the interpretation of CID
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spectra of unknown pept1des in terms of their amino acid sequence. The
remaining sections provide examples of tandem mass spectrometric
sequencing of three bacterial and one mammalian thioredoxlns (small
proteins of MY 12,000).
1.2 Past Atom Bombardment Ionization
The ionization technique usually referred to as fast atom
bombardment <I> has provided a fairly simple method for the ionization of
large polar molecules. Samples are dlssol"~d in a liquid matrix, applied
to a sample probe tip, and bombarded by neutral atoms of several keY
translational energy. It is generally agreed, however, that there is no
difference between mass spectra derived from bombardment ~ith ions or
neutral atoms (22). Rather, the ~ost Sl~llficant aspect of FAD is the
use of a liquid matrix, thus leadl~! to the use of alternative terms such
as "liquid secondary ion mass spectrometry" (23). Since most practloners
still U3e the term FAB, as originally coined, "FAB" will be used
throughout the work described here.
The general Batrix require..nts for FAB are that the sample must be
soluble in the matrix, the matrix must not react with the sample (at
least not in an unpredictable _anner), Ions from the matrix should be as
unobtrusive as possible, the viscosity should be low enough to allow for
sample diffusion to the surface, and the matrix should be sufficiently
nonvolatile so as to provide a stable bo.bardment surface for the
d~ration of the mass spectral scan (24-25). Aside from these matrix
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requirements p the optimum matrix choice is largely a matter of trial and
error. The most commonly used matrix used for peptides has been
glycerol, perhaps with addition of an acid, e.g~, acetic acid. Addition
of thiols, such as th1og1ycerol or a eutectic mixture of dithiothreitol
and dithioerythritol (OTT/DTE; 5:1) seems to increase the sensitivity
for most peptides. Thioglycerol alone appears to be the best matrix for
larger molecules <)4000 u), but due to its greater volatility it 1s best
used with a coolable sample probe (26).
Although cations are no doubt simply desorbed by FAS, the mechanism
for the formation of <M+8)+ ions is not yet clear. The most widely held
theory is that molecules are protonated within the liqUid bulk and then
desorbed. Observations leading to this conclusion are that addition of
acids to the matrix enhances the abundance of the <H+8)+ ion (27-29>, and
that the bulk concentration of the protonated molecule in a number of
cases correlates with the abundance of the (M+8)+ ion observed in the
mass spectrometer (30-31). These observations are only correlations,
that do not refute an alternative mechanism where (H+8)+ ions are
proposed to occur In the gas phase or in a hot high pressure gas phase
region near the matrix surface. The formation of (M+8)+ in the gas phase
of the 10n source 1s suggested by the similarities between FAB and
chemical ionization (el) mass ~pectra, calculations indicating similar
source pressure requirements (32), and , most significantlys experiments
demonstrating that gas phase basicity is of more importance 1n ion
production than is solution basicity (33). There may veIl be more than
one mechanism involved in the formation of (H+8)+ ions. Due to this
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confusion, there is presently insufficient knowledge about the ionization
process to choose the optimum matrix on theoretical groundsg
There seems to be little doubt that surface activity has a
significant effect on the ability to ionize peptides by FAB. This was
first suggested when it was noticed that the FAB mass spectrum of a
tryptic digest of glucagon lacked a signal for the peptide encompassing
the first twelve amino acids (34). This idea vas fu~the~ developed when
correlations were made between the hydrophobicity scale of Bull and
Breese (35) and the response of a peptide mixtu~e to FAB analysis (36).
These results, in addition to observations made at HIT (37), support the
conclusion that in peptide mixtures hydrophobic peptides, which
presumably tend to be expelled onto the matrix surface, give greater
secondary 10n yields than hydrophilic peptldes dissolved within the
matrix. It has been proposed (36) that this effect can be reduced in at
least tvo ways. First, the peptldes can be derivatlzed in a manner that
increases overall hydrophobicity; in particular, the carboxylate groups
can be converted to alkyl esters. Alternatively, peptide mixtures can be
fractionated by reversed phase high performance liquid chromatography
CHPLe>, thus creating fractions containing peptldes of similar
hydrophobicity. Of course, reversed phase BPLC separates peptides based
on both hydrophobicity and size, so such fractionation may not eliminate
this problem completely. For instance, a late eluting fraction may
contain both small hydrophobic and large hydrophilic peptldes.
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I.3 Collision Induced Dissociation
Although there are other means of 10n excitation, e.g., collision
with a surface (38), interaction with a laser beam (39), or with an
electron beam (40), the most frequently used method is collisional
activation (41-43). It is also the oldest method, since it was before
1913 that J. Jo Thomson observed the collision induced dissociation of
H!- Ions (44). Not until much later In the late 1960's (45-46) did
collisional activation become of interest to organic mass
spectrometrists, and not until very recently were peptide ions
coillsionally activated (47-49).
Ions with translational energies of several keY impinging on a
target atom have interaction tices on a time scale of about one
vibrational period, c~ 10- 14 s. This leads to the conclusion that ern
is a two step process - ion excitation, followed by dissociation. The
dissociation step, being a unimolecular decomposition, therefore can be
described along the lines of the Qu&siequilibrium Theory <OET) (50),
which has as its basic assumption that the excess energy 1s redistributed
over all degrees of freedom prior to the slover dissociation reaction.
It is generally considered that collisional activation involves an
initial electron excitation, at least for smaller ions, tut it has also
been suggested that much larger ions, e.g., peptide ("+8)+ ions, are
vibrationallyand rotationally excited (51-52>. Regardless of the
excitation mechanism, according to the QRT, the excited ion will undergo
energy randomization, and eventual localization of the excess internal
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energy into a bond leads to cleavage. In addition to ClD, interaction of
an incident ion with a neutral target will give rise to other processes.
The ion can be deflected at an angle greater than the acceptance angle of
the mass spectrometer, and thus not be observed. Since the amount of
scattering is proportional to (ao/v)2 where at Is the ion-target
interaction distance and v is the Ion velocity, scattering can be reduced
by increasing the ion velocity or decreasing the target gas size.
Another important process Is charge exchange, where the target gas (g) is
ionized at the expense of the precursor ion (m+):
g + m+ -----) g+ + m
This reaction 1s inversely proportional to the ionization energy of the
target gas, and will be discussed in more detail later. Other less
important reactions are charge stripping:
m+ -----) mZ+ + e-
and charge inversion:
m+ + g -----) m- + g~
All of these alternative processes are in competition with ClD, thus
reducing the efficiency of fragmentation.
Its generally known that fragmentation efficiency decreases with
increasing mass of the incident 10n. The reason for this can be due
either to reduced ion excitation or to difficulties in the dissociation
of larger Ions (CID Is a two step process). From theoretical
considerations, it has been proposed that very large molecules will
primarily suffer the loss of small groups rather than undergo the more
useful sequence specific fragmentations <53). Further support indicating
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that dissociation dynamics are the primaI}· influence on CID efficiency
comes from Derrick, et ale (51) who report large translational energy
losses <about 20 eV) for colllsionally activated peptide ions.
Translational energy loss (~B) is the difference in kinetic energy of the
incident lon, m+, and the coillsionally activatEd ion, m+·. From
conservation of energy, ~E = 0 + E., where 0 1s the gain in ion internal
energy and E. 1s the energy gained by the target gas. By making the
common assumption that E. is negligible, it would seem as though a great
deal of internal energy is available for fragmentation. The fact that
larger ions do not fragment as easily would therefore indicate that the
reduced CID efficiency is due to the dissociation process~ This
conclusion has been disputed by Russell, et ale <54) who show from a
number of experiments that E. 1s not negligible, but accounts for 75 -
90% of ~E. Apparently, a good deal of charge exchange occurs with keV
ions. As an explanation, Russell suggests that the interaction time
between the incident ion and the target atom is too short to allow the
ion to necessarily maintain its charge. Given a long lived ~col11sion
complex", (m---g)+, the charge would predominantly be associated with m,
since it would have the lover ionization potential; however, this may
not be the case for a short lived complex. Thus, the suprl~ing
conclusion 1s that low translational energy Ions can rec1eve more
internal energy as a result of decreased charge exchange during
collisional activation. In addition to the correlation between incident
ion translational energy and charge exchange, Russell points to other
work on simpler systems suggesting that charge exchange increases with
increasing incident ion mass. Based on comparisons between
photodlssociat1on data and CID spectra he concludes that the average
internal energy gained upon collisional activation is more on the order
of 2.5 eVe
As discussed above, the major pathwAYs in competition with CIO are
charge exchange and scattering& Reduction of the ion target size and
increasing th~ 10n velocity reduces the latter process, thus He is most
commonly used as the collision gas. Increasing the ion velocity requires
higher accelerating voltages, magnets with large radial curvature, ~~d
high magnetic field strengths; the JEOL BXI10/110 has a maxl~ilm
accelerating voltage of 10 kV for ions up to 14,500 u. Theoretically,
the accelerating voltage for this instrument could be increased at the
expense of the mass range, since most peptides studied are of molecular
weight much b~low 14,000. This possibility has not been examined.
Charge exchange can be reduced by selecting a collision gas with high
ionization potential, so He (IP a 24.6 eV) again 1s the best choice. If
1n fact charge exchange decreases with ion velocity, then it may be
desirable to use slover precursor ions. This, however, would presumably
lead to an increase in ion scatter, and there would be a trade off. Thls
effect is not been examined here.
1.4 Linked Scans for Double Focusing Mass Spectrometers
FolloYing collision induced dissociation, the r2sulting product ions
are mass analyzed. This can most siBply be accomplished by scanning the
electric field follOWing the collision region. If the precursor Ion is
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mass selected prior to collision then such scans are known as
mass-analyzed i~n kinetic energy spectrometry (HIKES). If the fully
accelerated precursor 10n m.+, dissociates to the product ion mz+, the
field strength, EI , required to pass 1D1+ 1s £1 III (m1/ml)K., where XI
is the field strensth required to pass ml+. Such scans have often been
used with reversed Nler-Johnson instruments, where the magnet (B) selects
with relatively low resolution the precursor ion, which undergoes
collisional activation in the collision cell (ee) positioned betveen the
magnet and the electric sector (E). This scan is also used with three
sector instruments of EB[cc]E geometry, which can select the precursor
ion with higher resolution than a D~et alone. The problem with E-scans
are two fold. First, the resolution Is loy <about 100>; second, the
translational energy loss (~B) discussed previously may lead to incorrect
<low) mass assignments.
A better method for the mass analysis of eIO fragment ions involves
the simultaneous scanning of the magnetic and electric fields in such a
manner that the ratio of their field strengths Is constant - the BIE
linked scan (for a review of i-scans and linked scans see chapter 9 of
ref. 43). Since the velocities of both product and precursor Ions are
the same, the ra t los m1/m1 and B1/Bz are equal. Fur thermore, s 1nce ml/mz
equals El/Bz (from the E- scan) then 81/E. and 82/82 have the same
constant value. The value of this constant 1s dependent on the mass of
the chosen precursor 10n. The product ion resolution obtained in such
scans can be quite high, 1000 or better, and the mass assignments are not
greatly affected by translational energy loss~ However, when BIB scans
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are carried out using only tvo sectors (8 ~nd B>, the precurscr ion
resolution is love This problem is eliminated if the p~ecucsoc ion 1s
mass selected prior to collisional activation. Thus, with four sector
instruments, the precursor ion Is selected with the first double
focussing mass Jpectrometer (M8-1, consisting of I. and 8.),
colllsionally activated after K5-1, and a BIB linked scan is carried out
with the second mass spectrometer ("5-2, consisting of 11 and 81).
A second type of linked scan was also used in this work. The BllE
scan ·ransmits all ions that have been fully accelerated and which
decompose to a selected product Ion. This scan 1s complementary to the
BIB scan in that it gives a spectrum of all parent ions that dissociate
to the chosen product ion. If the product ion mz+ is formed from
dissociation of ml+, and 1s trans.ltted at a magnetic field strength B.
with a magnetic radius R and electric field E. of electric sector radius
r, then:
where e is the charge on the ion, and VI Is the veIocl ty of el ther m'l+ or
~+ (they are equal>. Combining these two equations give~:
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Therefore the ratio 82/B is deter.lned by the mass of the chosen product
ion -2+. S1'~h scans have characterlst1~ally low resolution (c. <100>
and employ only two sectors, B and I, for its operation.
These tvo linked scans - BIB ~ld 82/1 - can best be visualised by
conslder1ns the a-I plane sho~) in '1,. 1.1. In this example, an iOD.
-.+. of ..as 1000 dissociates to a product ion, .J+' of ..ss 500. The
line I. indicates a nor..l ...s spectrua where the ..,net B Is scanned at
a constant electric field voltage B.. The diagonal line shows the values
of B and B th~t are scanned for a BIB scan where ./z 1000 Is selected as
the precursor ion. Point X indicates the values of B and 8 for which the
CID fr.,.ent ion ma+ • 500 Is trans.itted. The parabolic curve indicates
the B2/1 scan of the daughter ion -2+. An ion signal detected when the B
and B fields correspond to position I, indicates that the precursor Ion
must be ./z 1000.
1.5 Alternative Instru.entation for HS/MS of Peptides
Despite the success of four sector mass spectromet~rs, as described
herein. for the sequen~lng of peptides and proteins of unknown structure,
the cust of such instruments provides an incentive for the development of
less expensive mass spectromters that have the potential for HPTHS, as
defined earlier. Discussion of such instrumentation 1s varr8fited here,
since in principle the origin of the data Is not 1mportant as long as the
quality of the data allows for the unambiguous structure determination of
peptldes, proteins, or whatever Is being studied. Currently ~he greatest
0.5
Pigure 1.1: B-1 plane d1asraa 111uatratina tbe 11~~ ==sns BJ/B
<parabolic curve) and BII (linear curve) :or the hypothetical
case of a precursor Ion ~+ (a/z 1000) disloclatins to a product
ion ~+ (./z 500>.
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success has been obtained using a triple quadrupole <000> m4sm
spectrometer (55), where the first quadrupole selects the precur50r ion,
the middle quadrupole serves as the collision region p and the last
quadrupole mass filters the resulting product 10ns. In this study,
however, precursor ions were selected 80 as to pass a mass window 3 - 9 u
vide through the first quadrupole, and the largest precursor ion vas of
mass 1486 u. Bence, despite the potential of triple quadrupole mass
spectrometers it remains to be seen whether they can attain the
performance of four-sector instruments.
Fourier transform ion cyclotron resonance (FT-ICR), aore commonly
known as Fourier transform mass spectrometry (FTMS) , has also been used
for MS/MS studies of peptldes. Such instruments employ a cell located in
a fixed magnetic field. Pulsed excitation causes the ions to move In the
cell in a ~ircular path perpendicular to the magnetic fleld~ This
motion, the frequency of which Is depend~~nt on the ion mass, induces an
oscillating voltage on a pair of detector plates. This signal is
recorded and Fourier transformed to give a mass spectrum. For "SiMS
experiments, all ions except the precursor ions are pulsed out of the ion
cell, the remaining ions are collisionally activated, and the product
ions detected. A major problem with this technique is that the low
pressures required for operation are incompatible with the prescence of
the liquid matrix required for PAB ionization. Therefore, if Fp~ is to
be used, the ions must be generated outside of the FTMS instrument and
injected into the low pressure Ion cell. This has been achieved using
tvo quadrupoles as a means of steering FAB ions generated outside the
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superconductlng magnet throUlh the masnetlc field into the cell. There
the precursor ions are mass selecte~ anJ, in this case, undergo laser
ph~tudissoc1atlon (56-57). This arrange.ent 1s still 1n an experimental
staa-, and its capabilities have yet to be explored.
Alternatively, ions can be formed without. liquid aatrix and thus
can be ,enerated within or near the ion cell. Laser desorption and
secondary ion ..ss spectomtry (SIMS) without a liquid aatrix have bean
used. The efficiency of such ionization is mueh less than for FAB uslns
a liquid matrix, but since FTMS can store ~nns for several second. it is
hoped that sufficient sensitivity can be obtained. Por ex..ple,
precursor ions generated by laser desorption and SIMS on solid samples of
gramicidns D and S were BaSS selected (2 u mass window), collisionally
activated, and the product ions detected (58,59). The resulting spectra
were, however, of such poor quality that they would probably not be
interpretable had they been derived from a compound of unknovn structure~
Despite these shortcomings, FTMS and 000 may in the future provide
spectra of equal quality to those obtained with four sector instruments,
and may eventually come under the catagory of high performance tandem
mass spectrometry.
1.6 Preparation of Peptides for Mass Spectral Analysis
The need for clean, salt-free samples cannot be overemphasized. The
presence of the ubiquitous sodium and postasslum cations, in particular,
give rise to ions corresponding to (M+Na)+, (M+K)+, (M-Bt2Naj+,
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(M-8+2I) +, etc., which complicates the spectrum. Furthermore, it
distributes the molecular Ion signal over several species, the
sensitivity decreases and for low saaple concentrations the molecular 1011
signals may not exceed the background chemical noise (15). Vith this in
mind, vacuum distilled, or otherwise h11h1y purified, matrices were used.
Sample purification generally involved reversed phase BPLC using Vaters
Associates H6000A pumps and a 660 solvent programmer, a Rheodyne 7120
injector, and a B.~~an 160 UV absorption detector monitoring at 215 nm.
Vaters wBondapack C-18 columns were generally used at a flow rate of 1.5
ml/min with a linear solvent gradient of B10/trifluoroacetlc acid (TFA)
(1:0.0005) to CH)CN/B~O/TFA (1:1:0.00042) over 30 min. Distilled vater
further purified with a ftHl11i-Q~" system, Baker BPLC grade
acetonitrile, and Pierce Spectrograde TFA were used as HPLC solvents.
Glassware vas cleaned using the phoshpate-free detergent, "RBS-pf",
obtained from Pierce Chemical Company, and rinsed repeatedly in "H1111-Q"
purified vater.
1.7 Instrumentation and Data Acquisition
The majority of the work discussed in this thesis involved work
carried out on the JBOL 8X110/110 mass spectrometer consisting of tvo
N1er-Johnson double focusing instruments ("5-1 and M5-2) in tandem (Fig.
1.2>. A JBOL FAS gun operated at 6 KV using Xe as the FAS gas va~
recently replaced by an Antek ces1u~ ion gun (60). The cesium gun can be
operated at a higher primary beam flux than the Xe gun, thus providing an
increase in secondary ion emission. The ion optics of the JEOL BXIIO
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spectroBeter employs vertical focusing by quadrupole lenses before and
after the electric field, thus 1ncreQsing ion transmission as veIl as
allowing for a smaller magnet ,ap, which provides an increase in field
strength. The total vertical aagniflcat10n is about 3, and the taBge
magnification <be.. width) 1. -0.5. Mas8 dispersion Is increased and
image aberration decreased by non-perpendicular aagnetlc fl~ld incident
and exit angles. Both "5-1 and "5-2 have mass ranges extending to 14,500
u at 10 kV accelerating volt.,e.. Off axis detectors <16 stage electron
multipliers preceeded by 20 kV post-accelerating electrod2s) are located
after the collector slits of M5-1 and MS-2, with an additional detector.
located after the electric sector of "5-2, thus allowing for acquisition
of MIKES spectra. The distance betveen the collector slit of "8-1 and
the entrance slit of "8-2 is 35 C_, and contains one of the off-axis
detectors, as veIl as a lens system to focus the ion beam into the
collslon cell. Also contained within this region is an ion source for
M5-2, which has a built in box type collision cell. This ion source
collision cell Is routinely used for the acquisition of CID spectra using
all four sectors, but can be replaced by a stand-alone collision ~ell
that can be electrically floated up to 9.9 kV above ground. All of the
HS/MS data described here vas obtained using the collision cell (kept at
ground potential) of ion source 2.
Calibration of "8-2 for BIB linked scans has been reported for this
(61) and another four sector instrument (62). Without getting into the
details of the alternate calibration method, it will suffice to say that
calibration of the JEOL instrument Is considerably simpler, easier to
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use, and provides -.as ass1gnaents of accuracy 10.3 u. In this method, a
alxture of halide salts - CsI, RbI, KI, NaI, and LiC} - are ionl~ed in
ion source 2. A nor..l B-scan of "S-2 and subsequent asslgnaent of the
masses observed provides a Ican tiBe vs. ..as calibration table. Vhen
the reference voltage for the electric ••ctor 1. scanned 11nearly~ tho
actual electric field also chanles linearly. This, however, 1s not the
case for a aasnet1c sector where the field does not re.~nd linearly, as
shown in Pig. 1.3. The calibration table is used to determine the
reference voltage offset that vould allow for a linear B scan.
Alternatively, the electric sector reference voltage can be offset by
following the nonlinearity of the aarnet. In either case, the ratio BIE
.ust be kept constant throughout the scan, otherwise ion transmission
through "S-2 drups and ..ss asslgnaent errors increase. In actual
operation, a precursor ion ..ss is specified, and the JBOL DA5000
software calculates frOB the tiDe/aass table the proper B and B field
reference voltage scans. The mass range of the scan usually starts
around 50 u and extends to several tens of mass units above the specified
precursor ion.
PABMS using the JBOL inst~nt vas carried out using H8-1 at an
acceleratlol voltase of 10 kV. S101le scans were typically acquired at a
rate to scan fro. m/z 200 to 3000 in about 2.5 .in with 100 Hz filtering.
Saaples were dissolved in glycerol at a concentration of 0.5-2.0 nmol/~l,
and 0.5-1.0 ul of the solution vas applied to a stainless steel probe
tip. One half microliter of 30% aqueous acetic acid alone or in
combination with 5:1 dlthlothreitol/dith1oerythrltol vas then alxed with
s·
Magnetic Field Reference Voltage (V)
'igure 1.3: The stra1aht line 1s the ideal case of a magnet
responding linearly to a r.feren~e volt.,_, wherea. the curved
~lne indicates the actual ..,netic field (ex&IIerated) when the
reference volt8le Is scanned linearly.
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the saaple on the probe tip. cesium iodide cluster ions - (CsI)cCs+ -
were used to calibrate MS-l.
PABMS/MS vas carried out using all four sectors of the BI110/110,
with collision induced dissociation in the third field free region
(between "5-1 and "5-2>. Bellu. vas used as the collision gas at a
pressure sufficient to reduce the precursor ion signal by 50-70%. The
spectra were recorded at 30 Hz filtering using the same scan rat~ as used
for PAlMS. Scan rates tylce as fast were later found to prOVide spectra
of equal quality 1f the filtering vas reduced to 100 Hz. The resolution
of "5-1 vas typically adjusted to trans.it only the I~ species of the
<"+8)+ ion, and M8-2 vas operated at a resolution of 1:1000. For
precursor ions of lov abundance and/or high mass <)2000 u), the
resolutions of both M5-1 and M5-2 were decreased so as to increase ion
transaission.
Precursor 10n scans (82/1) were obtained using "5-1, which for this
purpose vas calibrated using the alkali halide salt mixture. The source,
alpha, beta, and collector slits were positioned so that a normal magnet
scan would operate at a resolution of 1:30008 However, since this type
of scan does not have double focusslna properties, the actual precursor
ion scans were of much lover resolution (c. 100).
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Section II
Verification of the DNA sequence of the gene coding for invertase
In Saccharomyces cerep;Ji." and location of the si tes of
N-glycosylatlon in external invertase
11.1 Introduction
The role of glycoprotelns in such diverse processes as cell
recognition, -etastasls, antigenic specificity, and .odulation of protein
r~ceptors has been the subject of auch investigation. As a .odel for
glycoprotein synthesis, yeast has been recognized as prOViding a
sl.pllfied alternative to .....llan syste-s (63). The s1.ilarlties
between yeast and higher eukaryotlc N~llnked glycoprotein synthesis
encoapasses tbe initial transfer of GleNAc~Glc) fro. the
dollchol-pyrophosphate carrier to asparaglnes in the protein, and the
subsequent re.oval of three glucose and one mannose residues. In
particular, the enzr-e invertase, which catalyzes the cleavage of
sucrose, bas been used for studies on glycoprotein synthesis (64--66).
The work discussed here vas carried out for the purpose of locating anrl
quantitating the sites of glycosylatlon within this enzyme.
Invertase, isolated frOB the yeast Saccbaromyces cererisiae has two
forms - a glycosylated excreted for. (external invertase) containing ~O%
carbohydrate by -ass, and a non-glycosylated intracellular form (internal
invertase) (67). Both are derived fro. the SUC2 gene, but fro. different
start codons (68-69). It has long been known that a necessary, but not
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suff1c1ent p requirement for N-llnked protein glycosylatlon is that the
~educing end of the oligosaccharide be attached to an asparagine located
within the sequence -Asn-Xxx-Ser(or Thr)-, where Xxx can be any amino
acid except proline. The amino acid sequence of invertase as deduced
from published DNA data (70), reveals fourteen such potential
glycosylation sites (sequons) per subunit. However, it was found thcLt
excreted invertase contained on the average only nine to ten N-linked
oligosaccharide chains per subunit (71). Thus, it remained to locate
those sequons containing carbohydrates and the extent of their
glycosy'~tion, as well as verify the DNA sequence on which the primary
structure of the protein was based.
This goal vas accomplished by using two complementary methods -
FABMS analysis of reversed phase HPLC peptide fractions, and more
traditional techniques involving Edman degradations, amino acid analysis,
and glucosam1ne analysis following acid hydrolysis of sequon containing
peptides. To simplify the characterization of external invertase, the
majority of the N-linked carbohydrate chains were removed using
endo-p-N-acetylglucosaminidase H (Bodo H), which leaves only one
N-acetylglucosam1ne attached to asparagine (72). The amino acid
analysis, Edman sequencing, and glucosaalne analysis was carried out in
the laboratory of Dr. Frank Haley at the New York Department of Health
in Albany, NY, as vas the isolation and purification of internal
invertase and Indo B treated external invertase. The confirmation of DNA
sequences using FABHS, which has been descr1be~ in detail elsewhere (5),
involves proteolytic or chemical cleavage of the g~ne product and
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compa~ison of the observed molecular weights of the resulting peptldes
with those predicted from the DNA sequence. Errors in the DNA sequence
or post translational modifications can be recognized on the basis of this
datae The N-terminal amino acids of the proteolytic peptldes can also be
determined by comparing peptide molecular weights before and after manual
Edman cycles carried out on each BPLC fraction, thus providing furth~r
information. N-linked glycosylatlon sites were identified In Bndo B
treated external invertase by the increase in mass corresponding to an
attached N-acetylglucosamine (+203 u), or multiples thereof, in seq\lon
containing peptlrl~s. FABMS analysis vas carried out on both
non-glycosylated intracellular invertase and Endo 8 treated external
invertase. It was established that the published DNA sequence was
essentially correct, vith the exception that proline was found in place
of alanine at position 390 of the external invertase. This can be
explained by a single base change (Gee --) eCC). Furthermore, thirteen
of the fourteen sequons were found to be glycosylated to varying extent,
and one sequon was not glycosylated.
11.2 Materials and Methods
Internal invertase and Indo B treated external invertase were
provided by Dr. Frank Maley at the New York Department of Health,
Albany, NY. Internal invertase vas amplified in a !YRl strain of yeast
from a BindIII digest of the~ gene and purified (71). External
invertase was obtained fro. Boehringer-Hannhelm, purified by a
combination of DE-52 and Sephacryl 8-300 chromatography (71,73), and vas
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found to be homogeneous on SDS-gel electrophoresis. External invert85e
vas deglycosylated by dissolving 27 mg of the purified enzyme in 11 ml
water and denatured in a boiling water bath for 6 min. After cooling,
0.5 M sodium citrate buffer (pH 5.5) vas added to give a final
concentration of 0.05 M. indo B (110 .U) vas added and the reaction
mixture vas incubated at 37 oc. After 9 hours more indo B <gO .U) vas
added. After a total of 16 h incubation, the precipitated deglycosylated
protein was collected by centrifugation.
Approximataly 20 nmo] ~f internal invertase vas suspended in 0.5 ml
of 0.1 M NB4BCOJ and 0.1 aM caC12 and digested with
N-tosyl-L-phenylalanine chloro.ethyl ketone (TPCKJ treated trypsin (50:1
substrate/enzyme) at pH 805 and 37 OC for six hours. The digest was
brought to d~ess on a Savant Speed-Vac vacuum centrifuge, and
redissolved in 0.5 .1 of 50 aM sodl~ phosphate buffer (pH 7.8) and
digested further with Staphylococcus aurcus (strain V8) protease (50:1
substrate/en~e) at 37 OC for eight hours. Twenty nmol of Indo B
treated external invertase vas digested similarly. Another 20 nmol of
Indo H treated external invertase vas digested with ~-chyaotrypsin <100:1
substrate/enzyme) at pH 8.5 and 37 OC in 0.5 .1 of 0.1 MNB~BCO) and 0.1
mH caC1J for 30 min. Bach of these d1sests were partially separated by
reversed phase HPLC as described In section I. The BPLC traces,
including the fraction cutoffs, are shown in Figs. II.l-!Ie3.
The molecular weights of the partially fractionated peptldes were
deter.toed by PAlMS using a Varian-KAT 731 double focussing ..as
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P1pre 11.1: BPLC chro..tolr.. of .~. allreua (.train VB) proterbse digestion of
a tryptic di,est of internal invertase. The ..rklnas lndlcat~ collected
fractions.
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Plpre 11.2: BPLC cJlroutogr.. of S. aurea, (strain VB) protease
di.eation of • tryptic dlS..t of Bodo 8 treated external inv.rt....
The -.rklDlS indicate collected fractlona.
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treated external invert.... The ..rklD1I ln~lcat. collected
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spectrometer of Mattauch-Herzog geometry that had been fitted with an Ion
Tech saddle field ~AB gun (15,27). This instrument has a mass range
extending up to 2000 u at 8 kV accelerating voltage. The neutral x~ beam
produced by the PAD gun had a translational energy of 6-8 keY ~1th an
equivalen: ion current of 30-4~ ~A. Spectra were recorded with an
oscillograph on UV-sens1tive paper. Use of glycerol as the FAB matrix
provides cluster ions of known mass every 92 u starting at mass 93 and
extending in some cases beyond 1000 u, with low abundance ions at every
mass between the clusters. Nominal mass assignments were made by
manually counting up from one of the glycerol cluster ions. The q~mples
were typically dissolved in glycerol at a concentrat~on of 0.5-1.0
nmol/NI. One half to one ~1 of this solution vas mixed with 0.5 ~l of
30% aqueous acetic acid and placed on the probe tip. For peptldes of
molecular weights exceeding the mass range of the Varian-MAT 731 mass
spectrometer (m/z 2000), FAB mass spectra were obtained as described in
section I using the JROL BXIIO/BXIIO mass spectrometer.
Up to four manual Bdman degradation cycles were carried out on each
HPLC fraction with the molecular weights of the shortened peptides
determined by FABHS after each cycle, thdS identifying successive
N-tera1nal amino acids. Reaction of the i-aa1no group of lysine with
phenyllsothlocyanate during the first Edman cycle results in the addition
of 135 u to the truncated peptide and allows the nuaber of lysines in a
peptide to be determined. The manual Bdaan procedure was carried out
using the method of Tarr (74) .adifled for use in conjunction with FASMS.
Ten to twenty nmol of proteolytic peptides were reacted with 10 ~1 of
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phenyllsothlocyanate/pyrldlne/hexafluoroisopropanol (5:19:1) and 20 ~l of
25% aqueous trimethylamine/pyridine (1:1) under nitrogen for 3-5 min at
45 OCe The mixture vas extracted tvice with heptane/ethylacetate (2:1)
and twice again with heptane/ethylacetate (10:1). The raactants were
evaporated to dryness, and the phenylthiocarbaayl-peptides were cleaved
with 20 ul of TFA at 45 oc. An aliquot of the mixture vas taken for
FABMS analysis and the remainder evaporated before the next Edman
degradation cycle.
TFA, pyridine, heptane, ethylacetate, and phenylisothlocyanate were
obtained from Pierce Chemical Co., Rockford, IL. TPCK treated trypsin
was purchased from Cooper Biomedical, Malvern, PA~ S aureous <strain
Va) protease was from Hiles Scientific, Naperville 1 IL, a-chymotrypsin
was obtained from Sigma Chemical Company, St. Louis, MO, and
acetonitrile vas purchased fro. J.T. Baker Chemical Co~pany,
Phillipsburg, NJ. Glycerol vas vacuum distilled. All other material was
of the highest quality available fro. local suppliers.
11.3 Results
In this work, PAlMS was used both to verify the DNA sequence and to
locate sites of asparagine-linked glycosylation in external invertase5
The .ethodology entailed the treatment of denatured external invertase
with Bndo H to remove all of the associated N-linked oligosaccharide
chains except for one of the tvo N-acetylglucosamines in the core region
of the oligosaccharide which reaalns attached to asparagine in those
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sequons that are glycosylated (72). Peptides resulting from chemical or
proteolytic cleavage that contain these sites will therefore be 203 u (or
multiples thereof) higher in mass than the corresponding non-glycosylated
peptides. This is de.onstrated in the PAB mass spectrum of HPLC fractj.on
3 (Fig. 11.1) of a tryptic digest followed by S aureus (strain VS>
protease (hereafter SPV8) digestion of non-glycosylat2d internal
invertase shown in Fig. 11.4(a), and the FAB mass spectrum of HPLC
fraction 3 (Fig. II.2) of a tryptlc/SPV8 digest of Bodo B treated
external invertase shown in Fig. II.4(b). The ion at mass 996 in Fig.
11.4(a) corresponds to the protonated molecule ("+8)+ of the sequon
containing peptide Phe-Ala-Thr-Asn-Thr-Thr-Leu-Thr-Lys from internal
invertase. By comparison, the same peptide derived from Endo H treated
external invertase is found at m/z 1199, which is 203 u higher, and
therefore has an additional N-acetylglucosamine attached. This
observation demonstrates that this sequon 1s at least partially
glycosylated. A similar approach was described by carr and Roberts for
the location of glycosylatlon sites in tissue plasminogen activator (13),
but in this case peptide:N-glycosldase P vas used to release the
oligosaccharide. Since in this instance the N-linked asparagine is
converted to aspartic acid, there Is a mass difference of one between
corresponding Ilycouylated and unglycosylated peptides.
Thirty-seven peptides were detected by FABMS in a tryptic/SPV8
digest of internal invertase, and their .olecular weights determined from
the spectra.. They were matched with the .olecular weights predlct@d from
the ..lno acid se~uence deduced fro. the published DNA sequence of the
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corresponding gene (70). These peptides (Table 11.1> encompass 55% of
the sequenc~, and are distributed throughout the protein, indicating that
the published DNA sequence is essentially correct.
Similar treatment of external invertase with trypsin and SPV8
yielded the 34 peptides shown in Fig. 11.5, which covered 63% of the
amino acid sequence. Eight peptides containing ten of the fourteen
glycosylation sites vere multiples of 203 u higher in mass than that
calculated for the corresponding free peptide, and are therefore
glycosylated. The peptides containing N-acetylglucosam1ne are shown as
heavy lines in Fig. 11.5. A peptide covering positions 77 to 105
encompassed four potential glycosylation sites (Asn(78>, Asn(92),
Asn(93), and Asn(99», but only haa an additional mass of 3 x 203 u,
indicating that three out of four sequons were glycosylated per molecule.
Since another peptide encompassing positions 84 to 105 contained an
additional 2 x 203 u, it would appear that by difference Asn(78) is fully
glycosylated and of the three sequons in peptide 84-105, only two are
glycosylated. A solution to this problem is presented below.
To more clearly define the sites of glycosylation and to obtain more
complete coverage of the protein sequence, an .-chymotryptic digest vas
carried out on another sa-pie of Indo B treated external invertase.
Since «-chymotrypsin is a less specific protease, only those peptides
where two or more N-termlnal amino acids were identified by subtractive
Edman degradation are shown beneath the trypsin/SPV8 peptides in F1g.
11.5. Of the 45 peptides isolated, which included 58% of the sequence,
Table 11.1: Trypt1c/~~ aureus (strain Va) protease peptides from
internal invertase
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Amino acid
post tionl
("+8)+ 2 N-termlnal
sequence)
6-18 1511 (T-S-D-R) 4
19-32 1724
68-76 952 (0-0- P-JCL) 4
91-105 1760 Y-N..N
121-126 802 E-Q
127-136 1089 S-xL-D
140-151 1317 N-P·-V
155-163 1183
164-170 820 (V-xL) 4
178-185 940 (xL) 4
191-196 638 S
197-204 976 G-P
253-259 837 A
260-265 664 (V)4
294-304 1337
305-311 779 S-S-H-S
312-318 710 F-S
313-318 838
327-331 600 <xL-xL-N)4
332-346 1624
347-355 996 (F-A) 4
356-371 1684 A-N-S
374-386 1437 (xL-V-Y)4
377-386 1062 (A)4
398-403 659 G
398-407 1220 G-xL-E
404-407 580 E
412-421 1128 V-S-A
416-421 784 S-F
431-438 1040 E-N-P-Y
439-447 1064 (M-S-V-N)4
452-456 673
457-462 679 V-Y
451-467 1276 V
494-506 1516 (H-T)4
506-510 677 K
507.. 510 549 F
I The am1no acid positions correspond to those of external invertase.
1 Nominal mass
J xL represents the isomeric amino acids leucine or isoleucine, both of
which result in a mass difference of 113 u upon one cycle of Edman
degradation.
4 One lysine is present in the remaining unsequenced region.
---------- -
Pigure II~5: The amino acid sequence of external invertase. Peptldes
observed by FASKS are underlined; heavy lines indicate those peptldes
containing one or more glycosylation sites. Results fro. two
proteolytic digest are shown. Peptides derived fro. S. aureU$
(strain V8) protease digestion of a tryptic digest are directly
beneath the amino acid sequence, and a-eh~otryptlc peptides are shown
below the trypticlS. aur,us protease peptldes. N... terainal amino
acids that were identified by PAlMS in conjunction with subtractive
Edman degradation are indicated as half arrows beneath the peptide
lines. Potential glycosylation sites containing the sequence
Asn-Xxx-Ser(or Thr) , where Xxx is any ..ino acid, are overlined.
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three potential glycosylatl~n sites not found in the tryptic/SPV8 digest
were uncovered. Peptides containing Asn(247) and Asn(493) were found to
have an additional 203 u, and are therefore glycosylated as isolated. In
the case of Asn(256), however, peptides ~ncompassing this sequon vere
found with and without an attached N-acetylglucosa~lne, thus
demonstrating heterogeneity 1n glycosylation at this site. These
experiments also resolved an ambiguity concerning Asn(92), Asn(93), and
Asn(99), which from the tryptic/SPV8 digest discllssed above, were known
to be glycosylated at only two positions. The FA8 mass spectrum of HPLC
fraction 7 of the ~-chymot~:·pt1c digest of Endo H treated external
invertase (Fig. II.6(a» contains an ion at mass 989, which corresponds
to the <H+8)+ ion of Asn-Asn-Thr-Ser-Gly-Phe-Phe (positions 92-98> plus
one additional N-acetylglucosamine. A single cycle of Bdman degrada~lon
carried out on this BPLC fraction, gave the FAB mass spectra of the
trucated peptidas shown in Fig. II.6(b). The ion at mass 672
corresponds to cleavage of Asn-GlcNAc. A second cycle of Edman
degradation and FABHS analysis yielded an observed ion at mass 558,
demonstrating that an unmodified asparagine 1s located at the second
position from the N-termlnus. Therefore, Asn(92) is glycosylated and
Asn(93) is not. Thus, by difference Asn(99) should be fully
glycosylated. In confirmation of this conclusion, a chymotrypt1c peptide
covering positions 99 to 107 was found to be glycosylated.
In the course of these studies an apparent ~nomaly vas found at
position 390. In one Bodo H treated external invertase sample, a
prominent tryptic peptide <"+9)+ 10n vas observed at mass 1312, which
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corresponds to the peptide encompassing positions 387 to 397 with Ala at
position 390, as predicted by the DNA sequence. In a different external
invertase sample a <"+8)+ ion at mass 1338 was found, which corresponds
to the same peptide with Pro at position 390. A ern mass spectrum (Fig.
11.7) ustng all four sectors of the JBOL 8XI10/8XI10 mass spectrometer,
as described 1n section I, confirmed this replacement. The types of CID
peptide fragment ions observed and the interpretation of these spectra
are discussed in detail in sections II and III. These results are
interpreted as being due to differences between protein samples. Similar
findings were obtained by sequ2nce and amino ~~td analysis of a peptide
containing position 390. It should be emphasized that between the two
procedures - FABHS analysis in combination with Edman sequencing and
amino acid analysis - about 99% of the external invertase sequence vas
confirmed.
11.4 Discussion
Quantitation of the glucosamine associated with each of the sequon
containing peptldes, a procedure carried out at the New York Department
of Health, yielded the results shown in Table 11.2. The sequon
containing peptides were isolated from cyanogen bromide or tryptic
cleavages of Bndo B treat~d external invertase. The isolated pept1des
were hydrolyzed and the glucosamlne vas quantified on an amino acid
analyzer. From this data, In combination with the FABHS results 1 It is
apparent that some potential glycosylation sites are completely
glyco~ylated (sequons 1, 3, 4, 6, 10, 11, 12, and 13), others are only
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Table 11.2: Quantitatlon of glycosylations sites in external invertase l
Peptide Sequon GlcNAc Sequon
pos! tion1 number Peptide) number Sequence
-----~~-------~-~---------~------------- ~---~-------~--~---------
1-21 1 1.00 1 Asn-Glu-Thr
3-21 1 0095 2 Asn-Asp-Thr
24-87 2,3 1.37 3 Asn-Asp-Ser
36-76 2 0.59 4 Asn-Asn-Thr
77-87 3 0.84 5 Agn-Thr-Ser
88-105 4,5,6 1.93 6 Asn-Asp-Thr
108-166 7 0.55 7 Asn-Ser-Thr
220-259 8,9 0.57 8 Asn- Gly·· Ser
308-408 10,11,12,13 4.00 9 Asn-Glu-Ser
440-513 14 0.56 10 Asn-Gly-Ser
11 Asn-Thr-Thr
12 Asn-Ser-Thr
13 Asn-Thr-Thr
14 Asn-Het-Ser
I The data shown in this table vas provided by F. Haley of the New York
Department of Public Health.
2 The isolated peptldes were derived from either cyanogen bromide
cleavage alone, or in combination with tryptic digestion. The numbering
corresponds to the amino acid positions within external invertase.
J Ratio of N-acetylglucosamine per peptide.
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partially glycosylated (sequons 2, 7, 8, 9, and 14), and one (sequon 5>
is not glycosylated at all. The FAIMS data indicated the presence of
partial glycosylation at sequon 9 by the observation of both glycosylated
and unglycosylated pept1des containing this site. However, FABHS did not
indicate partial glycosylation at s~quons 7, 8, or 9. The reason for
this is not clear presently. From the results in Table II.2, the total
glucosamlne content of all of the sequons in a subunit of invertase would
appear to be about ten, which is coapatible with the reported value for
Endo B treated external invertase (71).
This data does not, however, address the distribution of the
glycosylated sites within individual molecules. The recovery of eight
sites w1th a N-acetylglucosam1ne per sequon ratio of unity indicates that
essentially all invertase subunits contain eight fully glycosylated
sequons, those of 1, 3, 4, 6, and 10 to 13. Heterogeneity in the subunit
population would result fro. the degree to which the five other sequons
are glycosylated (sequon 5 is not glycosylated). Two possible
distr1butiohS can be iaagined which would average about ten
oligosaccharides per subunit. Ope 1s that half of the molecules are
fully glycosylated at thirteen sequons, and the other half at only eight.
The second possibility is that there is a heterogeneous population
containing eight fully glycosylated sequons, plus randoa glycosylation at
the remaining five sites. It Is not possible at this time to distinguish
between these alternatives.
The fact that asparagine is required at the amino tar.inal end of
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the sequon -Asn-Xxx-Ser(or Thr)- and that serine or threonine is required
at the carboxy terminal end was shown on replacement of asparagine with
glutamine or aspartic acid and serine or threonine with vallneG In both
cases these changes prevented in vitro glycosylation (75). Proline, when
placed at the Xxx position also impaired glycosylatlon <75-76). This
information appears to have been confirmed on comparison of 196 potential
N-glycosylation sites in 105 proteins (77). In addition to proline it
vas found that there vas a lack of glycosylation in those sequons
containing glutamic acid at Xxx, and in contrast to earlier reports
(78-79), sequons containing aspartic acid at Xxx were found to be
glycosylated. External invertase is another example where the presence
of aspartic acid doe2 not interfere with glycosylation, for as indicated
in Table 11.2 and Fig. II.5, sequons 2, 3, and 6 are all glycosylated.
tile finding that sequon 1, a glutamic acid cOlltalning sequon, 1s
completely glycosylated appears to be an exception to the suggestion (77)
that glutamic acid containing sequons are not glycosylated.
Vhy sequons 1, J, 4, 6, and 10 to 13 appear to be fully
glycosylated, while sequons 2, 7. ~, 9, and 14 are 50% glycosylated or
less is not clear. In some cases it might be the nature of the amino
acid in the Xxx region, but except for proline (75-77) there does not
appear to be a correlation between the amino acid at Xxx and the extent
of glycosylat1on. Even when the same amino acids are lnvolved~ such as
in sequons 7 and 12 (Asn-Ser-Thr), the latter Is fully glycosylated while
the former is only about half that. It would seem therefore that the
amino acids proximal to the sequons or the nature of the protein
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conformation influences the extent of glycosylat1on. Another factor to
be considered is the impairment of glycosylation due to the overlap of
two sequons such as that encountered with sequons 4 and 5, where Asn(92)
is fully glycosylated but Asn(93) 1s not glycosylated at all. This
finding suggests that that the presence of the oligosaccharide chain on
Asn(92) sterically blocks the N-glycosylation of Asn(93). The prevention
of glycosylation at Asn (92) by converting it to aspartic acid via site
specific mutagenesis should enable Asn(93) to be glycosylated, if this
hypothesis is correct.
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se~tlon III
Collision Induced Pragmentations of Peptide Ions
II!.! Introduction
Throughout the development of mass spectrometry as a means of
analyzing peptides, the study of fr~ent ion types, and to a lesser
extent their mechanisms of formation, have naturally been crucial for
sequence determination. The characterization of fragaent ions has
continued to be of considerable importance in the study of collision
induced dissociation of <"+8)+ peptide 10ns. Most of the ion types
resulting fro. collisional activation have also been observed in the mass
spectra of peptides using field desorption (YO>, che.lcal ionization
(eI>, and FAB ionization. Thus, vhat follows Is a discussion of sequence
ion types and .echanlsas already proposed, particularly with respect to
what bas been observed using PAB ionization, with additional co..ents
based on observations described herein. Hore significantly, three
preYious~y unreported ion types - d., va' and v. ions - will be described
in the context of an entirely different .echanlsB of formation. In an
atteapt to alter the fragBeDtatlon of peptldes upon collisional
activation, a nuaber of peptide derivatives were prepared, all of which
involve the conversion of the ..lno group(s) of the peptide to either a
chemically stable positively charged Iroup or a highly basic moiety.
These derivatives include the conversion of the £-amino group of lysine
to a 2,4,6-tri.e~hylpyrldln1um salt, aa1dinat1on, and the coupling of
1I1.2
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~-guanidlnoproplonlc acid to the N-term1nal amino group of the peptides
using a vater soluble carbodl1m1de. The latter derivative, which vas
easily prepared and dramatically altered peptide fragmentation, may prove
to be of practical use in the sequencing of peptldes and proteins of
unknown structure. Finally, some non-sequence specific fragmentations
are described. All of this forms a basis for general rules for the
fragmentation of peptides, and methods of 1nterpretting CID mass spectra
of protonated peptides discussed in Section IV.
Materials and Methods
2,4,6-tri.etbylpyridlnlUB salts
The £-amino group of lysine was selectively converted to a
2,4,6-trimethylpyridinium salt.
NHI 2
(CH2)4I
-NH--CH-CO- + >
The procedure, which has been described by O'leary and Samberg (80),
involves dissolving 0.055 g of 2,4,6-trimethylpyry11um tetrafluoroborate
in 4.0 ml carbonate buffer (001 " lICO) and 0.1 H NaBCO) combined to give
a solution of pH 9). Upon dissolution, the pH dropped to 1 and was
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brought back to pH 9 using a dilute solution of KOB. The volume vas
adjusted to 5.0 ml using the carbonate buffer. 20 nmol of peptide was
dissolved in SO ~l of this solutiQn, vortexed, and the sample vial was
purged with nitrogen. The reaction proceeded for 18-24 hrs at room
temperature; fresh solutions were made each time derivatives were
prepared. Although yields are not precisely knOVD v no unreacted peptide
ions were observed in the PAB mass spectrA (for example. see Fig.
III.3).
~. J.1nat ion
Employing the suggestions of Makoff and Halcolm <81>, a procedure
vas devised for the am1dinatlon of the N-terminus of peptides.
NH
CH3-t-OCH3 + H2N-CHR-CO-
NH
-----...;) CH3-~-NH-CHR-CO-
20 nmol of peptide was dissolved in 100 ul of 200 mM triethapolam1ne
buffer of pH 9. Equal volumes of 200 mM methylacetimidate ~l'1 and 200 mM
KOH were combined and the pH vas adjusted immediately to 9. Yithin 2 min
of preparation, 100 wI of this solution was added to the
peptide/triethanolamine solution. The reaction proceeded at room
temperature for 2-3 hrs. Again the yields are not knOVD; however, the
protonated molecules for both derivatized and underlvatlzed peptides were
found to be of abodt equal abundance, indicating an estimated yield ot c.
50%. The lov yield was probably due to the fairly rapid hydrolysis of
the reagent (t l/2 == 55 min at 200 C, pH 8.8, arid 0.1 14 NaCl> c Presumably
the yields would increase by repeating the procedure several times.
However, since the <H+8)+ ion of the derivatlzed peptides were
sufficiently abundant for CIO analysis this vas not done. Nor was the
methodology optimized, since a simpler procedure for obtainil.l a
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different peptide derivative resulted 1n a much aore dramatic alteration
of peptide fragmentations.
~-&uanldlDC;=oplonylatlon
This derivative involved the coupling of ~-guanldlnopropionlcacid
to the peptide N-terminal amino group using a water soluble carbodiimide
(82).
NHNH2-~-NH-CH2-CH2-C02H + H2N-CHR-CO-
1
50 nmol of peptide vas dissolved In 500 ul of 1 M~-guan1dlnoproplon1c
acid; to this vas added 50 ul of 0.4 H
l-ethyl-3-<3-dimethylaminopropyl)carbodiimide hydrochloride, and the pH
was adjusted to about 4.5. The reaction proceeded for 1.5 hrs at room
temperature. Derivatization of lysine containing peptides yielded the
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observation that the dider1vatized (where both e-NBz and o-NBz reacted)
<H+8)+ peptide ion abundance vas less than 10% of the monoderlvatized
(G-NB1 only> <H+8)+ peptide ion abundance (for example, see Fig.
III.2Ib). The apparent lack of reactivity of the £-NB2 of lysine is
presumably due to the pKa difference between .-NBJ (pKa-S) and £-NBJ
<pKaz:lO.5).
Since FAB ionization is sensitive to sample contamination, all of
the peptide derlvat:l.ves were desalted using Sep-Pak. el. cartridges
followed by reversed phase ~PLC. All BPLC peaks, excluding the solvent
front, were collected as one fraction. The Sep-Pak cleanup alone, using
0.05% aqueous TFA and 60% acetonitrile with 0.05% TFA in H20 as solvents,
did not eliminate the extraneous material, but was used to avoid
overloading the el. BPLC column. The BPLC equipment and the mass
spectro~etrlc procedures were described in section I.
Peptldes, l-ethyl-3-(3-dimethylaminopropyl) carbodilmide HCI,
~-guanld!nopropionic acid, and methylacetlmidate BCl were obtained from
Sigma Chemical Company, St. Louis t HO. Sep-Pak. CII cartridges are a
product of Vaters Associates, Milford, HA, and 2,4,6-trimethylpyryllum
tetrafluoroborate vas purchased from Alfa Products of Danvers, MA.
III.3 Nomenclature
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Throughout the early 1980's when the initial experiments elucidating
the fragmentations of pept1des in FARMS were first published, many
different notations were used to describe the cleavages involved. Since
then Roepstorff and Pohlman in 1984 (83) proposed a generalized
nomenclature for the ions produced by clevages of any bond aIOL! the
peptide backbone, and this, or minor variations thereof (Scheme 111.1)0
has become fairly standard. This is a simple scheme, implying no
mechanisms or structures, where the ~~r~e possible peptide cleavages are
denoted as types At S, and C, If the charge resides N-terminal to the
cleavage site, or X, Y, and Z, if the charge is C-termlnal. If the mass
of the ion observed differs by one or tvo hydrogens from the fragment
produced by simple bond clevage the notation "+1" or "+2" is used <the
original suggestion was to use prime and double prime). Subscripts are
added to identify the amino acid position at which fragmentation takes
place. Thus, Y2+2 (or Y2") indicates a C-terminal ion resulting from
cleavage of the CO-NB bond of the second amino acid from the C-termlnus
with transfer of two hydrogens to that ion. B2 indicates aN-terminal
ion resulting from cleavage of the CO-NH land of the second amino acid
from the N-termlnus without hydrogen transfer.
This notation had been adopted at a time when less vas known about
the fragmentation of <H+8)+ ions produced by PAB from peptides.
Furthermore, the relative abundance of those fragment ions were quite low
and often part of a cluster of peaks. Th~ scheme allowed for the
Scheme 111.1
9 ~2 9 ~3 9 ~4
C NH CH t NH CH ~ NH CH-C02H
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classification of any potentially encountered fragment by simple bond
cleavage with the addition (for positive ions) or loss (for negative
ions) of 0-2 hydrogens. There are mainly tvo problems' with this
nomenclature: (1) The capital letters A, C, and Yare also used as the
single letter code for alanine, cysteine, and tyrosine which can cause
confusion when discussing or labeling the spectra of peptides. (2) If
there Is a series of ions present that involve the addition of tvo
hydrogens, the spectrum or the text becomes cluttered with repetitive
+2'5.
We have by now extensively studied the CID spectra of a variety of
peptides and arrived at a good understanding of the relevant
fragmentation processes. It turns out that the abundant N-terminal ions
due to cleavage of either the CU-CO or the CO-NB bond never involve the
addition of one or tvo hydrogens, whl1e t for example, C-terminal ions due
to cleavage of the CO-NB bond most frequently add tvo hydrogens. Thus,
it is not necessary to use a nomenclature that allows for all randomly
possible combinations of bond cleavage and hydrogen addition, but should
restrict it to those that are mechanistically feasible and practically
encountered.
For these reasons we prefer a slight variation of the
Roepstorff-Pohlman notation. Lover case letters eliminate the potential
confusion with amino acid symbols and the mechanism of fragmentation is
taken into account by assigning the symbol "cg " to the fragment formed by
addition of two hydrogens (formerly Cm+2 or Can) and similarly using "Yo"
73
instead of Ya+2 (or Ya") as sumaarlzed in Scheme 111.2. Table 111.1
relates this modification to the earlier notation.
111.4 Charge Induced Fragmentations
Nearly all mechanisms proposed for the fragmentation of peptides
ionized by FAB have involved heterolytic cleavage of bonds proximal to a
protonation site. Por instance, bo Ions are thought to result from
cleavage of an amide bond following protonat1on of the amide nitrogen
(15,84-86):
----~... -CeO+ + H2N-
bn
Thus, ml acyl Ion and a neutral amine are formed.
Fragment ions of type a. are generally assumed to result from loss
of carbon monoxide from ba ions leading to the formation of immonlum ions
(15,87):
-NH-CHR-C.O+
bn
This mechanism has been confirmed by c~llislonal activation of the b1
10~s found in the FABHS spectra of the peptides Phe-Leu-Glu-Glu-Leu and
~-lipotropln (1-10) which leads to loss of 28 u to give the corresponding
Scheme 111.21
N-terminal Ion Types
H-(NH-CHR-CO)n.l-NH-CHRn-CEO+
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Scheme 111.2 (continued)
C-terminal Ion Types
+O:C-NH-CHRn-CO-(NH-CHR-CO)n-l-0H
or
&=C::N-CHRn-CO-(NH-CHR-CO)n-l-0~H+
1S
Scheme 111.2 (continued)
Non Sequence-Specific Ion Types
Internal Acyl Fragment Ions (denoted by s~ngle letter code):
Internal Immonium Ions (denoted by single letter code - 28):
+H2N-CHR-CO-NH=CHR
Amino Acid Immoniurn Ions (denoted by single letter code):
lIons resulting fro. the loss of an ..lno acid side chain (or
porti~ns thereof) are denoted ("+B)+-R or simply -R,
where R is the sinlle letter code of the amino acid involved.
snaand Rnbare the beta substltuents of the nth amino acid.
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Table III. 11
C-terra1nal Ions
ZD' or Z +1 II.D) z +1D •
N-terminal Ions
B···> bD a
CD" or C +2 =::a) CD D
I Cleavage occurs at the nth amino acid from the C-t9rminus for
C-terminal ions, and at the nth amino acid fro. the N-termlnus for
N-termlnal ions. The nomenclature originally proposed by Roepstorff and
Pohlman suggested the use of pr1.e and double primes to indicate the
addition of one or tvo hydrogens. Since then it has become popular to
~ use "+1" and "+2" for this purpose. Ion types dD• VD~ and va (Scheme
111.2) have no equivalent notation in the Roepstorff-Pohlman
nOllenclature.
~ ions (Figs. 111.1 and 111.2). The presence In these spectra of the
amino acid immonium ions for phenylalanine (m/z 120) and leucine (m/z
86); and glutamic acid <m/z 102) and leucine <m/z 86)~ respectively,
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indicate that the precursor ions were indeed the anticipated b} ions and
not spurious matrix related ions, a possibility which always has to be
considered In this low mass range.
Such a structure for aD ions may explain why aD ions containing
C-termlnal glycine are either absent or at very reduced abundances,
because of the reduced stablizatlon of the unsubstltuted immonlum ioo;
-Co-+NB2-CB2• Perhaps for this reason glycine often introduces a gap in
an otherwise continuous series of aD sequence 10nso A good example is
the CID mass spectrum of substance P shown in Fig. 111.16. In this
case, the only significant ions are of the type ag alld da ; as can be
seen, a, is of much reduced abundance compared to the other aa ions.
Ions of type cg are thought to occur via a hydrogen transf~r to a
protonated amide; its not yet known, however, where the hydrogen is
transferred from (15,86-88):
RaI
H-C-RbI
-CO-NH2+-CH-CO- ---....;> -CO-NH)+
RaI
+ {;-Rb
CH-CO-
In a coaparison of PAS and collision induced fragmentations of peptides
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Figure 111.1: The CID -ass spectrua of the b2 ion found in th~ FAS MaSS
spectrU8 of Phe-Leu-Glu-Glc~Leu. The 10n at ./z 24301 corresponds to
bz-lS, whieh ..y be due to dehydration of the aatrix ion co.ponent of
the precursor ion.
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Figure 111.2: The CID .... 8pect~ of the ~ 10D found in tbe PAD ....
spectru- of '-llpotropln (1-10)
(Glu-Leu-Ala-Gly-Ala-Pro-Pro-Glu-Pro-Ala). The Ion at -'. 84.0 re.ults
fro. dehydration of the Iluta.i~ aeid l.-oniua 10D, .J_ 151.1
corresponds to 108s of slyeerol frOB tb. precursor 100, and -'z 225.2 Is
bl -18.
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(89), 1 t vas found that this ion type, although abUlldartt 1n FAD spectra,
are not often observed in CID spectra. The same study also noted that bo
ions were generally more abundant in CID spectra.
Ions of type Ya are also presumed to result from proton transfers to
a protonated amide (15,84-88):
---->. -NH-CRn+1=C=O
+
An interesting observation Is that Yo ions containing N-terminal
proline (proline at position R. above) are particularly abundant, whereas
Ya ions resulting fro. cleavages C-terminal to proline (proline at
position R4+1 above) are either absent or of lov abundance. The former
aay be due to the greater basicity of N-alkyl amides, which would result
in the increased likelihood of protonating such positions, and therefore
lead to enhanced cleavage. However, it should be noted that the Y4 ion
of N-llethyl-Leu7-D-Ala' luteln1111l1 hor.one releaslll1 hormone (LBRB)
(Fig. III.25b) is relatively s..11, thus arguing against increased
basicity of N-alkyl amides as the main cause of abundant Ya iDns
containing N-termlnal proline. The eecond observation can be explained
by .echanism 2, proposed by Kl~shLln, et al. (84), since proline at
position Rat. vould not prOVide the proton needed for transfer to the
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protonated amide.
+
In support of this mechanism, these authors found that a N-permethylated
peptide gave virtually no ~M ions in its eI mass spectrum. In agreement
with this is the observation that Y3 in the CID mass spectrum of
N-methyl-Leu7-D-Ala6 LBRB (Fig. III.25b), Y3 1s found to be of low
abundance. Another explanation for these observations could be that
proline introduces conformational effects, although its not clear how
this might operate. There is so.e precedence for this suggestion as
conformational effects involving proline were demonstrated In a d1ffer~nt
fragmentation involving the loss of & benzyloxy group from peptide
derivatives in FDMS (90). The absence of Ya ions at positions C-termlnal
to proline is generally not a proble. because either xo ' zn' or zn+1 ions
(all three, any two, or one) are present. These Ions plus an abundant Yu
ion at the next position, lndlcat1na proline, usually eliminates
~onfuslon. Occasionally ions corresponding to y.-2 are observed,
particularly 1£ the y g-2 ion has a N-ter.lnal proline. Such 10ns have
the presumed structure (86):
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In any event, a conclusive explanation of the effect of proline on Ym
ions has yet to be made.
111.5 Reaote Site Pragmentations
Since charge induced cleavage is typically invoked to explain
peptide ion fragaentations, it might be expected that they would not
occur If the charge vas fixed. Trimethylpyrldlnium peptide salts were
made by reacting the £-NB2 of lysine with 2,4,6-trlmethylpyrylium
tetrafluoroborate. Upon FAB ionization, these derivatives were desorbed
."
as the quaternary (unprotonated) cation (for simplicity and analogy
denoted ~)t hence providing a peptide ion with a f~.xed charga (Fig.
111.3). All of the peptide derivatives were found to undergo some degree
of FAS induced fragmen~atlon. This Is in cont~ast to a previous report
(91), where in a single example, a small alkylated quaternary ammonium
peptide salt resulted in no significant FAB fragments. From this one
experiment, the authors deduced that all PAS peptide fragmentation
reactions require protonation of an amide nitrogen. Although this
appears to be t~ue for this one example, their conclusion seems to be
invalid for the case of pyrldlniua derivatives (Pig. III.3)c
Collisional activation of Mt ions resulted in the CID mass spectra
shown in Figs. III.4b-III.7b; the CID spectra of the corresponding
underivatized peptides are shown in Figs. IIIe4a-III.7a. Since the CID
fragment ions for the derlvatlzed peptldes are not protonated, but carry
a fixed po~it1ve charge, the structures are slightly different from those
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shown in Scheme 111.2, so for clarltyp Scheme 111.3 depicts the proposed
structures of the fragment ions resulting from collisional activation of
pyrldinium peptide cations. Those peptides derlvatized at the N-terminus
(Lys4-renln tetradecapeptlde (4-14) and substance P (2-]}» gave
predominantly aD and dg type ions; neurotensln (1-6>, with a C-termlnal
derivat1zed lysine, gave a variety of C-term1nal fragments, and
physalaemin, with a dervatlzed lysine in the middle of the sequence, gave
both N and C-terminal ions. Its interesting to note that the latter
~
peptide derivative gave abundant Ions only if the particular fragment
contained the pyridinium group. Generally, this der1vati~e had the
effect of reducing the abundance of internal fragment ions and amino acid
Immonium ions, both of which apparently require amide protonation to be
observed in significant abundanceG In summar/, fragmentations can occur
remote from the charge.
It is the opinion of the author that the same remote site
fragmentations also occur when (H~B)+ ions of peptides containing basic
amino ac~ds are collisionally activated. It has previously been noted
(15,86) that the location of basic am1no acids within a peptide sequence
has an effect on the types of fragment ions observed in FAB mass spectra
of peptides. Tbis has also been found to be true for col11s1onally
activated protonated peptides; i.e., basic amino acids ~t the N-termlnus
induce the formation of N-termlnal ions, and basic amino acids at the
C-terminus induce the formation of C-terminal ions (92). For charge
promoted fragmentations to occur, the proton ~ould first ne~d to be
transferred to an amide nitrogen froM the basic amino acid side chain.
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P1IUre 111.4: (a) The CID .ass spectrum of substance P (2-11)
(Pro-Lys-Pro-Gln-Gln-Phe-Ph.-Gly-Leu-H~t-NBJ).The fr.,.ent Ions
correspond to tho•• shown in Sche•• 111.2. (b) The tID •••• spectrum of
the S-N-2,4,6-trl.ethylpyrldin1ua (THP+) derivative of substance P
(2-11). The fr.,..nt ions correspond to th~~e depicted in Schea. 111.3.
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Figure 111.5: Ca) The CID aass spectrum of Lys~renin tetradecapeptlde
(4-14) (Lys-Ile-Bis-Pro-Phe-Bls-Leu-Leu-Val-Tyr-Ser). The fragment ions
correspond to those shown in Sch... 111.2. (b) The CID ~s spectrum of
the 6-N-2,4,6-trlaethylpyrldlniua (THP+) derivative of Lys4-renln
tetradecapeptlde. The fraament Ions correspond to those depicted 1n
Scheme 111.3.
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figure 111.6: (a)The CID ..ss spectrua of neurotens1n (1-6)
<(Glu-Leu-Tyr-Glp-Asn-Lys)0 The frapent ions c.orrespond to those shovn
in Scheme 111.2. (b) The CID ...s speetru. of the
£-N-2,4,6-trlmethylpyridinlua (TMP+) d.rivatlva of neurotenaln (1-6).
The .ore abundant ions below ./z 180 are due to r..ote site
fragaentatlons involving the side chain of tb~ derivatlsed 1781n~. The
fras-ent Ions correspond to those depicted in Scheme 111.3.
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Figure 111.1: (a) The CID mass spectrum of physalaemi"
«Glu-Ala-Asp-Pro-Asn-Lys-Phe-Tyr-Gly-Leu-Met-NB1)~ The ion at m/z
323.2 corresponds to Pl~-17; the ion at m/z 620.3 ..y ~esult froM loss
of 17 u fro. b, (b. Itself Is not very abundant). The fr.,..nt 10ns
correspond to those shown in Seh..e 111.2. (b) The CID "IS spectrum of
the £-N-2,4,6-trlmethylpyrid1n1ua (THP+) derivative of physalae.in~ The
fragm~t ions correspond to those depicted in Scheme 111.3.
Yn:
Scheme IU.3'
tR aR bn nTMP+·······NH- H
TMP+·······NH-CHRn-CO-NH2
~HR a
TMP+•••••••NH-tH n
H2N-CHRn-CO······-TMP+
O=C=N-CHRn-CO-.G.---TMP+
HN=CHRn- CO·u-a•••TMP+
~HR aI nH-CO-----··TMP+
HN=CH-CO-NH-CHRn_1-CO··_·---TMP+
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lFtna and Rnb are tne beta subs~ttu'Cnts of the nth amino &cid.
TtIP+------- indic,ates the remaining portion of the peptide,
vilieh contains the trlmethylpyrid1niulli group.
90
The subsequent cleavages should not, therefore, depend on which end of
the molecule the proton came from, and the location of the basic group
would be irrelevant. If, on the other hand, a basic amino acid does not
r~adl1y transfer a proton, and fragmentations occur remote from the site
of protonat1on, such a mechanism would explain the aforementioned
observations.
Further evidence that <"+8)+ peptide ions can undergo remote site
fragmentations 1s found 1n the similarities between the CID spectra of
pyridlnlum peptide derivatives and underlvat1zed pept1des containing
basic amino acidso Compare, for instance, the CIO spectra of substance P
(N-terminal arginine) in Pig. 111.16 and the pyridinlum dei1vat1ve of
substance P 2-11 (N-terminal Lys-pyrldlntu~) in Fig. III.4b. Both
contain predominantly ions of types aa and doe Also, compare these
spectra with the CID spectra of under1vatlzed substance P 2-11
CN-terminal Lys) shown 1n Fig. 111.4a, where aD and dD 10ns are found in
the presence of other ion types. The lover basicity of lysine, as
compared to arginine, seems to allow some remote site fragmentations (aD
and do>' as well as charge induced cleavages (bD). Histidine, with a gas
phase proton affinity of 232 kcal/mole is comparable to lysine, which has
a gas phase proton affinity of 230 kcal/mole (93), and has a similar
eifect on peptide fragmentations. No gas phase proton affinity data 1s
available for arginine or any guanidino containing molecule. Based an
the solution ~h3se pKa's for the side chains of these amino acids
(Bis-6.0, !.ys=lO.5 p and Arg=12.S>, arginine should be 100 times more
basic than lysine. This vaJ.ue, however, is proba.bly not valid in the gas
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phase; witness the difference between the pRats of histidine and lysine
vs. their gas phase proton affinities. Nevertheless, arginine Is likely
to have a much higher proton affinity than either lysine or histidine.
For the aforementioned reasons, it 1s believed that remote site
fragmentations, first observed by Gross et ale (94) in the CID mass
spectra of fatty acid anions, can occur in col1isionally activated <M+8)+
10ns of pept1des containing sufficiently basic sites.
A plausible mechanism for these fragmentations is depicted in Scheme
111.4, where the initial step involves homolytic cleavage of either Ca)
the NB-CQ bond or (b) the ew-CO bond. Subsequent steps involve
elimination of UNCO from the resulting radical cations to form 8 Q+l or
zD+1, depending on the site of protonation CN-terminal or C-terminal f
respectively). Although there is no conclusive evidence that this
mechanism 1s operative, it would appear as though sufficient energy is
made available during the collision process to make this possible. It is
difficult to predict the energy requirements for this reaction, but it
would seem as though about 3.5 eV (roughly the bond strength of CQ-CO or
NB-Cm> is needed. This Is well within the range of internal energy
transfered to peptide ions upon collisional activation predicted by
Derrick (51-52>, and quite close to the value suggested by Russell (54)
(see section I).
With respect to energy requirements for remote site fragmentations
of peptides, it is of interest that very little fragmentation is observed
in the eIO spectrum of the monoderlvatlzed pyrld1nium salt of the cyclic
Scheme 111.41
RnI
-NH-CH. + O=C=NH
-NH-CHRn-CO--NH. + •CHRn+1-CO-NH-CHRn+2-CO-
·C·
a
a b
-NH-CHRn-CO-NHfCHRn+lfCO-NH-CHRn+2-CO-
b
Rn+2,
Q=C=NH + ·C-CO--
lThe fragments labeled "N" correspond to 8+1 Ions when the charge
Is N-termlnal to the cleavage slte. The fragments labeled "en
correspond to z+l ions when the charge is C-termlnal to the
cleavage site.
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peptide gramicidin S (Flge 111.8), where one of the orn1th1nes 1s
derivatized. This Is in contrast to the pyridinium salts of linear
peptldes (Pigs. III.4b-III"7b>, and to the CID spec~rum of the ("+6)+
ion of underivatized gramicidin S (Fig. III.9). Clearly there is
sufficient energy available to induce both remote site fragmentations in
linear der1vatized peptides, and to fragment <M+B)+ ions of cyclic
peptides. V1thout getting into details, fragaentation of <"+8)+ ions of
cyclic peptides involves first a charle promoted ring opening, similar to
the formation of b. ions, to give a linear acyl Ion: B~-----CO+. Amino
a~ids fro~ the C-terminus of this 10n are subseg~ently removed in further
fragmentations. In the pyr1dln1um salt of gramicidin S, the low energy
charge induced ring opening is not possible. Instead, the formation of
fr~ent 10ns would require tvo remote site cleavages, the first to open
the ring and the second to fora the fragment. The lack of fragmentation
in the CID spectrum of the pyrldinium salt of gramicidin S seems to
indicate that sufficient energy is not available for this to occur. This
is in agreement with Russell's argument (54) against Derrick's assertion
(51-52) that >20 eV of internal energy Is made available upon collisional
activation of peptide ions. Twenty electron volts of internal energy, it
seems, would certainly allow further fragmentation of the derivat1zed
gramicidin s.
In addition to meeting the energy requirements, this mechanism
(Scheme 111.4) also has the advantage that both N and C-terminal ions
resulting from the proposed fragmentations are observed in the CID
spectra of peptldes (see Schemes 111.4-111.8). As will be demonstrated,
Lpro-VaJ-Orn(TMP+)-Leu-Phe-PrO-Val-Orn-Leu-PheJ
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Figure III.8~ Tbe CID .... spectrUN of the 8onoder1vatlzed cyclic
peptide Ir..lcldin S, where a S-asino Iroup f~o. one of the orn1thlnes
has been converted to a 2,4,6-trl.ethylp~rldln1um cation (TMP+).
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The CID BaSS spectrum of the underlyatlzed cyclic peptide
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aD+l ions decompose to aD and do; za+ 1 decompose to va and zoG This
same mechanism also explains the formation of V o 10ns, although an
alternative process involving amino acid side chain losses must also be
considered. This also suggests an explanation for the observation that
ag+l 1s t~·pcally found at fairly low abundance, vhl1e zD+1 is often of
significant abundance. The proposed structure of zn+1 (Scheme III.4) has
a radical alpha to the amide carbonyl and would therAfore be stabilized,
compared to the structure of &D+1. Three of these ions - dDt vD• and vD
- have not been previously reported; their characteristics and
mechanisms of formation are d~~~ussed next.
III.S.a Differentiation of Leucine and Isoleucine by Cleavage of the
~.Y-bond of C-terminel Fragment Ions of Peptides
In the course of demonstrating the capabilities of tandem mass
spectrometry for the sequencing of pept1des and proteins, it was noticed
that peaks 54 u higher than that corresponding to ions of type Yo were
often observed. Similar results were obtained by Drs. J. T. Stults
and J. T. Watson at Michigan State University using BIE linked scans on
a two sector mass spectrometer. and a collaborative effort was therefore
undertaken to characterize these ions and ascertain their information
content. This mass increment implied the retention of a remnant of the
next N-terminal amino a~ld and would nominally correspond to the loss of
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the a-group plus tvo hydrogens from the next YD 10n as shown in Path A~
+~=CH-CO-(NH-CHR-CO)n+l-0.j •
These fragment ions were assigned the ~ntat.ion va (89). However, as CID
spectral data of a large nu.ber of peptides of known sequence (95) as
well as those derived from proteins of unknown sequence accumulated, it
became clear that this fragmentation process 1s much more dependent on
the nature of the N-terminal ..lno acid of the fragment ion than is the
case with the other sequence-specific ions (aD' ba , Co' Xg • Ya ' and Zg>,
which involve only the cleavage of a bond along the peptide backbone
(Scheme 111.2). Most notable vas the absence of VA ions when aromatic
amino acids, glycine or alanine were involved, or those that carry a
substituent on the ~-carbon, such as valine, isoleucine, and threonine.
For the latter three, ions were observed at higher mass corresponding to
the retention of one of the substltuents at the ~-carbon. This
observation suggested that formation of va ions involves the cleavage of
the ~,Y-bond because such a fragmentation VCJld be diff~cult for aromatic
amino acids where it would require cleavage of a CHz-Ar bond. It also
would cause retention of the substltuents at the ~-carbon, but not at the
N-termlnal nitrogen atom. Furthermore, path A vas ruled out on the basis
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of exact mass measurements made at Michigan State in the normal FAS mass
spectrum of two peptides that exhibited va ions of sufficient abundance
(Table 111.2).
A B2/1 scan of neurotensin (1-6) (sequence No. 4 in TaLle III.3),
where the product iOIi vas specifi'd as m/z 607.3 (the Wi ion), gave a
broad peak characteristic of this scan (Fig. 111.10) around m/z 650.
82/1 scans, as discussed in section I, shov precursor ions that when
fully accelerated decompose to the specified product 10n. This mass
indicated that either Zs or zs+l ions (the resolu~i~n of these scans 1s
not sufficient to distinguish ions one mass unit apart) can decompose to
the Vs 10n. Two pathways CB or C) could account for the formation of wn
ions fro~ either zG or zo+1 as outlined in the case of N-termlnal leucine
in Scheme 111.5.
Of these, path B 1s intuitively less likely because it vould require
the elimination of CB~ or 0 in the case of valine or threonine,
respectively. The decision in favor of path C vas finally made by the
determination of the CID spectrum of a za and a zg+l ion that was
reasonably abundant in the normal FAB mass spectrum of flbrinopept1de A,
(sequence No. 31 In Table 111.3). When m/z 741.4 (z.> was selected by
H5-1 of the JEOL BlIIO/BlIIO four sector mass spectrometer, no signal at
m/z 699.3 corresponding to VI vas observed (Fig. III.lla), but the eID
spectrum of m/z 742.4 (z.+l) (Fig. III. lib) exhibited a strong signal at
m/z 699.1, proving the validity of path C.
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Table III.3: Partial listing of pept1des used 1n the study of wD ions.
The amino acids that giye rise to these ions are underlined.
1. Tyr-Gly-Ile-Arg
2. Gly-Gln-Leu-Lys
3. Leu-Thr-.¥a.l- Ala- Lys
4. <Glu-Leu-Tyr-Gl,u-Asn-Lys (Neurotensin 1-6)
5. Tyr-Gly-Gly-Phe-Leu-Lys (Leucine Bnkephallne-Lysln~)
6. Val-Gly-Ala-Leu-Ser-Lys
7. Trp-Q£.§.a-Gly.. Pro-Cysa-Lys
8.. Ac-Pro-Gln-Thr-Glu-Thr-Lysb
9. Val-Hls-!&y'~Thr-Pro-Val-Glu-Lys
10. Val-B1s-Leu-Thr-Pro-Val-Glu-Lysb
11. Ac-Gln-Ala-Ala-Phe-Val'-Asn-Ser-Lysb
12. Tyr-Gly-Gly-Phe-Het-Arg-Gly-Leub
13. Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg (Bradykinin)
14. Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe
15. Pro-Pro-Gly-Phe-~-Pro-Phe-Arg
16. Asn-Gly-Glu-Val-Ala-Ala-Thr-Lys
17. 1&!!-Gln-Gln-Ile-Gly-Ala-Leu-Lys"
18 • N- Formy1-nLeue-J&.!.l- Phe-!lI&llc-Tyr- Lys
19. Gly-Il~-Pro-Thr-Leu-.l&Y.-.l&Y.-Phe-Lys
20. Thr-Thr-~-1l[-Gln-Thr-~-Glu-Lys
21. Ser-Ile-Pn-Thr-Leu-bl-Leu-Phe-Lys
22. Pro-B1s-Pro-Phe-Bls-Phe-Phe-Val-Tyr-Lys
23. Ser-BIR-BIR-BIR-BI2-Thr-Byp-Val-Tyr-Lysb
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Table III.3 (continued)
24. Val-Asp-Het-Val-Val-Gly-Ala-Val-Pro-Lys
25. Pro-Lys-Pro~Gln-Gln-Phe-Phe-Gly-Leu-Het-NH2
26. Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Het-NB2
27. Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Het
28. Leu-Asn-Ile-Asp-Gln-Asn-Pro-Gly-Thr-Ala-Pro-Lys
29. Ser-Ala-Ala-Ala-G)~-Val-Thr-Asp-Ser-Thr-Phe-Lys
30. Tyr-Gly-Gly-Phe-Het-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr
31. Ala-Asp-Ser-Gly-Glu-Gly-Asp-Phe-Leu-~la-Glu-Gly-Gly-Gly-Val-Arg
(Fibrinopeptide A)
32. <Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-GLu-Ala-Tyr-
-Gly-Trp-Het-Asp-Phe-NB}
33. N-Formyl-Val-Gly-Ala-Leu-Ala-Val-Val-Val-Trp-Leu-Trp-Leu-
- Trp- Leu- Trp- NBCHzCH20B(Val-l gramicidin A)
• carbamidomethylated cysteine
b BIE scan with EB - two sector instrument
c nLeu = norleucine
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Scheme 111.5
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A particularly illustrative example is shown in Fig. III.12, which
represents the CIO spectrum of a tryptic peptide
(Gly-Ile-Pro-Thr-Leu-Leu-Leu-Phe-Lys, No. 19 in Table III.3> derived
from the redox protein thioredoxln isolated from E coli (96). Although
it is some.hat atypical, because it exhibits a contiguous series of Vo
ions (from w) to va) it serves to illustrate the information provided by
this fragmentation process. The important regions of the spectrum are
expanded in Flgs~ III.13a-g. Table l1I.4 lists the experimentally
determined values for the w3-WS ions as well as those calculated based on
~~th c.
Figure Il1.13a demonstrates the absence of a w2 ion (at m/z 201~1),
which would require the cleavage of a CB2-C68s bond (path C). Figures
III.13b-d show the w1• v4 , and w5 ions due to the e11m1natj,on of the
isopropyl radical from the side chain of leucine. Figure III.13e
illustrates the multiplicity of the w6 ions at m/z 701.6 for the cleavage
of the C~-OB bond (v6e ) and m/z 703.6 (V6b) for the cleavage of the
C~-CH3 bend (in those cases where the ~-carbon is substituted by two
groups of different mass, such as threonine and isoleucine, tvo va ions
are sometimes observed and they are labeled VOl and wnb by increasing
mass). The peak at m/z 688.6 1s a va type fragment, and is discussed
later in Section III.S.c. The peak labeled W6L (m/z fd.=675.5,
calcd.=675.46) in Figs. 111.12 and III.13.e is due to the z6+1 ion that
eliminates the side chain from the next C-terminal amino acid (Leu-S),
possibly through formation of a ring rather than a double bond (the side
chain lost is that of the amino acid indicated as the single letter
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Table III.4: List of wn ions in Figure II1.12
106
m/z(fnd.) m/z(calc)
Til 348.2 348. 18
w4 461.3 461.26
"'s 574.4 574.35
v6a 701.5 701.45
W6b 703.5 703.43
w, 788.~ 788.48
via 899.8 899.55
W&b 913.8 913.56
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subscript>:
\Ie have made the observation that this "secondary" va-type cleavage,
while not frequently observed, mainly occurs when the N-terminal amino
acid of zD+1 is of the type that cannot undergo cleavage of the ~,Y-bond,
such as with aromatic amino acids, and when the next amino acid 1s one
that readily cleaves at the ~,Y-bond, such as leucine or glutamic acid
(see also Fig. III. lIb).
Figure 11I.13£ is an expanded view of the region where the w7 ion is
observed which corresponds to the loss of the "side chain" of proline.
For this cyclic amino acid, homolytic cleavage of the N-C bond does not
lead to fragmentation; i.e., does not lead to a normal 2 a+l ion but
still permits further cleavage of the ~,Y-bond to form the V o ion:
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Figure III.13g expands the region around the WI ion group, which
involves the cleavage at isoleucine. In agreement with path C, the w1a
ion is found at m/z 899.8 Cealed. 899.53> and there is no significant
signal at m/z 885.5 (arrow in Fig. III.13g>, which should be observed if
the amino acid at this position were leucine. In addition, there is also
a peak (W1b) at m/z 913.9 resulting from the elimination of the ~-methyl
group.
The above ~epresents a detailed discussion of the characteristics of
we ions and the conclusions that can be ~r~~ from their mass, 1f
present, or from their absence. Table 111.3 (p. 99> is a partial list
of the large number of CID spectra that have been accumulated. A
significant Vo ion i~ obse~ved for the underlined amino acids. To be
representative, a number of peptides are included that do not exhibit any
Yo ions, although their elo spectra exhibit other abundant fragment ions.
chiefly of the type aD' ba • and YD. A number of conclusions can be drawn
from the presence or absence of this ion type 1n these sequences. The
most important of these is the fact that a basic amino acid at or near
the C-termlnus seems to be required for the formation of reasonably
abundant va ions. An interesting example is the pair of pept1des (No, 26
and 27 in Table III.3>, which indicates that a basic amino acid must be
part of the va Ion to trigger its formation, because only Pro-2 but
neither Pro-4, nor Gin-S, Glu-6 or Leu-tO give rise to a Vo ion.
Presumably the proton shown above the brackets in Scheme III.5, Path C 1s
attached to the basic side chain; the process thus involves remote site
fragmentation. Table III.3 also supports the statement made at the
109
Figure 111.13: Expanded regions of the spectrum shown in Fig. 111.12.
(a) the arrow points to the absence of the Vz ion (m/z 201) that would
have to be produced by cleavage of the CHZ-C6H5 bond of Phe in position
8; <b)-(d> cover the regions in which peaks due to ions v)-WS appear;(e) the complex set of peaks due to the multiplicity of va ions produced
by threonine; <f> the region around v7 and Y7; (g) the region that
permits identification of the amino acid in position 2 as isoleucine
rather than leucine; the arrow points to the location of wa If leucine
were in this position.
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outset that aromatic amino acids, glycine, or alanine do not exhibit this
fragmentation.
Of importance is the confirmatory aspect of the presence or absence
of a vD ion corresponding to amino acids at the N-terminal positions of
these ions, indicating the presence or absence of amino acid~ that
possess a readily cleaved ~,Y-bond. Furthermore, the m/z value of va
ions allow the confirmation of the position of amino acids substituted at
the ~-carbon, such as valine or threonine. The most significant aspect
of the fragmentation process discussed here is the possibility of
distinguishing leucine from isoleucine in peptldes that give rise to
C-terminal ions. This complements the similar significance of dD ions,
discussed in the follOWing section, observed for peptides that favor
retention of the charge on N-terminal fragments. A note of caution
should be added, hovever,because the fragmentation of a ~,Y-bond of a
side chain of an amino acid next to that representing the N-terminus of
the fragment may occur. The work discussed in this section (Section
111.5.a) has been published (97).
III.5.b
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Differentiation of Leucine and Isoleucine by Cleavage of the
~tY-bond of N-terminal Fragment Ions of Pept1des
Preliminary reports from this laboratory (89) have demonstrated that
in some cases, CID spectra of pept1des exhibit a type of N-terminal
fragment ion that allows leucine to be differentiated from isoleucine.
Specifically, ions 28 u or 42 u below an aa ion identify the N-terminal
amino acid of that aD ion as being isoleucine or leucine, respectively.
In this report, it vas further noted that glutamine, glutamic acid,
asparagine, and aspartic acid each may give rise to similar ions at
masses 57 u, 58 u, 43 u, anJ 44 u below the corresponding a~ ions.
Recently, a different laboratory, using similar instrumentation, made the
same observations and denoted these ions as being of type "0" (98)~ In
keeping with the use of lower case letters, "do" will be used instead.
In the previous re~orts of this ion type (89,98) it was tacitly implied
that it involves the elimination of part of the side chain as an olefin
(path D in Scheme II1.6). A detailed investigation of the structure and
mechanism of formation of da ions revealed that this is not the case and
that path E 1s operative. Tbis result also allowed for a rational
approach toward peptide derivatizations that would enhance the abundance
of these 10ns.
Precursor ion scans C81/E scans), where the magnetic (B) and
electric (E) sectors are scanned simultaneously keeping the ratio 82/E
constant (the constant being dependent on the mass of the product ion
chosen), were carried out using a number of da ions as the product ion to
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search for the corresp~nd1ng precursor 10n(s). A representative scan 1s
shown in Fig. 111.14, where the ds ion at m/z 522.3 of substance P vas
selected as the product ion. The major peak in this scan is in the
region of m/z 580 sugg~sting that as or as+l are the major ions that
decompose to d5• The resolution for this type of scan is not sufficient
to distinguish between these two possibilities. Two d1ff~rent pathways
can be postulated for the formation of dg ions from either an (path D) or
aQ+l <path E) as shown in Scheme III.6 for leucine. They are analagous
to those shown in Scheme 11185 for the formation of we ions. The radical
c!imination of path E is intuitively favored since path D would require
the elimination of CB2 or 0 for the formation of do ions from valine or
threonine, respectively. The decision in favor of path E was made based
on the CID spectra of a number of aa and aa+1 ions found in the normal
FAB spectra of several peptides. Representative of these are those shown
in Fig. III.lSa-b, where m/z 579.4 (as) found in the FAB mass spectrum
of substance P was collisionally activated to give the spectrum shown in
Fig. III.15a; the CID spectrum of m/z 588.4 (a5+1) Is shown in Fig.
III.ISb. The ds ion (calcd. mass 522e35> is not observed in the CIO
spectrum of as' but an ion at m/z 522.3 , corresponding to ds' is present
in the CIO spectrum of as+l, thus proving the validity of path E.
The CID spectrum of substance P shown in Fig. III.16 is
particularly illustrative of this type of fragmentation. It should be
noted that dD ions cannot form via path E from those ao+l ions containing
the cyclic amino acid proline at the C-terminus. This is in contrast to
zn+1 ions containing N-termlnal proline, which can form wo ' as was
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Scheme 111.6
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previously discussed. In agreement with path E, no d} or d4 ions are
found in Fig. 111.16.
Ions of type 8 0+1 with C-terminal lysine or glutamine will both
eliminate radicals of mass 58 u, as 1s represented by the 10ns d), ds•
and d6 in Fig. III.16. In the former case, an unstabilized primary
radical is eliminated, whereas glutamine eliminates a resonance
stabilized primary radical. Thus, it may be expected that do ions
resulting from cleavage of the ~,Y-bond of glutamine would be more
abundant than that from lysine. This is the case for substance P
(compare dJ with ds and d6). Although it cannot presently be stated
conclusively, this may be a way of mass spectrometrically differentiating
these isobaric amino acids. A tentative rule can be stated: if the
ratio do/aD is greater than one, glutamine is present; if do/an is less
than one then lysine is present. Further detailed studies are required,
however, to see how this rule holds up.
As discussed previously, cleavage of the ~~Y-bond in aromatic amino
acids is not favored and thus provides an explanation for the lack of Wo
ions for such amino acids~ This proves true for do ions, which also
require cleavage of this bond, as can be seen by the relatively low
abundance of d7 and d. in Fig. 111.16. The region around d7 is shown
expanded in Fig. III.17. In addition to d7 is an ion labeled d7Q in
Fig. III.I7, which is due to the 8 7+1 ion eliminating the side chain of
the next N-terminal amino acid (GIn), possibly through the formation of a
ring:
07+ 1-RQ
°7
w
(.)
z
«o
z
:=>
CD
«
w
>
I-
:5
w
0::::
d7Q
d7
760 780 800 820 840 860
m/z
Figure 111.17: An expanded region surrounding d7 of the mass spectrum shown in Fig.
II1.16. t--
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RAP n-1
H+ I
f I CH2 • CHRn
H-(NH--CHR-CO) 2-NH-tH ~H
n- " /
C
+ 11.an 1 0
-.. R~0-1
The amino acid side chain lost is indicated by the single letter
subscript. These secondary do ions are analagous to the secondary va
cleavages described before, and are most frequently observed when the
C-terminal amino acid of ag+l is of the type that does not readily
undergo ~,Y-bond cleavage.
Although not directly related to the dn type cleavages, the ion
marked a7+1-~ at mass 783 1n Fig. III.17 was of concern during the
study of the CID spectrum of substance P. A B2/8 sc~n gave a broad peak
at m/z 1275 indicating that the precursor ion was of tha type (HtB)+-RQ
<calcd. mass 1275.69), or an ion at a nearby mass. Collisional
activation of the FAB generated ion m/z 1275 gave the spectrum shown in
Fig. 111.18, demonstrating that the ion of mass 783 (Fig. 111.17) is
derived from this ion. The proposed mechanism for the formation of
a1+1-RQ is shown in Scheme 111.7. Its believed that the side chain of
one of the glutamines is eliminated, via a homolytic cleavage of the
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Figure 111.18: The eID mass spectrum of ~/z 1275.7 (Ka+-R ) found in the FAB mass
spectruB of substance P - Arg-pro-Lys-prO-Gln-Gln-Phe-Phe-81Y-LeU-Het-NB1 (No. 1 1nTable III.6). t-'
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Scheme 111.7
Rein RPheI I[H+]···a···NH-CH-CO-NH-CH-CO-NH-CH-CO-
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oc ,~- bond. The resu~ t1ng radical cation may then induce the seCOi£~'
cleavage, possibly via a d1radlcal cation. Although the process depicted
in Scheme III.7 leads to the formation of a seven member~d ring (because
of an intervening amino acid residue>, an analogous process involving
adjacent amino acids may occur, thereby forming a four me~bered ringe So
far, this is the only instance where an ion of type <H+B)+-R is
demonstrated to be a precursor for subsequent cleavages. Its poss1ble~
however, that additional cleavages will be found; e.g., znt1-R, etc •.
Cleavages of this type probably need additional energy beyond that
required for the more typical fragmentations (an' ba , etc.), which
explains their relatively low abundance. The ion aa+1-RQ of Fig. III.16
is formed by the same process from (M+U)+-RQ (see also Fig. 111.18).
Finally, the dlO ion in Fig. III.16 is found 42 u below BIO • The
presence of this ion and the absence of an ion 28 u lover than a10 proves
that leucine rather than isoleucine occupies this position. The dlO ion
resul ts from the elimination of an isopropyl radical from the a1o+1 ion.
A number of aD and aD+l ions with various C-terminal amino acids
from several peptides were collisionally activated. In all cases, only
the ag+l ion decomposed to form the corresponding do ion, thus adding
further proof to the mechanism of path E. These results are listed in
Table Ill.5.
Table 111.6 is a partial list of the large number of CID spectra
used in the study of dg ions. A significant dn ion is observed for the
Table 111.5: Presence or absence of d. resulting from collisional
activation of an and 8 a+l ions found in PAS spectra.
1 2 3 4 5 6 7 8 9 10 11
Substance P CArg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Het-NB2)
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tJrecursor ion ,
a)
8 1+1 d]
8 4
a..+l
as
8 s+1 d,
8 6
8 6+1 d6
1 234 5
Arg-Lys-Glu-Val-Tyr
Precursor ion ~
a)
8 J+1 dJ
8 4
8 4+1 d4
lxecursor 10n .da
8 7
8 7+1 d" ci 7Q
,,~
8.+ 1 de
Il4)
~+1
ale
8 10+1 d.o
1 2 345
Lys-Val-Ile-Leu-Phe
Precursor 10ri sJ.
8 J
a J+1 d)
8 4
8 4+1 d4
~-llpotropln (1-10) (Glu-Leu-Ala-Gly-Ala-Pro-Pro-Glu-Pro-Ala)
Precursor ion ~
8 2
1 234 5
Phe-Leu-Glu-Glu-Leu
Precursor ion ~
a2
•
•
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underlined amino acids. To be representative, a number of pept1des are
included that do not exhibit any dA ions, although their CID spectra shov
other abundant fr.,.ent ions. Prom this table it can be seen that the
presence of a basic 881no acid N-ter.lnal to the cleavage site seems to
be required for the formation of reasonably abundant da ions. This
conclusion is in agreement with that which would be predicted from the
mechanism of path I, and suggests a aethod for enhancing the formation of
da ions. Prom all these data one can predict that relatively abundant da
ions viII be for.ed for amino acids that contain an aliphatic substituent
c: the ~-carbon (except proline), but not for aromatic amino acids,
alanine, and glycine. A basic aaino acid N-term1nal to the primary
cleavage site is a prerequisite.
Scheme 111.6, path F, also illustrates how aD could be formed from
aa+1. This mechanism requires the presence of a ~-hydrogen for
elimination, and thus explains why aD ions with C-terminal glycine, which
lack this hydrogen, are of particularly low abundance (~ in Fig.
111.16). This is not to imply that the aforementioned immonium structure
for aD ions is incorrect, nor that the ~echanism involving elimination of
CO from acyl Ions (ba) is wrong. As vas shown previously (Pigs. III.l
and 111.2), collisional activation of bg ions lead to a loss of 28 u,
which is best explained via the formation of the a. 1.-onium structure.
Rather, it seems as though there are tvo ways of forming an' and that
there are two aD structures, namely the remote site fragmentation of path
P and the charge induced fragmentation involving an acyl precursor ion.
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Table 111.6: Partial listing of peptides used In the study of the or1aln
of dg ions. The underlined amino acids give rise to significant dD ions.
1. Arg-I-~-~ys-Pro-~-~-Phe-Phe-Gly-~-"et-NB2 (Substance P)
2. Arl-.Ln-~l!-XI!-Tyr
3. Lys-y.&!-!k-1&ll-Phe
4. Arg-Tyr-J&J.l-Gly-Tyr-.I&Y.-Glu
5. Val-Bis-Leu-Thr-Pro-!Il-i!K-Lys
6. Pro-Bls-Pro-Phe-His-Phe-Phe-iI!-Tyr-Lys
7. Lys-A=d-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg (Lya-bradykinin)
8. Lys-Ile-Bls-Pro-Phe-H1s-~-~-YIl-Tyr-Ser
(Lys4-renin tetradecapeptlde (4-14»
9. <Glu-Ala-Asp-Pro-Asn-Lys-Phe-Tyr-Gly-~-Het-NBz(physalaemln)
10. Phe-Leu-Glu-Glu-Leu
11. Glu-Leu-Ala-Gly-Ala-Pro-Pro-Glu-Pro-Ala (~-lipotropln)
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It could, therefor~, be argued that since there laay be two ao
structures, the above collisional activation studies involved only the
non-lmmonium a~ ion (path P, Scheme 111.6). Therefore, it may be
possible that a properly chosen immonlum aD ion would, upon collisional
activation, undergo the mechanism of path D. However, the CID spectra of
the &1 10ns of Phe-Leu-Glu-Glu-Leu and ~-lipotropin (1-10), shown in Figs
III.19a-b indicate that this Is not the case. The amino acid immonlum
ions at m/z 86, m/z 102, and m/z 120 demonstrate that the FAB generated
ions selected for collisional activation ~ere 8 1 ions and not unrelated
matrix ions. Since ~oth of these 8 J Ions do not contain basic amino
acids, they are likely to be of the immonlum structure. As can be seen,
neither of t~.em lose 42 u as would be predicted from path D.
Altering fr~tat1oDS via derivatizatioD of pept1des
Based on the mechanism of path B for the formation of dD ions, it
would appear that placing a strongly basic group at the N-terminus of a
peptide would enhance this process. Such a derivative ought to favor the
remote site fr~entat1ons that lead to aD and dD and therefore inhibit
the charge induced fragmentations leading to 10.1S such &5 bD- The first
derivative tested involved amldlnation of the N-termlnus (81). The rapid
hydrolysis of the reagent, methylacetimidate hydrochloride, required
ca~eful control of pH and immediate use of the prepared reagent solution.
The procedure (see section Il1.2) did not provide a co~)lete reaction;
nevertheless, there vas sufficient signal upon FAS ionization to obtain
the CID spectrum of the amidlne derivative of ~-llpotropln (1-10) shown
131
(a)
F
LJ(J
z
~
z
::>
CD
<
UJ
>t=
:5
LLJ
a:::
L
60 80 100 120 140 160 180 200 220 240
ml'z
(b)
w
U
Z
c(
0
z
=>
CD
oc(
w
>~
:5 L
w
a::
E
2202001801601008060 120 140
m/z
Pigure 111.19: (a) The CID -.ss speetrua of ./z 233.1 (al ) found in the
FAB mass spectrua of Phe-Leu-Glu-Glu-Leu. (b) The CID mass spectrum of
_/z 215.1 (At) found in the PAB ..a. speetru. of B-llpotropln (1-10)
(Glu-Leu-Ala-Gly-Ala-Pro-Pro-Glu-Pro-Ala).
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in Fig. III.20b. Comparison with the CID spectrum of the underlvatized
a-lipotropin (Pig. III.20a) shows that the increased basicity does
enhance the formation of aD and da ions.
A sl.pler derlvatlzation procedure involving the coupling of
~-guanldlnoploplonlc acid to the N-ter.lnus using a v8ter soluble
carbodi imide (sea sec t lo~. III. 2) provided the means of a t ta~hlng a Vl2~Y
ba~ic moiety (a guanld1no group> to the N-teralni of peptides. Pigure
III.20c shows the CID spectrum of o-N-~-guanld1noprop1onyl~-llpotropln
(1-10). As can be seen, the further increase in basicity of the
N-terminus over either the free peptide (Fig. III.20a) or its amidine
derivative (F1g. III.20b) has the effect of greatly 1ncraasing the
abundance of ag and da ions.
From the derivatization of lysine containing peptides one can deduce
that the N-terminal aEino group reacts in preference over the £-NH2
group. For example, the FAB mass spectrum of derlvatlzed
Val-Bis-Leu-Thr-Pro-Val-Glu-Lys (Fig. III.21b), the monoderivatlzed
<H+8)+ ion (m/z 1035.5) Is approximately ten times more abundant than the
diderivatlzed (H+8)+ Ion (m/z 1148.5). The CID spectrum of the former
(Fig. III.22b) de.onstrates that the N-terminus, rather than the £-NBz
group, Is modified in this reaction. (This Is exactly opposite behavior
from the reaction of lysine with 2,4,6-trimethylpyrylium
tetrafluoroborate.) The introduction of the N-terminal guanidino group
has a major effect on the fragmentation of this peptide, as can be seen
by comparison with the CID spectrum of the unmodified peptide in Fig.
(a)
Glu - Leu -Ala - Gly-Ala.- Pro - Pro -Glu - Pro -Ala
Ys
PEP
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Plgure 111.20: (a) The CID .... spect~ of underlvatlzed _-llpotropln
(1-10) (Glu-Leu-Ala-Gly-Ala-Pro-Pro-Glu-Pro-Ala). (b) The CID aass
speetru8 of the .-N ..ldlne derivative of _-llpotropln (1-10). (e) The
CID .... spectrua of .-N-'-suan1d1noproplonyl _-llpotropln (1-10).
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I1l.22a. It should also be pointed out that the normal FAB
fragmentations are also affected upon der1vatlzatlon (compare Figs.
III.2~a-b), suggesting that the same fragmentation mechanisms described
here for collision induced dissociation also applies for FAB induced
dissociations. Figs. III.23'-b and III.24a-b show further comparisons
between underlvatlzed and derivatized Phe-Leu-Glu-Glu-Leu and
Pro-His-Pro-Phe-B1s-Phe-Phe-Val-Tyr-Lys, respectively.
These experiments provide further evidence for the occurrence of
remote site fragmentations in collision induced ~.d PAS induced
dissociations of peptides; i.e., use of this derivative made it possible
to observe the effect on peptide fragmentation of adding a basic group to
a peptide. S. A. Hartin has also observed the effect of removing basic
groups, using Edman degradations to cleave arginine and other amino
acids, on FAB and CID fragmentations of pept1des (15,92>. Similar
results were obtained, suggesting again the possibility that remote site
fragmentations occur in both FAB ionization and CID of peptides.
Although the studies described here primarily involve the fragmentation
of (H+8)+ peptide ions upon collisonal activation, its believed that
these results may also apply to PAS induced fragmentations.
It should be pointed out that In addition to the mechanistic uses of
this derivative, it may prove helpful in more practical applications.
For instance, a peptide lacking appropriately positioned basic amino
acids may, upon collisional activation, give neither da nor Wo ions
required for the differentiation of leucine and isoleucine. Such a
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Pigure 111.21: (a) The PAl 8888 speetrum of underlvatized
Val-Bls-Leu-Thr-Pro-Val-Glu-Lys. <b) The ,AI aass spectrua of the
reaction mixture result1nl fro. '-guanldlnoproplonylation of the same
peptide. The arrow points to the ("+8)+ ion Gf the bis-derivative.
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Figure 111.23: (a) The CID mass spectrWl of Phe-Leu-Glu-Glu-Leu. (b)
The CID mass spectrum of the a-guanidinopropionyl derivative of the same
peptide.
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Figure Ill.24: (a) The CID mass spectrum of
Pro-Bis-Pro-Phe-Bis-Phe-Phe-Val-Tyr-Lys. <b) The CID mass spectrum of
the .-N-~-guanldlnoproplonylderivative of the same peptida.
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peptide could be derivatlzed, thus inducing the forlnatlon of do. Or in
certain cases, the CID spectrum of a peptide may not provide an
unambiguous sequence; by derivatizing the peptide, a different set of
sequence ions could be generated, thereby resolving the ambiguity.
Furthermore, use of this derivative for eIn studies induces cleavage
between the first and second amino acids and thereby allows for the
sequence determination of the two N-termlnal positions.
Cleavage of the ~,~-bond of C-terminal Fragment Ions
of Pept1des
The remaining ion type to be discussed has proven to have a
particularly elusive mechanism. Nevertheless, its presumed structure and
general characteristics, with respect to the conditions under which it
forms, have been determined. In this case, ions 55 u higher than that
corresponding to ions of type Yo were observod. This mass increment
corresponds to the loss of the R-group plus one hydrogen from the next Yn
ion as shown below:
·(R~+H)
patn C
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Being a C-terminal ion, it seems reasonable to assign these ions the
notation va.
Table 111.7 provides a partial list of peptides that upon
collisional activation give these 10ns. Those amino acids for which a
significant vn ion were observed are underlined. It vas noticed that
aromatic amino acids (including histidine> as veil as amino acids
containing a functional group or an additional aliphatic group at the
~-carbon produced the most prominent vn ions. Furthermore, it became
~pparent that a basic amino acid C-terminal to the point of cleavage was
required to trigger this fragmentation, thus suggesting the likelihood of
yet another remote site fragmentation mechanism. Although the underlined
amino acids provided the most abundant va ions, it seems as though other
amino acids may also result in these ions <but at a reduced abundance),
and are therefore not underlined in Table III.7. Since most other amino
acids produce much more abundant va under the conditions that promote V o
ions, vD ions (at a nominal mass equal to va+l) are often overlooked.
Two observations indicate that the structure depicted 1n path G is
correct. First, exact mass measurements of v6 • v
"
and v. ions found in
the FAB mass spectrum of D-Ala~lutelnlz1ng hormone releasing hormone
were consistent with this structure CTable III.S). The reference ma3S
for v6 was the I2C doubly charged molecular ion, (M+ 29) 2+ at m/z 598.8,
and Y7 (m/z 762.4) was used for both v7 and v.. The presumed structure
of Y7 was used to calculate this reference ~ass~ The use of y, for this
purpoae seemed reasonable since YD Ions ver~ found throughout the
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Table 111.7: Partial listing of peptldes used In th2 study of the origin
of va ions. The amino acids that give rise to abundant va ion8 are
underlined.
1, Val-Gln-Tr2-Leu-His-Asn-Glu-.xAl.-Gln-Leu-Pro-,Am-A!a-Arg-Bis-Ser-NB1
2. Val-Gln-Trp-Ile-B1l-Asn-Glu-YIl-Gln-Leu-Pro-AsQ-A!l-Arg-B1s-Ser-NHz
3. 'Val-Gln-Tr2- Leu-lli-Asn-i!Y.- Val-Gln- l1e- Pro- Asp-AlJ.-Ara- 615- Ser- NU}
4. Glu-Bls-Trp-Ser-I.I!:-Gly-Leu-Arg-Pl'o-Gly-NHz
5. <Glu-~~-Trp-~-~-Gly-Leu-Arg-Pro-Gly-NB2
6. <Glu-Ris-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly
7. <Glu-Bis-Tt2-~-~-Ala-Leu-Arg-Pro-Gly-NBz
8. <Glu-B1s-Trp-~-II£-Ala-(N-He-Leu)-Arg~Pro-Gly-NBl
9. Ala-A12-~-Gly-Glu-GlY-AlR-lhl-Leu-Ala-Glu-Gly-Gly-Gly-Val-Arg
10. Ala-Asp-Ser-Gly-Glu-Gly-Asp-Phe-Leu-Ala-Glu-Gly-Gly-Gly-Val
11. Thr-AlR-~-Lys-Glu-Gly-Glu-Phe-lll-Ala-Glu-Gly-Gly-Gly-Yil-Arg
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spectrum. Second, the small v4 ion at mass 383.3 In the ern spectrum of
~AlaLLHRB (Pig. 111.25a) was shifted by 14 u in the CID spectrum of
N-Me-Leu-D-Ala6-LHRH (Fig. III.25b). The regions of interest in these
tvo spectra have been expanded and are shown in Figs. III.26a-b.
Although these ions are not very abundant, this result clearly
illustrates that the structure of va includes the amide nitrogen. (It
should also be noted that w4 is of the same mass for these two peptides,
as expected, providing further proof that wg ions do not contain this
nitrogen.)
Evidence indicating the mechanism of formation of these ions was
gathered using the same precursor-~roduct ion studies described for da
and va. The BZ/E scan for v6 of D-Ala6-LBRH gave the spectrum shown in
Fig~ III.27. Unfortunately, no particular precursor ion Is promlnent t
rather a number of small peaks corresponding to lhe regions around Y6'
x6 ' Z7' Zit zQ' Ma+-Ry, and the ("+8)+ ion itself are observeds The 10ns
marked C were present in the same scan using a blank glycerol sample, and
are not related to v6• Collisional activation of FAD generated fragment
ions provided the data summarized in Table 111.9. Column tvo of this
table lists the ratio of the abundance of v6 resulting from the
collisional activation of the 10ns listed 1n column one, over the
abundance of the precursor ion. It would seem as though nearly all of
the ions decomposed to v6, although to varying extents. However, there
seems to be some preference for Y6 P x6+1, and z7+1, which is in agreement
with the B2/8 scan of Fig. III.27. The ion Ma+-Ry In the FAD mass
spectrum was of too low abundance to obtain a useful CID spectrum.
Table 111.8: Exact mass measu~ement of va 10ns found 1n the FAD mass
spectrum of D-Ala~lutelnizlnghormone releasing hormone.
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10 9 a 7 6 5 432 1
<Glu-81s-Trp- Ser-Tyr- (D-Ala) - Leu-Arg·· Pro-Gly- NHz
Elem comn of VA ion
Cz484,N'd06
C3)8'~1I0.
C36Bs.,NazOIO
caw mass
567.3367
730.4000
817.4321
"eud MSS
567.3384
730.4026
817.4328
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Pigure 111.25: (a)The CID ..ss spectrua of D-Al.~lutelnlz1nlhOr8one
releaslnl hormone - <Glu-Bls-Trp-S8r-Tyr-(D-Ala)-Leu-Ars-Pro-Gly-NB1
(No. 7 In Table 111.7). (b) The CID .... spectrua of
N-.ethyl-Leu7-D-Ala~lutelnlz1nlhOrBone releasini hor.one -
<Glu-Bl.-Trp-Ser-Tyr-(D-Ala)-(N-"e-Leu)-Ar~Pro~Gly-NBJ (No. 8 in Table
111.7).
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The same set of experiments were carried out for va_ The B2/E scan
for this ion (Fig. 111.28) also showed small peaks in the regions
corresponding to y., XI' and ("+8)+, and had a relatively larger peak at
a mass corresponding to either 2 9 or Ma+-Rw• Collisional activation of
Ma+-Rw (m/z 1066>, Z9 (m/z 1068>, and z9+1 (m/z 1069> demonstrated that
Ha+-Rw and zg+l both decompose to VI to about the same extent.
Although these Ion studies were not as conclusive as those for dD
and wa ' it appears as though Ya , xD+l, and za+t+1 more readily dissociate
to VD. Other ions do likewise, but to a lesser extent. It has also been
demonstrated that ions resulting from loss of an amino acid side chain
may also lead to V o ions. As a result, a number of mechanisms can be
envisioned and are depicted in Scheme 111.8. The fact that this process
favors aromatic amino acids as well as those that have functional groups
or aliphatic substltuents at the ~-carbon suggests that at some point the
R-group is eliminated as a radical (such a radical would be more stable
than those for other amino acids). The observation that a variety of
precursor ions lead to va' without anyone predominating, also suggests
that at some point the side chain is eliminated as a radical. Those vg
ions originating fro. za+t+1 may result from the mechanism of path H of
Scheme III.S. This scheme also shows possible mechanisms for the
formation of va 10ns originating fro. Ya • xD+l, and CM+H)+-Rae In short~
the ability of the .,~-bond to undergo homolytic cleavage seems to be of
importance in the formation of Vge
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Figure 111.27: The precursor lon scan (IJ/I) of D-Ala-LBRH (No. 7 in
Table 111.7), where -'z 567.4 (v,) vas chosen as the product lon~ The
ions labeled G were found 1n blank scans us1D1 Ilycerol alone. The
saal1 peak aarked --Y· indicates loss of the tyrosine side chain fro.
the (M+B)+ ion. The r...1n1na labels lnd~eate the ion types that are
located in the 11&88 rqlons of each peak.
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Pigure 111.28: The precursor ion scan (B2/1) of D-Ala-LBRB (No. 7 in
Table IIIA7), where ./z 817.4 (v.) vas ehosen .. the product 10D. Th.
iona labeled G were found In blank sean. uslna Ilyc.rGl alone. The peak
..rked R_V· lndlcat.. 10•• of the t~ptopban side ehaln fro. the (M+B)+
10n (the 10DS z. and _.+ 1 are _180 In this IIU. rqion). The rmut.1n1nc
labels indicate tbe Ion type. that are loeated 1n th..... rac10na of
each peak.
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Table II1.9: Summary of CID spectra of precursor ions that give rise to
V6 (m/z 567.3> of D-Ala~lutelnlz1nghormone releasing hormone.
Abundance ratio
Precursor- of v,/precursorb
--------- -----------------
Z6 0.0
%6+ 1 0.0
Y6- 2 0.0
Y6- 1 005
Y6 1.0
x6 0.0
x6+1 0,8
v7 0.4
Z7 0.4
z7+ 1 0.7
• FA! generated Ions at masses corresponding to the following ion types
were ma~s selected and collisionally activated.
b The peak height of m/z 567.3 (v,) found In each CID spectrum was
divided by the peak hei,ht of each precursor lon, as measured from a FAB
spectrum of D-Ala6-LIIlUIct Bach CID spectrWl vu obtained at the same
electron &ultipller set tins.
Scheme 01.8
Rn+1 Rn H+
I I f ~
• CH-CO-NH-CH-CO-\NH-CHR-CO n-l-0H
zli+,+l
path H
Rn+1 H+
tH=C=O + "Rn + NH=CH-CO-~H-CHR-Cqn-l-0H
Vn
o Rn H+
II I ~ ~
• C-NH-CH-CO-\NH-CHR-CO n-l-0H
xn+l
path I
co + ·Rn + NH=CH-co-tNH-CHR-C~n.l-0H
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Scheme 111.8 (continued)
H Rn H+
I I '( }NH-CH-CO- NH-CHR--CO n-1-0H
Yn
path J
H-Rn + NH=CH-co-tNH-CHR-C~n-l-0H
Vn
Rn+1 Rn H+
I I If )
-NH-CH-CO-NH-CH-CO-\NH-CHR-co n-l-0H
(M+H)+
path K
Rn+1 H+
I • ~ ,
-NH-CH-CO-NH-CH-CO-\NH-CHR-CO n-l-0H
(M+H)+"Rn
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R 01"+1 11
-NH-CH-C- + NH:CH-CO-'(NH-CHR-CO}n.,-0H
Vn
sequence are also observed in the CID spectra of pept1des. Those that
IIIc6 Miscellaneous Ions
Certain types of ions not directly related to the amino acid
II
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can potentially create some confusion 1n data interpretation are of the
type generally referred to as "internal fragment" ions. Previously
observed in FAB spectra (87), these are of the structure shown 1n Scheme
111.2. The C-terminus is an acyl ion, and the N-term1nus 1s a Yo type
cleavage. Because of the tendency of proline to induce Yo cleavages,
internal fragment ions containing N-terminal Pro are frequently of
significant abundance, the ions labeled PT, PTL, etc. of Fig. III.12
are good examples. These ions are labeled using the single letter amino
acid code, and are usually of reduced abundance at increasing mass.
Related to these ions are those referred to as "internal fragment - 28"
ions (Scheme I11.2)0 These presumably result from the elimination of CO
to give an immonium ion, and are generally observed only if the
corresponding internal acyl fragment ion is also present.
Internal fragment ions containing threonine or serine frequently
eliminate H20; such ions are found 18 u below the corresponding internal
fragment ion. In addition, aD' bl , and occasionally xg lens containing
these amino acids also may eliminate vater.
As alluded to previously, lon~ corresponding to amino acid side
chain losses, or portions thereof, from the <H+8)+ ion a~e usually
observed. In an effort to determine the types of cleavages for each
I
J
•..
I
I
I
I
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amino acid, the CID spectra of a few of the more readily available
polyamino acids, e.g., Trp-Trp, Leu-Leu-Leu, etc., were obtained.
Obviously, any resulting R-group losses could be assigned to that
particular amino acid. Unfortunately, not all amino acids could be
studied in this manner. Those that could not were assigned R-group
losses based on observations made on a nUMber of CID spectra of ordinary
peptides. The same studies also allowed for the assignment of certain
low mass ions (e.g., immonium ions, Scheme 111.2) as being derived from
particular arino acids. This data is listed in Tables 111.10.
III.7 Conclusion
This section has summariz£d the types of fragmentations observed in
the CID spectra of <H+8)+ peptide ions, and Table 111.11 describes how
the masses of some of these Ions are calculated. The observations
described here have proven useful in the interpretation of eIn spectra of
pept1des of unkovn sequence, and Table III.12 is a summary of these
observations.
It is possible that 3ddltional Ion types may be discovered,
but these viII likely be either of low abundance involving higher energy
~rocesses, or vill not be directly related to the peptide sequence. In
particular, the I-group losses deserve additional characterization. Ions
corresponding to ba-17 and aa-17 have been observed on occasion, but have
yet to be correlated with particular peptide structures. Furthermore,
the mechanisms described here could undergo refine.ent; perhaps to the
point of predicting the types and abundance of ions for a given peptide
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Table III.10: Neutral losses and low mass ions observed for each amino
acid.
Amino acid NeutrAl losses..J...vl. Low maSL ions (mtz)
Methionine- 48, 75 56, 61, 104
LysineA 45, 59, 72 30, ~6, 84, 101,
128, 129. 130
Glutamine 45, 59, 72 30, 56, 84, 101,
128, 129, 130
Glutamic acid- 36, 45, 60, 62, 73 84, 91, 102
Leucine- 44, 57 44, 86
Isoleucine 44, 57 44, 86
Tyrosinea 107, 108 91, 107, 136
Phenylalanlnea 91, 92 91, 103, 120
Ser1nea 31 60
Valine- 31, 43 41, 55, 69, 72
Tryptophan- 130 77, 117, 130, 132, 159
Arginine 59, 70, 87, 100, 112
Asparagine 58 70, 87
Aspartic acid 59 88
Cysteineb 90, 91, 92, 103, 104 133
Proline 70
Threonine 45 74
Histidine 82, 110
Alanine 44
• Masses were obtained from CID spectra of peptldes containing only one
type of amino acid.
b carbamldomethylated cysteine
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Table 111.11: Assignment of m/z values of fragment ions. A
Mass of amino acid residues (-NH-CHR~
Ala ::r 71 ~O4 Gly = 57.02 Ser z 87.03
Arg =- 156.10 His = 137.06 ThI = 101.05
Asn • 114.04 lIe = 113.08 Trp III 186.08
Asp =- 115.03 Lys :: 128.09 Tyr a 163.06
Cysbz 161.01 Met = 131.04 Val = 99.07
Glu :: 129.04 Phe = 147.07 Xle = 113.08
GIn = 128.06 Pro = 97.05
Basic mass value of each ion series
N-terminal series C-term1nal series
a = -26.99
b :II 1.01
c = 18.03
x = 45.00
y a 19.02
z = 1.99
• The mass of a fragment ion can be calculated according to the following
examples:
Mass of bs = 1.01 + sum of first 5 amino acid residues.
Mass of Y7 = 19.02 + sum of last 7 amino acid resfduesu
b Carboxymethylated cysteine.
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Table II1.12: Summary of observations pertaining to the interpretation
of pept1des of unknown sequence.
Presence and position of basic amino acids
Arg at C-terminus: predominantly C-terminal ions, including vo ' va'
and YD-2
Arg at N-termlnus: predominantly aD and do
Lys or His at C-terminus: C-terminal ions including wD ' vo' and Yn-2,
plus some N-terminal ions (usually bo)
Lys or His at N-terminus: predominantly aD' bo ' and cia' plus some
C-termlnal ions <usually Yo)
No basic amino acid: predominantly ba and Yo
yo: Vo ions with N-term1nal c~u, GIn, or Leu are most abundant;
those with N-termlnal Lys, Cys, Met, Pro, Ser, Asp, Asn, lIe,
Val, Thr, or Arg are less so
Vo: va ions with N-terminal Asp, His, Ile, Phe, Ser, Thr, Trp,
Tyr, or Val are more abundant than the remaining amino acids
do: dD ions with C-terminal Glu, Gin, or Leu are most abundant;
those with C-terminal Lys, Cys, Met, Ser, Asp, Asn, lIe, Val,
Thr, or Arg are less so; those with Phe, Tyr, His, and Trp are
of low abundance or absent; Gly and Ala do not give rise
to do ions
CD: infrequently observed in CID spectra
Pro: no Zg or z~+l ions with N-termlnal Pro are possible;
Yo ions with N-termlnal Pro (H-Pro-~~xD-2-Xxx)H+] are
usually very abundant; YD ions resulting from cleavage C-terminal
to Pro [(B-Xxxg_1-Xxx)&+) are of low abundance and may be absent
Gly: aD ions with C-terminal Gly are usually of low abundance and
may be absent
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saquence. The results reported here are a step 1n this direction, an~
some general fragmentation rules are discussed In the next section, which
describes some methods for the interpretation of CID spectra of unknown
peptides.
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Section IV
Interpretation of CID Mass Spectra Obtained from Peptides of Unknown Sequence
Using the Computer Programs SBQPBP and ALTSEQ.
IV.l Introduction
Although CID spectra almost always contain extended series of ions
of the same type, they are frequently complicated by the presence of more
than one ion type, some of which may not form a complete series.
Furthermore, an ion type may not consistently glv~ rise to the most
abundant ions. In other words, it is typically not possible to determine
a sequence by subtracting the masses of a fev of the more abundant ions
located throughout a spectrum. In the simplest cases (such as substance
P, Fig. 111.16) that may be all that 1s r~quired, but interpretation is
generally more complicdted and time consuming. Thus, it becomes
desirable to develop computer programs to speed the interpretation as
well as increase the likelihood of arriving at all sequences that account
for most of the ions found in a spectrum.
Past efforts at such programs were directed mostly at the
interpretation of PAlMS spectra of single component samples, but,
nevertheless, could be used for interpreting CID mass spectral data. One
approach (99-103) involves the generation of all amino acid combinations
that account for the molecular weight of the peptide (either the nominal
mass or exact mass) as determined from the <"+B)+ ion. A set of
sequences are then derived from these amino acid combinations, which
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correspond to all permutations of each amino acid combinations For each
of these pe~mutations the m/z value of the expected fragments (chiefly
those of type aD' bo' Co' Xa , YD' and Zg of Scheme III.2) are calculated
and compared with those appearing in the spectrum of the unknown. T01s
set of sequences are then scored, the highest scoring sequences being
those that account for th~ most fragment ions found in the spectrum. In
this approach, the CPU time involved becomes too long for sequencing
peptides larger than 800 u unless the amino acids are limited in some
manner to fewer than the 20 occurring in proteins. Thus, it has been
suggested that an amino acid analysis be carried out beforehand (101-102)
to limit the number of sequences to be scored. This, however, negates
one of the major advantages of tandem mass spectrometry - the ability to
s~quence peptides present in a mixture. Alternatively, it has been
suggested that an exact mass measurement of the <H+H)+ ion vould limit
the number of possible sequences (103). Besides adding to the effort
involved, there 1s also the problem that standards of known mass would
need to be added to the sample, and in a mixture of unknowns many
standards may have to be added. The addition of multiple standards would
likely lead to a reduction in the (M+8)+ ion beam intensity, which would
degrade the quality of the CID mass spectra.
A second type of computer aided interpretation of CID spectra has
been developed at M.I.T. <104>, which involves a more interactive
approach employing a graphics display of the data. This algorithm
displays all series of ions above a chosen abundance threshold that
differs by amino acid residue masses (-NB-CBR-CO-) (see Table 111.11),
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thus enabling easy visualization of potential extended series of 1,ons of
the same type.
A third method of sequencing peptides fro. mass spectral data has
been employed in a number of laboratories (84,105-101) where small
portions of the peptide sequence (often referred to as a subsequence) a~e
determined starting at the N-termlnus. These subsequences are extended
until a list of complete sequences is generated. This general procedure
has been demonstrated previously using EI (107) and CI (84) mass spectral
data of derlvatlzed peptldes. In both cases, the masses of tvo Ion types
were calculated for all possible amino acids located at the N-termlnal
position. If the calculated Ion masses for a particular amino acid are
observed in the mass spectrum, that amino acid is stored as a likely
candidate for the N-termlnus. All such candidates are similarly extended
by one amino acid until the peptide molecular weight is reached.
In • similar algorithm applied to PAB mass spectra of underlvatlzed
peptldes, Ishikawa and Niva (105) begin by creating a list of all
possible subsequences three amino acids long_ Each of these are tested
as subsequences encompassing the N-terBinus. For example, one possible
start1na subsequence Asp-Glu-Tyr may give rise to bl , b2, and b~ ions at
m/z 116, 245, and 408. The list of observed fras-ent ion masses are
searched for ions at these calculated aasses, as veil as those
corresponding to au' CD' Ya • and z.+2 ion types. The subsequences are
given scores based on the fragaent ion intensity that can be accounted
for; those with the highest scores are re~alned as likely N-termlnal
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subsequences that are then extended further two amino acids at a time,
and given scores as just described. Eventually the subsequences may
reach a point where their masses equal the peptide molecular ve1ght,
whereupon they are stored as possible sequences of the peptide. Those
with the highest subsequence scores are then considered to be the most
likely sequences for the peptide.
A different approach for the buildup of subsequences has recently
been demonstrated by Siegel and Bauman (106). Since it 1s not known if a
particular fragcent ion is a N-terminal or a C-terminal ion, this
procedure generates all possible combinations. Foe instance, If only tva
fragment ions are considered, the two ions must either be both
N-terminal, both C-terminal, or one of each - four possible combinations
to be considered. For each combination, the assigned N and C-terminal
ions are mathematically re-expressed as N-terminal ions. The mass
differences between the re-expressed ions are then checked agalnst a
table of calculated mass differences that corres~ond to combinations of
amino acids plus a mass value that depends upon the type of cleavage
involved. From these mass differences, possible amino acid extensions of
each subsequence are generated until eventually the peptide molecular
weight Is reached. This procedure, although not as time consuming as the
approach presented by Matsuo et a1 (101), still takes quite some time.
It has been reported that the CPU time required for the analysis of ten
to twenty fragment ions requires one to three hours using a DBC PDP-IO
computer (106). Since CID spectra typically contain more than forty
ions, such data would require considerably more CPU time.
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The algorithms described here are to some extent a combination of
these subsequence buildup routines (84,105,107) and a scoring scheme
similar to that of Matsuo's program (101). They are, however, much
faster and probably more reliable because they take into account the dD'
vD' and va ions, which were not known to these authors, and also take
into account internal fragment ions (Scheme 111.2). Two subsequencing
algorithms are described here. The first, SEQPEF, generates subsequences
based on the presence of fragment ions at calculated masses, and does not
consider fragment ion abundances. The second, ALTSEO, generates
subsequences in a similar manner, but uses fragment ion abundances to
determine the most likely set of subsequences. Experience has shovn that
ambiguities in a peptide sequence derived from CIO spectra are most
frequently encountered at th~ N-terminus due to the lack of a l and bl
ions; a2 and b2 ions often correspond to the sum of more than one
combination of amino acids and would in any case not permit the
derivation of their sequence. Therefore, the subsequence buildup in
these algorithms begins with the C-terminal positions, and amino acids
are added on one at a time until the subsequences either account for the
mass of the precursor ion or cannot be extended further. Those
subsequences that account for the mass of the precursor ion are stored in
a list of complete sequences.
The list of complete sequences are then used as the input for a
sequence scoring procedure. This part of the algoLlthm is similar to
Matsuo's program (101), except that the list of sequences to be scored
are derived from the subsequence routine rather than from all
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permutations of amino acids that account for the mass of the precursor
ion. In addition and as mentioned above, aany more Ion types are taken
into consideration (Scheme 111.2). This final scoring is necessary,
because it accounts for the fragment ion current derived from internal
fr8g8ents, immonlum ions, etc., which are not sequence specific and are
therefore not incorporated in the subsequence scores. A further
advantage of subjecting the list of complete sequences to a final scoring
procedure Is that the resulting scores reflect the fraction of product
ions (or product ion current) that can be accounted for as one of the ion
types listed 1n Scheme 111.2. This 1s in contrast to the scores obtained
during the subsequence generation routine, where a single fragment ion
may be counted more than once. For instance, a Y2 ion containing Leu-Leu
has the same nominal mass as a b2 ion containing Asp-Glu (m/z 245), yet
the final score for the sequence Asp-Glu-Leu-Leu (or any
Asp-Glu- •••••• -Leu-Leu sequence) should only reflect the fact that
m/z 245 can be accounted for by at least one 10n type.
To simplify the discussion of these algorithms some terms need to be
defined. A subsequence is an amino acid sequence that does not account
for the entire -ass of the precursor ion. The programs are capable of
operating on 300 subsequences. Por each subsequence there are 18
possible 111no acid extensions, since glutamine and lysine have the same
nc.inal aass, as do leucine and isoleucine. Once a subsequence is built
up to the point where it accounts for the mass of the precursor ion it
becoaes a complete seaue~l. Scores, or figures of merit, are assigned
to subsequences, amino acid extensions, and co.plete sequences.
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Bxtensi~n.Jcores are assigned to all 18 amino acid extensions for each
subsequence 0 Subsequence lsores are the accumulated values of the
extension scores of the amino acids that were incorporated in a
particular subsequence. The sequence scores are determined for each
complete sequence. This score includes peaks due to internal fragment
ions, amino acid immonium ions, etc., which are not sequence specific.
The subscript n (as in an' bap etc.) refers to the general ion type
at any position, whereas 1 signifies a particular position under
discussion. The letter m refers to the total number of amino acids 1n
the correct sequence (which is, of course, not known at the outset).
Thus, Yi and bm- i indicate cleavage at the same CO-NH bond. The
subscript j will refer to the jth amino acid extension; i.e., j can vary
from one to eighteen.
The total CPU time for the subsequence generat1Gn and final scoring
procedures using SBQPEP on ninety fragment 10ns takes less than five
minutes using a VAX 11/750 computer. Hore typically, CID spectra
containing forty to sixty fragment ions requires less than tvo or three
minutes of CPU time. ALTSBQ, a more rigorous approach, requires about 20
minutes for an input of forty to sixty fragme~t ions. This program 1s
meant to be used in the relatively few cases where the faster SBQPEP does
not prOVide satisfactory sequence possibilities. Vith this in mind,
ALTSEQ Is not inconveniently time consuming, since data from several CID
spectra can be processed as an overnight batch job.
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IV.2 Generation of Complete Sequences Usil~ SEQPEP
The data input is a file containing a list of the observed fragment
Ion masses each with an associated ion abundance~ The mass list should
be in ascending order ending with the precursor ion mass, <H+B)+p and ion
abundances should be reasonably accurate relative to each other. In
SEQPEP, the generation of complete sequences 1s accomplished without
using ion abundances; however, abundances may be used in determining the
sequence score for each complete sequence (see Section IV.4). 1£ for
~nme reason the relative abundances are not readily obtainable, SEOPEP
vill still function, except that final scores will be based on the
numbers of product 10ns, rather than product ion current.
IV.2.a Generation of Subsequences Using SEQPEP
The subsequence buildup begins at the C-terminus and extends one
amino acid at a time towards the N-terminus. The calculations begin by
determining the initial values for Yion and B10n:
Yion = R + 2.0
Bion = (M+9)+ - R - 1.0
where R is the C-termlnal group <peptide-eO-R). Thus, for unmodified
peptides, where R Is a hydroxyl group. Yion equals 19.0 and Blon equals
the mass of the precursor ion, (H+8)+, minus 18.0. Yion Is the basic
mass value that is added to the amino acid residue mass (-NB-CHR-CO-) to
obtain the mass of y. (see Table 111.11). Blon is the mass that Is to be
subtracted from the <H+8)+ m/z value to obtain the peptide acyl 1011
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(peptlde-CO+>, which corresponds to bm •
Prom Yion, values for YI and XI are calculated for all j amino acid
extensions (aa j ):
YI • Yion + aaj
Yion + aa· + 26.0J
The data input is searched for product ion masses eqUal to these
calculated valu£s within a specified error range (± 0.5 u). If a Y. or
XI ion is found for an amino acid extension, then the masses of the
remaining ~tentia~ C-terminal ions are calculated for that extension:
YI+54.0 :z YiOD + aa j + 54.0
YI+55.0 • Yion + aa j + 55.0
y.+68.0 :II Yion + aaj + 68.0
ZI := Yion + aaj - 17.0
ziti • Ylon + aa j - 16.0
The data input Is searched for masses corresponding to these calculated
values. Although the amino acid in the next position (position m-l) has
not been determined yet, the program looks ahead to see if ions
corresponding to VI (y.+54.0), Vz (y.+55.0), or Wz wi th a ~-methyl
substi tuent (YI+68.0> are present.
Similarly, am-I and bm- I are calculated for all j amino acid
extensions (j-l to 18):
&m-I • B10n - aaj - 28.0
If 8 m- l or bm- I are found in the data input then the product ion mass
• • - • .. •• ~. ,..,JI]
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list is searched for the calculated value of C~-l:
cm- 1 z Blon - aa j + 17.0
Once the presence of the various Nand C-terminal ion types have
been detarmined for each amino acid extension, the extension scores are
~alculated. The extension scoring Is discussed in detail later, but in
general an extension score equals the number of product ions (In the
input data) an amino acid extension can account for. For instance, If a
particular amino acid accounts for three observed product ions (eeg., YI'
bm- 1, and 8 m- I>, then the extension score for that amino acid extension
equals three.
Those amino acids with extension scores above a s~eclfied threshold
value are then retained and become the first set of subsequences where
each subsequence is one amino acid long. This threshold 1s typically one
fourth of the highest extension score In each set of amino acid
extensions. Thus, each subsequence generates its own set of amino acid
extensions, and each such set has its own threshold value. The
subsequence scores for this first set of subsequences equals the
corresponding extension scores. New lion and Bion values a~e calculated
for each subsequence equal to Y. and bm-.~ These are derived from the
data input if YI or bm- I were present in the spectrum; otherwise the
calculated values are used.
This first set of suhsequences are each extended one amino acid at a
time. At each step, ion types are calculated for all possible amino acid
167
Yn+55.O, and Ya+68.O - as just discussed. Thr~e additional ion types are
calculated for amino acid extensions following the C-terminal position:
V :::I Y10n + 55.0D
W :a: Ylon + aa j - 16.0 - SCj11
d = sion - 27.0 - SCjII
where sCj is the mass of the ~-substituent of the jth amino acid
extension. Ions VI and WI ar£ never observed, and dm is usually not
reliably identified in a CID mass spectrum (far the structur~l
assignments of these ions see Rcheme 111.2>. Therefore, these ion types
(VI' WI' and dm> are not checked for amino acid extensions for the first
(C-term1nal) position.
For each subsequence, a set of amino acid extensions and extension
scores are determinede Once again, those with extension scores greater
than the threshold value form the N-terminal position of the new set of
subsequences. New 8ion and Yion values ~re determined for each
subsequence, which correspond to the new subsequence's lowest mass bo and
highest mass YD, respectively. Furthermore, each new subsequence has its
own subsequence score, which equals the old subsequence score plus the
extension score.
One can see that the n~.ber of subsequences quickly becomes
overwhelming. If, for instance, every subsequence generates five new
subsequences, 625 subsequences are formed after only four steps (54).
For this reason subseque.~ces with the lowest subsequence scores are
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purged (to a total of 200> when the number of subsequences exceeds a
specified limit (maximum ~ 300 subsequences).
Subsequences are extended one amino acid at a time until all of the
subsequences either account for the mass of the precursor ion or cannot
be extended further without exceeding it. The former subsequences are
stored as complete sequences. The maximum number of complete sequences
is 300; occasionally this limit is reached, at which point only the 200
with the highest subsequence scores are cetalned. Once the subsequenclng
routine is finished, each complete sequence is subjected to a final
procedure where the sequence scores are determined for the complete
sequences (Section IV.4). The overall procedure is depicted in the flow
diagram of Scheme IV.I.
A simple example illustrating this procedure may prove instructive.
Table IV.l lists product ions for the hypothetical eIn spectrum of
<"+8)+ ~ m/z 588.4. To simplify this example the maximum number of
subsequences will be limited to tvo (rather than 300). Yhen the number
of subsequences exceeds two, all but the subsequence with the greatest
subsequence score viII be purged. Scheme IV.2 depicts the calculations
for the C-termlnal position (polition m). Peptides derived from
proteolyt~c digests always have C-terminal carboxyl groups (except,
perhaps, the peptide containing the protein C-terminus), and, in general,
C-term1nal peptide modifications are not as frequently encountered as
N-terminal modifications. If a C-terminal modification is suspected, the
program could be ran several times using various C~termlnal groups. Por
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each C-term1nal group, different initial values for Y10n and Blon would
be calculated, and different results would be obtained. In this example,
the C-terminus viII be assumed to be unmodified. Since the C-term1nus 1~,
unmodified the initial values of Yion and Bian are l~.O and 570.4,
respectively. From Yion, only tvo product ions 1n Table IV.1 are found
that can be accounted for as YI. The ion of m/z 147.1 corresponds to YI
if a (glutamine or lysine) 1s at the C-terminus, and m/z 120.0 is y. for
T. There are no ions that could be XI. An ion at m/z 104.0 also
corresponds to zl+1 for T. From B10n (m/z 570.4) only m/z 513.4 and
m/z 442.3 match bm~1 for G and Q, respectively. No product ions match
with any possible am-I ions. Thus, only T, a, and G could be at the
C-terminus. 0 has two ions indicating its presence (YI and b~-l) and
therefore has an extension score of two; G has only one (bm-.) and has
an extension score of one. Certain peaks found at lov mass in CID
spectra of peptides are due to amino acid immonium ians (e.g.,
phenylalanine at m/z 120 and methionine at m/z 104) and are therefore not
sequence-specific. For this reason, such ions are not used in the
determination of extensions scores. Bence, for the amino acid extension
T, both Y. (m/z 120.0) and z.+1 (m/z 104.0) correspond to such ions and
the extension score for T is therefore zero. The threshold for extension
scores is one fourth of the highest extension score (0.25 x 2). Both G
and a have scores above the threshold and are retained as the first set
of subsequences. The subsequence scores for Q and G equal tvo and one,
respectively. The new Sian and Yion values for Q were derived from the
mass list of Table IV.I, as vas Bion for the subsequence G. However,
Ylon for G 1s not in the data input and 1s calculated to be 76.0. Scheme
r
I
~
L
I
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IV.3 depicts the possible amino acid extensions for the subsequences 0
and G. The only amino acid extension for 0 with an extension sco~e
greater than the threshold is F, resulting in the new subsequence PO.
The subsequence G has two amino acid extensions with extension scores
greater than its threshold, yielding tvo additional subsequences - AG and
HG.
At this point the number of subsequences (FO, AG, and HG) exceeds
two, the maximum number allowed in this example. Therefore only the
sUL_equenc~ with the highest subsequence score is reta~ned for further
calculations (in actual use, when the number of subsequences is 301 or
more, all put 200 of the subsequences with the highest subsequence scores
are purged) a thus, the subsequence FO 1s sequenced further, and these
calculations are shown in Scheme IV.4. The extension scores for F and Y
are both zero since 120.0 and 104.0 correspond to immon1um ions for
phenylalanine and methionine. Two new subs2quences are generated - MFQ
and C'~Q, where Co indicates carboxymethylated cysteine. The subsequence
C'PQ cannot be sequenced further; however, tyrosine placed at the
N-terminus of MFO yields a sequence equal to the mass of the precursor
ion, and the complete sequence YHFQ is stored.
Once the subsequencing routine is completed the sequence score for
YHFQ Is determined. In this process th~ immon1um ions for methionine
(m/z 104.0), phenylalanine (m/z 120.0), and tyrosine Cm/z 136.1>, and the
cyclized 1mmonium ion for lysine (m/z 84.0) are recognized. The R-group
losses for tyrosine (m/z 481.4), phenylalanine (m/z 497.4), methionine
.
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Table IV.I: Product ions for the hypothetical CID mass spectrum of
<"+8)+ = m/z 588.4
84.0
104.0
120.0
136.1
147.1
267.1
277.1
279.2
294.2
295.2
348.3
425.3
441.3
451.4
481.4
497,.4
513.4
516.4
588.4
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Scheme IV.2
Position m
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Yion
19.0
19~0
Bion
570.4
570.4
Amino acid
extension
T
Q
G
a
Product ion
masses (ion type)
120.0<YI)' l04.0Cz1+})
147.1 (Ya)
S13.4(bm-.)
442.3< bm- a)
Extension scores
T = 0
a = 2
G = 1
Cutoff = 0.25 x 2 = O.~
New
subsequences
a
G
Subsequence
scores
2
1
Bion
442.3
513.4
Yion
147.1
76.0
Scheme IVr:1
Position ,-I
SUbsequence: Q
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Yion
147.1
Blon
442.3
442.3
442.3
Amino acid
mensIon
p
F
Y
H
Product ion
masses (ion type)
294.2(Y2)' 277 .. 1(zz}' 348.3(Yz+54)
295.2(bo - z)' 267.1(am- 2)
279.2(bm- 2)
277.1(8m- z)
Extension scores for the subsegu~e Q
F • 5
y:ll 1
a • 1
Cutoff a 0.25 X 5 • 1.25
New
subsequences
Fa
Subsequence: G
Subsequence
scores
7
BioD.
295.2
Yion
294.2
Yion
76eO
810n
513.4
513.4
Amino acid
extension
A
A
H
Product !on
masses ~ 10n type)e
147.1(Y2)
442. 3( bm- J)
348. 3( 8 m- 2)
Extension scores for the subsequence G
A :8 2
B =- 1
Cutoff = 0.25 x 2 • 0.5
New
subseQ1llnces
AG
HG
Subsequence
scores
3
2
Blon
442.3
376.3
X1Qn
147.1
213.1
IOjal new subsequences
FO
AG
BG
Subsequence scores
7
3
2
Schell! IV.4
Position m-2
Subsequenc:e: PO
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I!2n
294.2
294.2
!Wl
295.2
295.2
295.2
Amino acid
extensiJUl
M
C·
H
F
y
Product ion
!I;ses (lon type)
425.3(Y3)' 451.4(x)), 348.3(w)
481.4(x3)
136.1(am- 1)
120eO(Bm- J)
104 •O( 8 111- J)
Bxtension scores for the subsequence FO
H == 3
Co • 1
Ii' = 0
Y = 0
Cutoff = 0825 x 3 = 0.75
New
subsequences
MFQ
C'PQ
Position 11-3
Subsequence
scores
10
8
Bion
164.1
!34.1
YiO!l
425.3
455.4
Yion
425.3
Subsequence: IO'Q
AIIlno acid
extension
y
Subsequence: C'PQ
Product ion
!lSses (Ion typeL
588 •4[ ( M+B) ... )
Yion
455.4
AIIino acid
extension
Product ion
masses (ion type)
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(m/z 513.4), and lysine (m/z 516.4) are also identified. The internal
fragment HF is also identified as the ion at m/z 279.2. The remaining
ions in Table IV.l were already identified as sequence specific fragment
ions during the subsequence buildup. In this idealized case, the
sequence score for YHFQ equals 1.0, since all ions in the data input
(Table IV.I> were accounted for as one of the ion types shown in Scheme
II1.2.
Although this discussion (Section IV.2.a) deals specifically with
the program SEQPEP, the same general procedure is u~~d in ALTSEQ. The
main difference 1s in the scoring of amino acid extensions. SEQPEP
determines extension scores based on whether an amino acid extension can
or cannot account for product ions in the data input. In ALTSEQ these
scores are calculated using the product ion abundances, where the score
is essentially the summation of abundances of ions that an amino acid
extension can account for (see below)~
Certain amino acids are known to interfere with the formation of
particular ion types, which therefore give rise to gaps in an otherwise
continuous series of ions. As a result, provisions have been made to
overcome such difficulties. Since Yi 10ns are often not found at
positions C-terminal to proline, the value Yi+1 1s calculated:
Yi+! :I: Yion + aaj + 97.0
where 97.0 1s the residue mass of proline. When ions are found at the
mass corresponding to Yi+I' the remaining C-terminal ion types for
position i are calculated and the mass list is searched for these ions.
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A similar problem arises when glycine is at the C-termlnal position
of an a i ion. Such 10ns are frequently of low abundance p but usually
only cause problems in sequencing if an ions are the most prominent ion
series in the spectrum. For subsequences where aD ions were found at
each position, it is possible for the algorithm to search for ions at
masses corresponding to ai-I:
ai-I = Bion - aaj - 28.0 - 57.0
where 57.0 is the residue mass of glycine. If 8 i- 1 is found in the data
input but there are no other ions indicating the presence of amino acid
j, then amino acid j Is assigned the threshold score, which ~':lo~'s 1t to
be incorporated in the next set of subsequences. Since glycine causes
such difficulties only when the spectrum is dominated by an ions, the
user has the option of disabling this feature.
The speed of SEQPEP Is attributed to a number of factors. Host
importantly, subsequences are extended one amino acid at a time, whereas
previous programs (105-106> extend subsequences by two or more amino
acids at a time. These programs were designed to be used with FAD mass
spectral data, which is more likely to contain sequence Ion gaps than CID
mass spectra obtained with a four-sector instrument, and therefore
justifies the use of the more time consuming multiple amino acid
extensions. A second factor that limits the CPU time involves the
periodical purging of subsequences with low subsequence scores.
Typically, if the number of subsequences exceeds 300, 100 of the lowest
scoring subsequences are purged, and the remaining 200 are extended
further. A third time saving measure allows the computer to search only
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small portions of the fragment ion mass list. For instance, if low mass
N-term1nal ions have been calculated, the mass list search begins with
the previous N-terminal ions and works its way down~ This prevents
unnecessary mass comparisons. Finally, subsequence masses may converge
(e.g., .. VTF, .. TVF, .. XSF, and .• SXF, where X indicates leucine or
isoleucine>, and in such cases the calculations for extending the
subsequence need only be done once~ The program identifies these
instances, and the CPU time is cut furth~r.
IV.2.b Scoring of Amino Acid Extensions in SEQPEP
In Section IV.2.a extension scores were described as being equal to
the number of product ions that the amino acid extension can account for.
However, additional manipulations of extension scores have been
incorporated in the program. Based on what is known about collision
induced dissociation of peptide ions (Section III.3>, these manipulations
increase the liklihood that the correct amino acid extensions will
receive the highest extension scores. SKQPEP was written primarily as a~.
aid 'n the interpretation of CID mass spectra of proteolytic peptldes
(particularly tryptic peptides) , and therefore the scoring scheme seems
to be biased towards this purpose. However, the ability to retain
between 200 and 300 hundred subsequences allows many of those with low
scores to be sequenced until stored as a complete sequence for further
scoring. Thus, insp1te of this bias a correct subsequence that is
assigned a low subsequence score may still be retained until it is stored
as a complete sequence.
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Once the calculated ion masses have been identified within the list
of observed fragment ions for all of the amino acid extensions, each
extension 1s scored. The scoring proceeds by calculating aN-terminal
score (based on the presence of N-terminal ions), and a C-terminal score
<based on the presence of C-terminal ions) for each amino acid extension.
The e~tension score 1s a summation of these two scores. Ions at masses
equal to the mass of an amino acid immon1um 10n are not included in the
score, since such ions are not indicative of the peptide sequence.
The N-terminal scores are calculated ~s follows. If a bo ion is
present, the score is increased by oneo Cleavages N-termlnal to
arginine, histidine, or lysine rarely produce aD ions, so only if an
amino acid extension is not arginine or histidine is its N-terminal score
increased by one if aD is present. Since lysine is isobaric with
glutamine this condition cannot be imposed for lysine. Likewise,
cleavages at histidine 01' arginine rarely result in Co ions, and, in
general, cn ions are infrequently observed in CID spectra of peptides.
The typical exception 1s when both aD and bD ions are also present, hence
the N-termlnal score is increased by one 1f CD 1s present and if the
amino acid extension Is not arginine or histidine and both aD and bn are
found. The score Is also increased by one if a do ion 1s observed for
serine, valin~, threonine, leucine or isoleucine, asparagine, aspartic
acid, glutamine, glutamic acid, methionine, and cysteine, but only if the
corresponding aD or bg ion is also observed. When scoring amino acids
for the C-terminal position (position m), dg 10ns are not calculated or
included in the score.
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Next, a C-terminal score is assigned to each amino acid extension.
A C- terlil1nal score is always increased by ol~e 1f Yg is present g The same
is the case for xg ions. The ions Yi+54, Yi+S5, and Yi+68 correspond to
the ions Witl' va+l • and Wi+1 vi th a a-methyl substi tuent. Since the
amino acid at the next position has not yet been identified, these ions
are of limited significance, so the presence of an ion at any, or all, of
these masses vill increase the C-term1nal score by only one~ because only
one of these 1s likely to be a real fit. Cleavage of the N-CH bond of
proline cannot give rise to za or 2 0 +1 ions, hence, only if the amino
acid extension is not proline 1s the C-terminal score increased by one
when either (or both) zn or ~D+l ions are present. The remaining
C-terminal scoring is based on the presence of wa or V o ions, which are
not included ~n the scoring of the C-term1nal posj.tion (position m). The
presence of a va ion at other positions increases the score by one if the
amino acid extension is cysteine, methionine, proline, serine, aspartic
acid, asparagine, glutamic acid, glutamine (or lysine)~ arginine, leucine
(or isoleucine>, valine, or threonine. If a va ion is present, the
C-terminal score is increased by one if the amino acid extension is
threonine, isoleucine (or leucine>, valine, serine, histidine,
phenylalanine, tryptophan, or tyrosine.
At this point each amino acid extension has recieved either a
C-terminal score, a N-term1nal score, or both. The extension score 1s a
summation of these two scores, but before summing, it is possible to
attenuate the effect of the N or C-termlnal scores on the extension
score. For instance, if a subsequence contains arginine it is unlikely
iii
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that cleavages N-terminal to that arginine would result in significmlt
N-terminal ions. Thus, amino acid extensions derived primarily from
presumed N-terminal ions are probably incorrect. In such cases, the
N-terminal score can be reduced by some arbitrary amount (by a factor of
0.333). Likewise, the C-terminal score can be dimlnshed if no basic
amino acids are found 1n the subsequence. After attenuating the N or
C-termlnal scores, they are summed.
The extension scores (the sum of the Nand C-terminal scores) can be
attenuated further in certain cases. If the peptide being sequenced was
derived from a tryptic digest it is unlikely that arginine can be present
at positions other than the C-terminus (position m), unless followed by
proline or if its at position 1 or ~-l. If such a misplaced arginine is
an amino acid extension then the extension score 1s attenuated. The same
is true fer lysine; however, glutamine 1s isobaric with lysine and the
extension scores cannot be treated similarlyo Since histidine gives by
far the most abundant lmmonium ion (110.0 u), the absence of this ion
vhen other immonium ions are prasent argues strongly against the
likelihood of histidine being present. Under such a condition, the
extension score for a histidine extension is divided by two.
The extension scores undergo one final manipulation, which involves
a process similar to normalization. To take two extreme examples, the
extension score for glycine is based on only seven 10n types - zn (or
za+ 1), Yn' xa' yn+54 (or yQ+55, or ya+68> , aD' bD, and CD - wherea~ the
extension score for threonine is based on eleven Ion types - Zg (or
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~D+l), xQ ' YD, Va' Vo with a ~-methyl substituent, va with a ~-hydroxyl
substituent, ya+54 (or ya+S5, or yo+68> , an' ba , CD' or do. Bence the
extension scores ~or each amino acid extension are divided by a factor
ranging from 6.0 to 8.0, depending Dn the particular amino acid present.
Alao 4,ne, arginine, gly~1ne, proline, and histidine are normalized by a
factor of 6.0; cysteine, glJtamine (or lysine), phenylalanine,
methionine, serine, tryptophan, tyrosine, and valine by 7.0; asparagine,
~spartic acid, leucine (or isoleucine>, and glutamic acid by 7.5; and
threonine by 8.0. These normalization factors were chosen somewhat
subjectively, but generally reflect the numbers of fragment ions that can
be expected for each amino acid. Since the presence and location of
basic amino acids seems to have the major influence over the number of
ion types observed, rather than the type of amino acid at each position,
the variation between normalization factors is a conservative choice.
One final aspect of th~ normalization is that some amino acid extensions
may lack a Yo ion because of the possibility of proline being in the next
position (see Section III.4). In these cases, the normalization fdcturs
are reduced by one, since the number of expected ion types Is reduced by
one.
User Spec1f1~d Parameters in SEQPEP
A certain degrEe of fle~ibility has been built into the subsequenc2
generating routine, which allows the user to specify several parameters
affecting the algorithm's operation. The number of subsequences that are
retained before purging those with the lowest scores Cfenerally 300). and
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the number of highest scoring subseq1lences retained aft~r purging
(generally 200), can all be specified by l~e user. Modified amino acid
masses can be entered, and it 1s also possible to provide the proaram
with an approximation of the gas phase basicity of the modified amino
acid; this has an effect on the amino acid extension scoring just
described. Three choices are available; the modified amino acid can be
very bas1c (like arginine>, moderately basic <like histidine or lysine>,
or non-basic. If the modified amino acid is specified as being very
basic then it will affect the extension scores In the same manner as
arg~~1ne, and 1f its moderately basic the modified amino acid will affect
the extension score in the same manner as lysine and histidine (see
above). The presence and type of cysteine blockin~ group can be
specified, and if th~ C-terminus is modified, the mass of the
modification 1s required to carry out the calculations. Also, when it 1s
expected that the N-terminus is blocked, all subsequences that cannot be
extended further are stored as complete sequences so that the remaining
unsequenced mass may be considered as the mass of the N-terminal blocking
group. The user is allowed to slightly offset the mass of the C-termlnal
group R (peptide-CO-R). For instance, a YI ion containing lysine equals
12801 + 19.0. If its known that the low mass ions deviate by several
tenths of a mass unit, the user can choose to use a value slightly
different from 19.0 in the calculations. Normally this 1s nLt required.
Also the user can enter an error value. POL example, 1f the mass
difference between tvo ions equals 114.45 u and the typical error value
of 0.5 u has been chosen, then this mass difference is considered to
correspond to the residue mass of asparagine (114.04 u), whj,ch 1s within
.
•
r
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the range 113.95 u and 114.95 u, while 115.03 u, th~ value for aspartic
acid, falls outside.
For each subsequence, there are eighteen possible amino acid
extensions (or more, if there ar~ any modified amino acias), each of
which rec1eves an extension score. Those with scores above a certain
fraction of the highest scoring amino acid extension are allowed to be
passed on to form part of the next set of subsequences. This fraction
can be selecte~ by the user, but a value of 0.25 for this fraction seems
to be adequa~:.
The type of enzymatic or chemical cleavage that produced the peptide
under study c~, be specified. If a tryptic cleavage 1s specified, the
program treats a C-terminal Gln/Lys as lysine. Furthermore, all amino
acids characteristic of the chosen cleavage method are retained as
candidates for the C-term1nal position. For instance, if in a tryptic
peptide lysine at position m had a score greater than the thl"eshold, but
arginine did not, all amino acid extensions with scores greater than th n
threshold are retained (each associated with their excension scores);
arginine is also retained and is assigned a score equal to the threshold
. value. This allows arginine (a tryptic cleavage site) to be included in
the first set of subsequences even though there were no ions indicating
its presence. This procedure to some extent overcomes difficulties that
arise in the rc~atlvely infrequent event that the tvo C-terminal
positions cannot be sequenced from the CID mass spectrum.
•
-•
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Since the t~o N-terminal amino acids are sometimes not
differentiable, the program is capabl~ of storing all subsequences as
complete sequences If the remaining unsequenced mass 13 less than a
certain value. This value vas chosen to be 372 u, slnc~ the maximum
remaining unsequenced mass for two amino acids would be that for two
tryptophans. Complete sequences with unsequenced mass values less than
372 u that cannot poss~bly be composed of any combination of amino acids
are rejected, unless, of course, an N-terminal modification or a modified
amino acid are expected. Additionally, use of this option frequently
generates complete seqp-nces that are subsets of longer complete
sequences; these subs~ts are later purged.
If a portion of the N-terminal sequence is known from Edman
degradations, this partial sequence can be entered. As a result,
subsequences are extended from the C-term1nus up to the point where th~
entered sequence account.s for the remaining mass of the precursor 10n.
Ions derived fro~ the known amino acid sequence are identified and the
subsequences are stored as complete sequences.
Alternatively, a known C-terminal sequence can be entered. The ions
derived from this sequence are identified and subsequences are then built
up using the entered C-terminal amino acid sequence as the initial
subsequence. This feature has been of use when CID 3pectra give
prominent ions of one or two types that clearly identifies a portion of
the C-terminal region, but the remainder cannot be so easily determined
by inspection. In one case, prominent bD ions in a CID spectrum of a
•
•
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peptide >1300 u clearly gave the sequence of all but the three N-terminal
amino acids. The obvious C-terminal sequence vas entered into the
program, which then completed what turned out to be the more arduous task
of sequencing the N-terminus.
IV.3 Generation of Complete Sequences Using ALTSBQ
As discussed above, SHQPEP determines extension scores bas.d on the
presence of ions at calculated masses, and the ion abundance has no
influence on these scores. Henc~. it was ot interest to devise a similar
algorithm in which extension scores were dependent on both the presence
of ions at calculated masses as well as their abundances, and to compare
the results with those produced hy SBQPEP. It vas thought that such an
algorithm may provide the correct sequence i~ t~~se cases where SEQPEP
fails. For this reason~ an alternative interpretive comp~~er program,
ALTSEQ, was written. The data input format is identical to that requ~red
by SEOPEP except that ion abundances are added, since the extension
scoring (as well a~ the final scoring of the complete sequences) is based
on product ion abundance.
£
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IV.3.a Generation of Subsequences Using ALTSEQ r
As in SEQPBP, the subsequence buildup begins at the C-terminus acd
extends towards the N-termlnus. For ALTSBO, however. the first set of
su,sequences are formed by generating all combinations of tvo amino acids
and assigning each two amino acid subs£quence a score. The scoring
I
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scheme is discussed in de:ail later, but 1n general equals the sum of the
abundances of product ions that each subsequence can account for. As
many as 300 tvo amino acid long subsequences with the highest subsequence
scores are retained for further calculations. Use of an initial set of
C-term1nal subsequences tva amino acids long surmounts the relatively
ipfrequent problem that may occur, particularly for larger peptides f
where the tvo C-termlnal positions cannot be differentiated. For
instance, in the hypothetical case of a CID mass spectrum containing only
Yo ions vhere YI is absent, the program will generate all possible two
amino acid sequences that account for the ~ass of Yl.
Following the determination of this first set of two amino acid long
subsequences, the program extends these subsequences one amino acid at a
time until the mass of the precursor ion is accounted for. As with
SEQPEP, each subsequence has an associated value corresponding to its
lowest mass bo ion (Blon) and its highest mass Yo ion (Yion). The
N-terminal fragment ions are calculated for each amino acid extension as
follows:
a = 8ion - aa j - 28.00
b = Bion - aajD
CD = Blon - aa j + 17.0
dD = 810n - 27.0 - sCj ~
where sC j is the side chain of amino acid j when cleaved at the ~,Y-bond,
and aa j is the residue mass of amino acid j. Likewise, the C-termlnal
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ions are calculated for each possible amino acid extension:
v = Yion + 55.0D
W :II Yion + aa j - 16.0 - sC jD
X 3 Yion + aa· +26 .. 0Q J
Ya :: Yion + aaj
Yn- 2 • Y10n + aa j - 2.0
z = Yion + aa j - 17.00
zD+ 1 = Yion + aa j -16.0
Following these calculations, the mass list 1s searched for observed
ions matching the calculated values, within a user-specified error limit,
and the extension score is determine;. Although each subsequen~e may
have eighteen or more amino acid extensions (depending on the number of
modified amino acids entered), only a few of the highest scoring
extensions are retained. The number of amino acid extensions retained
per subsequence is a variable that can be selected by the user -
typically only five. Thus, for each subsequence, five new subsequences
(extended by one amino acid) are generated. Of course, this leads to
five times as many extended subsequences for each cycle of subsequence
extension, and the number of subsequences soon exceeds the size of the
variable arrays. This program is capable of carrying out calculations on
300 different subsequences, each of which may yield 5 new subsequences
for a total of 1500. For this reason, only 300 of the new subsequences
with the highest subsequence scores are retained. As in SIQPBP, the
•
•
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limitations. If the number of complete sequences exceQds 300, all ex~ept
the 200 vith the highest subsequence scores are purged.
IV.3.b Scoring of Amino Acid Bxtensions by ALTSSQ
As already mentioned, several N and C-terminal ion types are
calculated for each amino acid extension. The list of observed fragment
ions are then searched foe masses corresponding to the calculated values.
The score for each amino acid extension 1s a summation of th~ fragment
ion intensities for which a match is found. The large number of ion
types, however, increases the likelihood of almost any amino acid
extension attaining a high score. Thus, the challenge vas to devise as
many constraints on the types of ions to be included in the extension
score without limiting the programs ability to interpret the CID spectra
of a wide variety of peptldes. Host of these constraints were based on
information discussed in Section III.
The first set of constraints was to not search for particular ion
types for certain amino acid extensions. For instance, Zo and za+1 ions
are not formed at positions containing proline, since the pyrrolld1ne
ring prevents the formation of fragment ions resulting from cleavage of
the N-CD bond. Likewise, VA 1s not determined for Gly, Ala, 81s, Phe,
Tyr, and Trp, since this ion Is either not possible or of low abundance
for thesE amino acids. Only Val, Thr, and lIe <which at this point has
not been differentiated from leucine) can form vg ions with a ~-methyl
group, only Thr can form Vo with a a-hy~roxyl group, and only lIe (or
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Leu) can form vg with a ~-ethyl substituent. Gly, Ala, and Pro cannot
form V o ions.
In other cases, certain ion types are searched, but they may not be
included in the extension scoring. Ions of type w. with a-hydroxyl or
ethyl groups are not of significant abundance, neither are dg ions for
Ser, Val, Thr, and Arg, and are not included in the extension scoring.
The reason for this 1s that 1f such ions were determined fo~ the correct
amino acid extension, they would be of low abundance and omitting them
would not greatly affect the ext2nslon score. On the other hand, if such
ions were assignea for an inco~rect amino acid extension and were of high
abundance, including them in the score would favor the incorrect amino
acid extension. If a fragment ion mass corresponds to the mass of a
nonsequence-spec1flc amino acid lmmon1um tOOt then that ion is not
scored; neither are c~ ions unless the associated an and bg ions are
also present.
Another set of scor1n~ constraints is applied if basic amino acids
CArg, His, Lys(or GIn), or a basic modified amino acid) are absent. If
there are no basic sites in a subsequence, y g -2, wD ' and va are not
1ncl~ded in the extension score. Furthermore, 1f YD , za' and 2 0+1 are
absent then xD ions are not used 1n the extension scoring. Likewise, if
xD and YD are absent then Zg and za+1 are not scored.
If a basic site is present, only va ions for Val, Thr, Ile(or Leu),
His, Phe, Tyr, and Trp are included in ths score. A further constraint
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involves comparing the summed ion abundances of Xa , YD' Za' and zQ+l with
the individual ion abundances of YD-2, va' and vD- These latter three
ion types have not been found to be of overwhelming abundance compared to
the corresponding xa' Yo' z.' and za+1, and with this in mind» the
individual 10n abundances of Ya-2, va' and va must each be less than
three times the aforementioned su~ed abundance to be included in the
extension score.
One final scoring constraint involves the determination of sequence
ion gaps for amino acid extensions. A gap 1s defined as the absence of
an' ba • and Yo ions for amino acid extersions of subsequences not
containing a basic site, or the absence of ao ' bo ' Ya ' and xQ for
extensions of subsequences with basic sites. It is rarely the case that
the eorrect sequence does not have one of these Ion types at each
position. Therefore, if such a gap is found for a particular amino acid
exte~~1cn, then that extension score is halved. In only two cases are
amino acid extensions with gaps not t~eated 1n this manner. Peptides
with N-term1nal arginine typically exhibit a continuous series of aD 10ns
(plus do ions); however, if glycine is at the C-terminus of an aD ion,
such ions are of much reduced abundance or perhaps absent (see Section
III). Thus, when an amino acid extension is found to have a sequence ion
gap, the subsequence is checked to determine if aD ions were found at
each position. If so, the algorithm searches for an' bo ' and Yo ions for
glycine at the position N-term1nal to the amino acid extension. If any
of these ions are found, then this extension score is not halved and the
new subsequence is only allowed to be extended by glycine. For example,
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if a subsequence ...Met-Phe, is found to have am-I and am- 2 fans, and an
extension, Tyr, is foulid to contain a sequence gap (as defined above>,
then y~, 8 m- 4 , and bm- 4 ions for .•• Gly-Tyr-Het-Phe are searched. If any
of these three ions are found in the data input, then the extension score
for Tyr 1s not halved. However, the new subsequence .• ~Tyr-Met-Phe will
then only be allowed to have glycine as its next amino acid extension,
since this 1s the only way to explain the sequence gap for the position
containing Tyr. The other way ~n vh1ch sequence gaps may legitimately
occur is 1f proline is at the position N-terminal to the amino acid
extension. As vas discussed in Section III, the Yo ion for proline
«(B-Pro-(Xxx)a-z-Xxx]O+) is typically very abundant; however, the Yo ion
resulting from cleavage C-terminal to proline «(B-(Xxx)a-.-Xxx]B+) is
often absent. Thus, 1f a sequence ion gap is found for a particular
amino acid extension, the mass list is searched for a YD ion for proli.le
at the posit~on N-terminal to the amino acid extension. If such an ion
is found, then the extension score is not halved, but only proline will
be allowed as the next extension for the new subsequence.
IV.3c User specified parameters 1n ALTSEQ
Hust of the user specified parameters discussed for the program
SEQPEP were also incorporated in ALTSBO~ some of which affect the basic
operations of the algorithM. For instance, the maximum number of
subsequences to be operated upon 1s 300 r but a lower value can be chosen.
A match between a calculated mass and an observed fragment ion mass
occurs if the difference is within a specified error range. This error
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r&lge is typically! 0.5, but other values can be entered. As discussed
previously, the number of amino acid extensions allowed per subsequence
can be entered; however, the best results were obtained by allowing only
5 extensions per subsequence.
As in SRQPBP, modified amino acids CAn be included if the mass of
the side chain is entered. The modified amino acid can be specified as
having a basic or non-basic side chain, as this has an effect on the
extension scores. Since the C-termlnal subsequence begins with all
combinations two amino acids long, the type of proteolytic cleavage that
the peptide was derived from is irrelevant for ALTSEQ. However, tryptic
cleavages are still important for distinguishing C-terminal lysine from
glutamine. As in the case of SEQPEP, there 1s no other way to
distinguish between these two amino acids. Of course, the mass of a
cysteine blocking group, If present, must be entered, and provision is
made to store all subsequences with an unsequenced N-terminai mass less
than 372 u. This insures that correct sequences are retained in those
cases where the CID mass spectrum does not provide information allowing
the differentiation of the first tvo N-term1nal positions.
The presence of an N-terminal blocking group can be specified, and a
mass range for the blocking group can be entered. If a particular type
of blocking group 1s suspected, the mass of that group can be specified.
In such instances, the program will store those subsequences that account
for the mass of the precursor ion either with or without 'the blocking
group (in case there actually 1s no N-terminal group). If there 1s a
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C-terminal modification, the mass of this modification must be entered.
N-terminal sequences determined from Edman degradations can be
entered, whereupon the program will generate subsequences up to the point
where the entered sequence accounts for the remaining mass of the
precursor ion~ The fragment ions for the N-terminal sequence are then
identified prior to storing the complete sequence. Likewise, a
C-terminal sequence (deduced perhaps from hand calculations of an
abundant ion series> can also be entered. The fragment ions for the
C-~~~minal sequence are identified and subsequences are extended one
amino acid at a time from there on.
One further feature allows the user to specify the presence or
absence of particular amino acids. Although an amino acid analysis would
provide such information, this is not applicable to mixtures of peptides.
Nevertheless, the low mass amino acid immonium ions can provide some
limited information. If an amino acid 1s specified as being ab~ent, no
extension using this amino acid is allowed. On the other hand, if an
amino acid is known to be presen t, subsequences are gener.,1 teo as iJ~':u·~.~{,
but the co=~lete sequences are checked to make sure that this amin0 t~1~
1s located somewhere within the sequence. Of cou~se, ~h1s does not apply
to complete sequences with unseq'lenc~d N-terminal poslt1~ns~ since th~
amino acid specified as being present in the peptide may be a part of
this unsequen~ed region.
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IV.4 Calculation of Sequence Scores for Complete Sequences
This part of the algorithm is similar to that described by Matsuo
(101), in that a list of complete sequences are scored according to the
number of fragment ions each sequence can account for. In this program,
however, the list of sequences has been generated by the buildup of
subsequences (from SEQPEP O~ ALTSEQ) rather than the generation of all
possible sequences that account for the peptide molecular weight.
Furthermo~e, many more types of ions (Scheme III.2) are considered in the
scoring descr:bed here. Given the known types of fragment ions that can
result from collisional activation of protonated peptide molecules, each
complete sequence is assigned tva scores. The first is the fraction of
the total number of ions that are accounted for; the second is the
fraction of the total product ion current that can be accounted for. Of
course, the latter score cannot be determined if the data input for
SEQPEP does not include ion abundances.
Low abundance precursor ions derived from fast atom bombardment
ionization are likely to contain a sig1flcant contribution of matrix
related ions. This portion of the precursor ion signal manifests itself
in a CID spectrum by the presence of evenly spaced ions starting with the
precursor ion, and separated by the molecular weight of the FAB matrix
(e.g. 92 for glycerol). Of course, all complete sequences are
considered to have accounted for them. The type of matrix is entered by
the user.
197
Since all sequences can lose small fragments, such as H20, all
sequences are also considered to have accounted for ions vithin 18.0 u of
the precursor ion mass.
It has been observed that aD and bD ions that contain serine or
threonine will often be accompanied by ions 18 u lover, corresponding to
a loss of H20. These bo-18 and ao-18 ions are therefore included in the
score, but only if the corresponding bg or aD ions are present and only
if they include serine or threonine.
Occasionally, low abundance ions corresponding to an+l are observed
in eIe spectra of peptides, particularly if there is a basic amino acid
N-termlnal to the cleavage site. These are scored only if such a basic
amino acid is present and 1f either the corresponding bo or aD Ion is
also present.
Ions with the structure B~-CRR-CO-(NB-CHR-CO)D-NB-CHR-CO+are the
most frequently observed internal fragment ions, and are included in the
scoring. Immonium-type internal fragment ions corresponding to the
aforementioned structure minus 28 u are also observed and scored r but
only if accompanied by the acyl-type internal fragment ion shown above.
As with an and ba , acyl internal fragment Ions contalning serine or
threonine can lose B10, and are therefore Incl~ded in the score if the
corresponding undehydrated acyl internal fragment ion is also present.
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scored, as are the do and va ions. In addition to the normal do and Wo
ions, there are the so-called secondary d and w 10ns (Section III)
resulting from side chain cleavages remote from the primary point of
cleavage. Since secondary d and v ions become less prominent as they
become more removed from the primary cleavage site, only those that are
one or tvo positions removed are scored.
CIO spectra of a few polyamino acids were obtained for the purpose
of identifying specific neutral losses of side chains and/or low mass
ions, e.g., amino acid immonium ~~ns, characteristic of particular amino
acids. These observations in conjunction ~ith those made on CIO spectra
of other peptides has allowed for the compilation of two lists (see Table
111.10). The first list contains the masses of the neutral losses from
the precursor ion that can be expected for each amino acid. The second
list contains the low mass ions for each amino acid. These Ions
resulting from side chain losses from the precursor ion and the low mass
immonium ions are identified for each complete sequence and are included
in the sequence score.
Having determined the presence, or absence, of all these ion types,
the program calculates the scores. The fragment ion masses that were not
accounted for in each sequence possibility are stored and can be lncluded
in the final output.
Since the amino acid pairs glutamine and lysine, in addition to
leucine and isoleucine, have the same nominal masses and are as yet
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undifferentiated, the program makes this differentiation, if possible~
The only way glutamine and lysine can be differentiated by this program
is if it has been specified that the peptide was derived from a tryptic
digest. In this case, if there is a glutamine or lysine at the
C-terminus the program assigns it to be lysine. Ions at m/z 84 are
usually indicative of lysine, resulting from cyclization and elimination
of NH 3; however, both glutamine and glutamic acid immon1um ions can also
cyclize to form ions at this mass <although to a lesser extent than
lysine). Hence, the presence of such an ion may not be conclusive
evidence for the presence of lysine~ Leuc~ne and isoleucine can be
differentiated based on do and Wo ions. Ions of type do for leucine will
result from the loss of 43 u from the associated ao+l ~on, whereas for
isoleucine, this loss will be 29 u. Likewise, the -0 ion for leucine
will result from a 43 u loss from the associated znt1 ion, while for
isoleucine this loss will be 29 u. If there 1s any ambiguity, for
instance, the presence of both a do 10n indicating leucine and a va ion
indicating isoleucine, etc. t the program will leave it to the user to
make this differentiation. Of course, 1f there are no dD or va ions the
program will leave leucine and isoleucine undifferentiated.
IV.5 Bxamples using SEQPEP and ALTSEQ
As discussed previcusly, the major difference between SEQPEP and
ALTSEQ 1s in the extension scoring. SEOPEP determines extension scores
based on the presence or absence of product ions at calculated masses,
whereas in ALTSBQ these scores are a summation of the product ion
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abundances of ions observed at the calculated values. Thus, subsequences
with the highest subsequence scores, as determined by ALTSEQ, are those
that account for the most product ion current in the data input. For
SEQPEP, subsequences with the highest subsequence scores are those that
account for the most product ions regardless of the ion abundance. Both
programs thus generate lists of complete sequences, which are then
subje~ted to the final scoring procedure where sequences scores are
calculated for each complete sequence. These tvo methods (of SEQPBP and
ALTSEQ) for the calculation of extension scores may in some cases provide
different results, and it remained to be determined ~nY veIl each progLam
was able to interpret different CID mass spectra.
As these programs were developed, they were tested with eIO mass
spectral data obtained from a vide variety of peptides. Representative
of these are the twenty peptides listed in Table IV.2, which shows the
results from SEQPEP, and Table IV.3, where the output from ALTSEQ is
shown. Host of the CID spectra of the peptides 1n these tables are
depicted elsewhere in this thesis; nine of them have not and are
therefore shown in Figs. IV.I-IV.9o The peaks in these figures have not
been labeled, since the point here is to indicate the complexity of the
eIO spectra obtained for each pept1deo In only one case <substance P>,
is the CID data sufficiently simple that the sequence can be deduced
manually in a matter of a few minutes. The same data input was used for
both programs, and the number of fragment ions (ranging between 40 and 94
Ions) is shown in the second column. The fragment ion masses used for
the data input for all twenty peptldes are listed in Table IV.4, and the
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Figure IV.I: CID mass spectrum of bradykinin.
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Figure IV.2: CID ..SI spectrua of Lys-bradyklnln.
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Plgure IV.3: CID DaSS .pectrum of a tryptic peptide from the th1oredox1n
isolated fro. the eyanobaeterlu. Anlblfna.
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Figure IV.4: CID mass spectrum of a tryptic peptide from the thioredoxln
isolated from the cyanobacterium Anabaena.
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Pigure IV.5: eIO -.ss spectrUB of a chr-otryptic peptide fro. the thioredoxin
isolated fro. rabbit bone ..rrow.
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P1sure IV.6: eID ..ss spectrUB of • chy.otrypt1c pe9tlde fro. the thloredoxin
isolated f~o. rabbit bone marrow.
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Figure IVR7: CID mass spectrum of a ~~ aureOU$ protease peptide from the
thioredoxin isolated from rabbit bone marrov.
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Figure IV.S: CID aass spectrum of a.~ aureou~ protease peptide from the
thloredox1n isolated fro. rabbit bone Marrow.
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Figure IV.9: CID IIUlSS ":Mtctrwa of a S. aur.OIl~ protease peptide fro. the
thloredoxln isolated fro. rabbit bone -arrow.
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Table IV.4: Product ion masses used as input for the programs ALTSEQ and
SEQPEP to obtain the results shovn in Tables IV.2 and IV.3.
1. <ELYENK 83.70, 85.75, 101.69, 128.77, 135.79, 146.73,
156.79, 196.92, 200.97, 208.91. 215.92, 224.87,
225.87, 243.93, 244.95, 260.92, 264.78, 292.91,
314.93, 372.10, 374.15, 388.01, 390.09, 407.10,
416.09, 445.18, 478.21, 501.05, 517.18, 537.19,
553.20, 579.24, 586.13, 593.08, 603.17, 607.23,
631.12, 650.16, 670.47, 685.36, 688.49, 692.50,
704.44, 705.40, 717.48, 718.53, 720.39, 721.30,
731.53,732.58, /33.54,734.39,759.57,760.45,
777.40
2. <EH\lSYALRPG-NH 2 70.13,86.12,87.12,100.20,110.11, 112D16,
130. 15, 136 . 21, 159. 10, 170.08, 172. 14, 221. 24 ,
235.26, 249.17, 251.18, 253.23, 274.15, 306.13,
311.24, 312.27, 322.21, 328.19, 354.14, 375.17,
382.25, 383.28, 393.15, 407.16, 425.26, 435.25,
439.17, 440.13, 441.28, 453.24, 467.32, 496.27,
504.26, 510.29, 512.31, 522.20, 538822, 567.26,
569.33, 639.05, 657.46, 658.35, 659.35, 667.10,
673.34, 675.36, 685.36, 701.29, 702.21, 703.3~,
729.24, 730~26, 745.54, 746.46, 756.09, 760.28,
762.36, 770.35, 788.23, 817.41, 869.32, 915.29,
931.38, 932.43, 941.41, 946.20, 948.55, 955.31,
974.37, 997.24, 998.38, 1003.39, 1025.25, 1066.52,
1069.40, 1083.33, 1085.42, 1094.40, 1111.29,
1139.41, 1140.34, 1152825, 1178.41, 1180.20,
1181 .44, 1196. 50
3. ELAGAPPEPA 69.81, 85.94, 101.92, 125.90, 167.00, 186.92,
195.01, 199.02, 215.02, 227.00, 237.95, 242.96,
295.94, 313.94, 323.98, 353.09, 371012, 393.14,
395.06, 413.12. 414.23, 437.13, 442.14, 464.08,
492.04, 50B.14, 510.09, 523.14, 539.25, 581.33,
608e3B, 636.31, 638.18, 679.31, 693.20, 709032,
765.29, 834w27, 878.36, 894.30, 906.35, 951.50
4. PHPFBFFVYK 109.73, 165.75, 206~65, 234.63, 256.99, 262.88,
284.86, 294.99, 309.81, 312.91, 331.79, 353.96,
364.11, 382.07, 431.99, 451.09, 460.06, 479.03,
500.90, 529.46, 588.07, 616.08, 648.19, 675.80,
687.42, 703.63, 735.38, 763.39, 775.60 p 823.55,
824.53, 840.47, 892.53, 910.31, 967.65, 971.47,
981.72,1009.70,1013.89,1041.41,1084.64,
1102.83, 1111.73, 1122.79, 1144.61, 1172.81,
1189.77, 1190.73, 1205.81, 1221.87, 1246.79,
1259.92, 1260.64, 1267.12, 1274.18, 1276.07,
1290 . 91, 1300 . 98 , 1301. 88 , 1302 . 77, 1318 . 60
209
Table IV.4 <continued)
5. RPKfJaFFGLH~~\iE2 70.24, 84.14, 87,25, 112.00, 129.01, 2261.15,
253.96, 27i.02, 296.90, 354.05, 451.23, 522.21;
579.26, 650.39, 707.44, 783.35, 797.32, 837.41 s
854.30, 925.15, 930.47, 984.36, 1001.38, 1058.35;
1059.35, 1129g52, 1171.37, lI89~41, 1198.50,
1217.42, 1229.49, 1242.32, 1247.37, 1260.37,
1272.59,1275.36,1285.59, 1288.71, 1~89.55,
1299.72,1303.42,1330.43,1331.61,1347.70
6. ~YHLTPVEK 70. 01, 72.05, 110.03, 166.05, 169.07; 178w02,
193.06, 1971107, 199.09, 209.10, 220"GB) .:.~23. 11 r
237.05, 251.03, 258.14, 276.03, 280;) ~ 6; ~~90. 08,
126.07, 350.:25, 352. 16, 367.31, 375.24) 380.13,
4:'3.26, 451.24, 470.21 , 472.22, 520. :=Ll _' 540.27,
54L.~24, 555.28, 556.22, 557.16, 573.2:·j~ 581.34,
619.31, 627.30, 647.17, 686.25, 690.'+1, 748.46,
·7~4~64, 776.04, 791.28, 794.20, 807.09~ 823.36,
849.45, 861 .41 , 862.36, 863.45, 865. 31 , '-l77.58 f
U7f: .. 40 J 879.34, 891.40, 904.34, 906.43, 922.50
7. .6ADPNKFYGLH-NB1 69.84, 83.88, 119.98, 129.00, 136.00 r 183.00,
212.05, 229.08, 298.04 p 323.23, 340.16, 368.22,
395.23~ ~22.19, 438.27, 464.30, 481.25, 487.29,
509.11, 566.32, 609.56, 610.50, 620.33, 741.58,
756.42, 766.64, 784.33, 801.30, 811.54, 820.58,
855c59, 897.56, 919.43, 925.57, 947.52, 951.81,
966.49, 968.60, 977.55, 995.56, 1004.46, 1023.74,
1047.69, 1089.53, 1117.83, 1134.59, 1138.56,
1147.61, 1158.62, 1160.99, 1161.75, 1190.64,
1203.58, 1208.63, 1217.50, 1221.63, 1248.73,
1250.68, 1265.60
8. RPPGFSPFR 69.80, 86.89, 111. 98, 119. 90, 130. 01, 154 . 94 ,
165.00,167.00, 175.00, lQS~09, 209.10,217.02,
226.08, 227.18, 236.96, 252.10, 254.10, 273.98,
301.78, 304.72, 305.73, 322.91, 371.03, 376.1'~,
381.06, 402.17, 417.20~ 419.10, 425.27, 451.23,
473.19, 474.26, 489.11, 490013, 510.27, 527.30,
528.24, 561.30, 572.36, 598.35, 614.37, 637.30,
642.22, 651.31, 679.32, 694.38, 711.39, 736.29,
764.27, 779.43, 782.42, 805.40, 858.49, 861.41,
876.32, 886.33, 902.46, 904.47, 929.53, 931.27,
960.43. 969.48, 973.27, 974.47, 983.34, j99.26,
100i.45, 1008.41, 1014.62, 1018.53, 1030.52,
1043.65, 1060.50
9. KRPPGFSPFR
10. TTLSQTLEK
11. VDMVVGAVPK
12. GIPTLLLFK
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Table IV.4 <continued>
69.77, 86.84, 111.85, 119.85, 166.92 1 174.97,
184.93, 216.95, 251.97, 256.97, 258.01, 268.02,
273.95, 281.86, 284.91, 301.80, 305.04, 305.92,
353.96, 370.77, 375.91, 398.97, 402.02, 417.06,
419.20, 451.16, 473.15, 474.08, 486.07, 4B9.12 t
490.16, 506.09, 561.07, 579.21, 636.27, 637.28,
651.36, 655.40, 679.21, 694.25, 700.36, 726.45,
736.31, 742.35, 764.13, 805.43, 839.38, 861.21,
902.40, 904.47, 958.49, 986.48, 1030.43, 1032.52,
1044.54, 1057.56, 1060.47, 1088.55, 1101.56,
1116.46, 1129.53, 1130.88, 1146.62, 1158.71,
11 71•58 , 1188 •50
83.85,85.89,100.85,146.98,175.02,185.04,
187.08, 203.08, 215.07, 215.99, 275.87, 298.13,
299.05, 316.24, 317.05, 330.11, 385.22, 389.22,
403.24, 41~. 16, 417.19, 420.24, 430.24, 444.17,
446.32, 457.25, 459.11, 472.27, 473.22, 490.18,
498.17,513.24,531.20, 544.21, 614.36, 618.29 t
631.27, 632,25, 644.28, 672.31, 673.27, 688.40,
689.50, 705.42, 713.30, 717.37, 727.41, 745.58,
759.38, 762.54, 774.57, 802.40, 818.60, 844.64,
846.73, 856.76, 860.74, 873.78, 874.81, 886.82,
888.63, 891e86, 902.82, 904.i2, 919a86, 932.62,
947.76 1 948.60, 960.99, 961.77, 962.80, 963.71,
975.75, 976.83, 977.78, 1003.01, 1003.93, 1004.85,
1005.60, 1020.50
71.66, 103.90, 171.00, 214.99, 244.10, 247.02,
270.99, 312.06, 327.22, 343.14, 346.09, 398.25,
414.18, 417.30, ~26.26, 445.14, 455.04, 471.31,
502.07, 539.23 j 544.14, 554.20, 570.26, 573.13,
601.26, 638.32, 669.39, 672.40, 695.44, 723.55,
743.26, 771.57, 800047, 826.57, 838.64, 897.69,
908.68, 910.76, 915.62, 939.58, 941.67, 952.68,
953.81, 955.87, 956.71, 966.87, 969.60, 970.21,
971.84, 983.77, ~~6.98, 998.53, 999.91, 1014.60
69 •83, 85 •96 , 120 •00 , 143. 10, 14 7. 07, 171. 11 ,
181.08: 199.09, 216.17, 227.21, 268.27, 284.23,
294.23, 312.19, 329.26, 348.20, 351D26, 369.31,
397.31, 407.35, 425.34, 454.45, 461.30, 464.34,
482.31, 520.43, 538.43, 546.34, 567.48, 574.41,
577.26, 595.42, 633.52, 659.51, 675.53, 680.59,
688.55, 701e58, 703.65, 708.68, 717.57, 718.50,
742.45, 760.74, 788.77, 829.81, 831.84, 855.64,
899.9~, 901.67, 913.78, 915.77, 928.92, 929.82,
944.76, 957.81, 985.88, 1001.60
,
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'fable IV. 4 (con t 1nued)
13. KKG<iKVGEF 84.07, 101.09, 129.09, 186.04, 195.1~, 239.11,
240.06, 257.20, 276.93, 295.15, 297.16, 314.21,
331.17, 357.24, 413.26, 414.25, 442.21, 459.38,
470.02, 485.26, 542.49, 543.38, 563.43, 570.34,
579.33, 598.48, 627.43, 633.33, 641.38, 669.48,
690.35, 691.47, 699.17 y 726.54, 733.34, 748.26,
764.25, 769.66, 790.45, 818.44, 827.35, 855.29,
873.36, 876.41, 884.42, 889.35, 890.46, 892.29 1
902.45, 903.31, 904.51, 916.62, 918.37, 919.52,
929.32, 948.32, 961.41, 962.17, 968.33, 974.54,
975.46, 976.42, 977.42, 989.48, 990.38, 1002.35,
1003.42, 1004.48, 1020.50
14. FHALSEKF 84.06, 102.05, 110.06, 120.08, 129.06, 166.06,
181.05,185 .. 08,193.06,209.07,212.09,240.05,
241.04, 257.07, 268.08, 285.13, 294.19, 304.19,
356.20, 399.14, 441.~3~ 442.26, 469.21, 477.06,
486.33, 494.20, 510.24, 528.33, 538.28, 556.18,
564.34, 599.28, 607.37, 623.31, 635~37, 657.34,
667.28, 678.37, 685.32, 694.29, 702.24, 727.25,
728.35, 749.21, 785.43, 786.24, 813.46, 815.24,
831.19, 857.38, 869.46, 886.29, 887.52, 897.37,
901.26, 90Ss38, 906.19, 918.52, 919~39, 920.29,
921.35, 926.23, 933.43, 934.26, 947.31, 960.31,
961.42, 962.27, 978.50
15. VLDSAGDKLVVVD 72.27, 84.26, 86.26, 129.20, 185.22, 203.16, 213.27,
226.27, 229.25, 233.31, 244.32, 256.20, 283.21,
298.16, 301.21, 316.21, 328.27, 331.17, 341.32,
369.24, 397.34, 414.22, 415.24, 446.07, 485.34,
513.37, 572.38, 584.01, 613.47, 656.22, 658.06,
672.45, 686.91, 727.25, 741.51, 758.34, 759.25,
772.33, 785.55, 786.09, 787.24, 800.28, 813.36,
829.41, 871.50, 881.46, 899.48, 914.40, 915.35,
928.56, 941.26, 956.59, 970.37, 985.06, 986.54,
998.50, 1002.56, 1010.30, 1011.35, 1027.05,
1055.47, 1069.30, 1097.37, 1101.37, 1117.49,
1126.50, 1143.39, 1154.34, 1168.34, 1171.36,
1196.35,1214061,1228.35,1230.40,1241.48,
1256.25, 1257.60, 1272.53, 1286.62, 1298.71,
1311.49, 1313.42, 1314.45 t 1329.50
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Table IV.4 (continued)
16 . KFNVV FIE 72 . 18 p 84. 15, 87. 10 , 101. 18, 120. 16 t 129 • 21, 186. 15,
214.16, 217.18, 229.20, 231.19, 248.21, 261.21,
262.16, 276.17, 319.23, 328.08, 345.19, 362.18,
373.09~ 376.17, 390.15, 427.16, 433.32, 442.21,
459.27, 470.19, 475.17, 476.15, 487.22, 504.19,
515.17, 532.23, 558.24, 561.27, 575.32, 586.22,
603.21, 632.16, 657.32, 660.29, 674.21, 685.33,
702.29, 779.29, 821.13, 849.30, 906.44, 920.35,
934.22, 949.18, 962.41, 980.33, 993.40, 1005.37,
1018.30, 1021.41, 1022.12, 1032.33, 1036.33,
1049.25,1050.02,1051.04,1052.31,1057.21,
1063.30,1064.28,1065.32,1066.28,1079.28,
1109.50
17. VDVDOC·KDIAAEC·E 72.26, 134.25, 187.29, 21Sa25, 231.20, 244.27,
249.26, 277.29, 290.20, 300.27, 309.11, 314~27,
330.14, 340.20 j 357.35, 388.14. 392.26, 405.21,
411.20, 428.21, 429.34, 445.33, 473.13? 482el1,
491.37, 500.10, 509.07, 520.28, 526.28, 544.37,
553.21, 580.30, 587.58, 606.25, 617.48, 635.31,
642.64, 677022, 687.22, 693.32, 705.31, 722.44,
734.29, 748.33, 808.13, 819.55, 833.15, 847.05,
849.46, 859.37, 890.11, 902.46, 904.20, 920.27,
930.63, 936.37, 948~49, 962.12, 973.48, 1015.45,
1016.97, 1019.43, 1033.51, 1043.77, 1061.75,
1086.78,1089.89,1097.11,1104.54,1113.84,
1132.74, 1203.81, 1332.70, 1375.33, 1426.60,
1476.87, 1478.71, 1490.76, 1492.80, 1504.55,
1507.80, 1520.49~ 1522.68, 1524.46, 1535.80,
1548.80, 1567D75, 1580.80, 1583.46, 1593.37,
1596.48, 1597.52, 1598.99, 1609.90, 1640.70
18. NFQTEILDSDK 100.91, 119.95, 234.15 p 262.13, 276.06, 279.13,
316.21, 331.15, 349.25, 359.09, 390.19, 464.34,
473.36, 488.39, 491.38, 518.27, 577.32, 602.39,
620.25, 645.36, 690.35, 716.65, 733.51, 744.38,
819.37, 846.75, 887.43, 903.85. 920.51, 928.52,
961.16, 974.65, 1048.38, 1048.97, 1074.60, 1103.96,
1121.57, 1135.72, 1163.84, 1179.90, 1194.11,
1205.98,1206098,1208.11,1209.23,1210.02,
1221.97, 1237.69, 1250.13, 1252.86, 1266.00,
1280.15, 1292.37, 1293.38, 1294.33, 1309.70
19. SIPTHLIXK
20. KIDEHIG
Table IV.4 (continued)
69.75, 85.93, 103.92, 147.01, 171.18, 173.15,
181.09, 199.16, 201.10, 216.04, 227.14, 260.30,
298.14, 302.14, 312.25, 328.21, 330.21, 346.24,
373.44, 381.22, 399.31, 415.36, 427.34, 443.43,
484.32, 486.43, 512.23, 528.43, 530.33 9 540.46,
556.31, 615.28, 617.38, 625.56, 627.47, 641.51,
643.36, 672.46, 685.69, 687.47, 701.48, 702.64,
726.61, 728.69, 738.83, 744.54, 756.71, 772.44,
813.73, 815.75, 841.61, 869.78, 883.84, 89/.84,
911.66, 913.02, 928.69, 929.91, 941.75, 943.53,
954.04, 958.86, 967.91, 971.06, 985.69, 997.61,
999.74, 1000.97,1015.60
83.91, 85.94, 109.97, 129.03, 191.99, 197.13,
208.15, 214.12, 223.16, 249.11, 251.25, 267.10,
326.21, 357.21, 380.23, 382.16, 400.28, 439.20,
455.15, 458.25, 467.20, 486.35, 495.08, 510.24,
523.38, 570.27, 595.42, 623.44, 638.34, 680.55,
683.43, 694.49, 697.43, 708.61, 736.66, 738.62,
754.53, 766.70, 781.77, 793.73, 811.50
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relative abundances can be gleaned from the associated figures. As an
example, Table IV.S depicts the relative abundance values used in the
case of ~-lipotropin (entry no. 3 of Tables IV.2 and IV.3). The
approximate CPU time required for the combined subsequence generation and
final scoring procedures is listed in the third column <minutes:seconds).
The fourth column shows the sequence scores obtained for the correct
sequence if it was successfully determined by the program. These scores
are the fraction of the total product ion current that can be accounted
for as discussed in Section IV.4. The scoring of complete sequences Is
slightly different for ALTSEO and SEQPEP, which accounts for the minor
variation in scores between Tables IV.2 and IV.3. For example, in ALTSEQ
cn ions are not scored unless both an and bn ions are present, whereas cn
1s always included in the final scoring of the complete sequence list in
SEQPEP. The fifth column shows the ranking, where a rank of I means that
the correct sequence was assigned the highest score. The last column
lists the figure number where each eIn mass spectrum is shown.
For all of the data listed in Tables IV.2 and IV.3 the maximum of
300 subsequences were operated upon, although fewer subsequences can be
used resulting 1n a much reduced CPU time. For instance, allowing a
maximum of only one subsequence in SEQPEP 1s sufficient to correctly
determine the sequence of D-Ala6-LHRH (entry no. 2 in Tables IV.2 and
IV.3) in about five seconds. ALTSEQ requires approximately ten seconds
allowing a maximum of three subsequences. Of course, when using these
programs for the interpretation of CID data of peptides of unknown
sequence its best to allow the maximum 300 subsequences to be operated
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Table IV.5: m/z values and relative abundances derived from the CIO mass
spectrum of ~-lipotropin (entry no. 3 of Tables IV.2 and IV.3> that were
used as data input for SEQPEP and ALTSEQ.
Relative abundance
69.81
85.94
101.92
125.90
167.00
186.92
195.01
199.02
215.02
227.00
237.95
242.96
295.94
313.94
323.98
353.09
371.12
393014
395006
413.12
414.23
437.13
442.14
464.08
492.04
508. 14
510.03
523.14
539.25
581.33
608.38
636.31
638. 18
679.31
693.20
709.32
765.29
834.27
878.36
894.30
906.35
951.50
3.99
1.67
1.44
1.. 66
3.77
10.26
3.02
2.20
8.90
3.45
4.23
8.53
7.28
2.56
27.48
2.66
4.85
3.47
3.53
3.00
2.66
2.91
8.95
2.13
2.23
6.36
100.00
1.75
5.56
4.97
2.76
1.86
3.91
1.72
1.88
6.23
15.49
2.64
6.84
5.48
5.50
(M+H) +
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upon. In all cases, the user-specified parameters were the standard ones
discussed in Sections IV.2.c and IV.3.c; no C or N-terminal sequences
were entered nor were any amino acids specified as being present or
absent to obtain the results in Tables IV.2 and IV.3. For peptides with
C~terminal modifications (carbo~~amide), the mass of the modification was
entered, and the presence of N-terminal blocking groups was entered when
such was the case. For ALTSEO, the mass of the N-terminal blocking group
(pyroglutamic acid) was also entered, whereas for SEQPEP all subsequences
that could not be extended further were stored in the final list of
complete sequences regardless of the remaining unsequenced mass. For
real applications its usually known from other experiments if
post-translational modifications are to be expected. For instance,
peptides not amenable to Edman degradations are probably N-term1nally
blocked.
As can be seen from Table IV.2, SEQPEP in most cases assigned the
highest sequence score to the correct sequence. For ent~y 9, however,
the correct sequence vas ranked fourth. In this peptide there is a
particularly abundant ion that cannot yet be assigned, which happens to
be at a mass corresponding to Yq (m/z 1032.5) if the N-terminal Lys-Arg
of the correct sequence is reversed. As a result, the highest ranked
sequence Is Arg-Lys(or Gln)-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg. The correct
sequence for entry 13 1s ranked fifth. In this case, there are a number
of sequences with similar scores where the highest ranked sequence is
assigned a score of 0.85 and the correct sequence Is assigned a score of
0.84. This illustrates the importance of critically examining the
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computer output to determine which sequence has the most continuous ion
series, and the fewest sequence gaps. Such was also the case fer entry
lB, a peptide of previously unknown sequence where the fourth ranked
peptide gave the most reasonable fragmentations and continuous series of
fragment ions. In some instances, an ambiguity cannot be resolved and
further experiments are required. The output of these programs are
therefore to be considered as an aid in the interpretation of CID
spectra, and to reveal whether the data fits more than one structure.
These pOSSibilities must then be sorted out, sometimes by performing
additional experiments involving perhaps derivatizations or a step of
manual Edman degradation.
There are three peptides in Table IV.2 that could not be sequenced
by SEQPEP - entry 7 (physalaemin>, entry 15, and entry 17. The crD
spectrum of entry 15 lacked reasonably abundant ions resulting from
cleavage between Ala(S) and Gly(6) , and for this reason the correct
sequence cannot possibly be determined from this spectrum alone. Its
interesting to note, however, that the highest scoring sequence~
Val-Leu-Asp-Ser-Arg-Ser-Lys(or Gln)-Leu-Val-Val-Va!-Asp, 1s partially
correct. The peptide of entry 17 resulted in one of the most complex ern
spectra :~~ountered in this work. Hours were spent attempting to
manually determine the sequence of this peptide without success. It vas
hoped that the computer algorithms would provide better results, yet
neither SEQPEP nor ALTSEQ (Table IV.3) were able to determine this
sequence. The sequence was finally determined from other peptides
encompassing the same refion of the protein (rabbit hone marrow
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thioredoxin, see Section VIII).
An example of the output generated by SEQPEP Is shown 1n Fig. IV.IO
for a tryptic peptide of the thioredoxin isolated from E. coli. The
output for ALTSSQ is similar.
Nearly the same results were obtained using the computer program
ALTSEQ, where most of the correct sequences were assigned the highest
sequence score (compare Tables IV.2 and IV.3). There are, however, some
differences between the outputs of these two programs. Of interest 1s
that ALTSEO cannot determine the correct structure of substance P from
its very simple CID spectrum. By observing the generation of
subsequences and the subsequence scores while the program was in
operation indicated that the subsequence P-Q-Q-F-F-G-L-H-NB2 (correctly
determined up to this point) did not have a sufficielltly high subsequence
score to be retained for further calculations. It appears that the
program identifies matches between C-terminal ions calculated for the
wrong amino acid extensions and what are actually the high abundance an
(and do ions). Since the lower mass aD ions (81-a4) from which the
correct sequence 1s deduced are of lower abundance, the wrong
subsequences and amino acid extensions are assigned much higher scores
than the correct subsequence. Presumably, the reason SEa~EP works for
substance P is because 10n abundance has no influence on the subsequence
scores~ This is not to indicate that SEQPEP is always more capable of
sequencing pept1des that give rise to simple CID spectra. There have
been cases (not shown in T&ble IV.2> in which a peptide sequence is
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..... Pile: 11011
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r~rDa-ld~thyl.tedcysteine
No modified ..l~o Beida .~clfled
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Deduced Sequoaee: G I • T L L L , I
IeaalnlDi ....1 0.0
IDten.tty .eor~: 0.959
Score: 0.914
• Iou dIou bIOD.I c lou b-ll
1 0.0 0.0 0.0 0.0 0.0
2 143.1 0.0 171.1 0.0 0.0
] 0.0 0.0 261.3 0.0 0.0
4 0.0 0.0 369.3 0.0 351.3
5 4S4.~ 0.0 482.3 0.0 464.3
6 ~7.' 0.0 595.4 0.0 571.3
7 680.6 0.0 701.7 0.0 0.0
• 0.0 0.0 855.6 0.0 0.0
• Ioaa 8+1 Iou yIOIIII
-lone
I 0.0 0.0 147.1 0.0
2 0.0 0.0 294.2 0.0
3 0.0 0.0 407.4 0.0
4 0.0 0.0 520.4 546.3
5 0.0 0.0 633.5 6'9.~
6 717.6 718.5 0.0 760.7
7 0.0 0.0 831.8 0.0
a 0.0 928.9 ,.u.8 0.0
9 0.0 0.0 1001.6 0.0
a-II at'0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
!I IOIUI " IOD.I v+l' Iou vtl6 IGI18 ,-2
0.0 0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0 0.0
341.2 0.0 0.0 0.0 0.0
461.3 0.0 0.0 0.0 0.0
374.4 0.0 0.0 0.0 0.0
0.0 688.~ 701.6 703.7 0.0
788.1 0.0 0.0 0.0 829.8
0.0 0.0 899.9 0.0 0.0
0.0 0.0 0.0 0.0 0.0
IJu.mal fnc-at I..
538.4 m..u.
531.6 1m.&.
425.3 rru.
425.3 IPI'L
312.2 PI'L
312.2 1ft
121.2 LL
227.2 LL
1".1 "
....... t....t_t.
• '9.1
L 16.0
I 86.0
, 120.0
• I!'GUP 108_
I. 929.'
L 946.1
I 944••
L 957.8
L 957.1
L 957.1
I 957.1
Ualdeot\fled laa.
216.11 ( 0.11)
]29.26 ( 0.13)
'.2.45 ( 1.56)
901.67 ( 2.03)
915.77 ( 1.27)
Iat.mal fnc-at lou - co
397.3 rn.L
]97.3 IPI'L
21at.2 ftL
214.2 1ft
199.1 LL
199.1 LL
171.1
"
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675.5 6 L
913.1 0 T
520.43 mJ.L
510.43 IrTLL
.al.15 m.L
.07.35 mL
2M.U m.
214.23 1ft
111.01 "
Figure IV.10: The partial output created by SIQPEP for the peptide of entry 12.
Only the results for the highest scoring sequence Is reproduced here.
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easily deduced from a continuous series of very prominent bo ions where
the CIO spectrum also contains a few other ions of much less abundance.
If the data input for SEQPEP includes the lower abundance ions, its
possible that several incorrect amino acid extensions may account for
more of these ions, and the correct amino acid extension will account for
only one ion (bol. Since product ion abundance plays no role in the
subsequence generation routine of SEQPEP, the correct amino acid
extension may not recieve the highest extension scores and the correct
complete sequence may not be identified. Of course, in such cases the
lov abundance ions could be eliminated from the data input and SEQPEP
would correctly determine the structure. Alternatively, peptides that
give rise to simple CID spectra could be sequenced manually.
Also of interest is that the structure of bradykinin (entry no. 8>
is not identified by ALTSEQ. However, if it is specified that histidine
is not present in the structure (which can be deduced from the absence of
the histidine immonium Ion at m/z 110>, ALTSEQ correctly determines the
sequence of bradykinin. Entries 15 and 17 could not be sequenced, as was
the case using SEOPEP.
In this list of twenty peptides there was one, physalaemin (entry
no. 7>, for which SEQPEP was not able to determine the correct sequence,
whereas ALTSEQ was able to do so. However, the correct structure was
ranked fifth with a score of 0.82. The highest ranked sequence,
<Glu-Va!-Ser-Pro-Asn-Lys(or Gln)-Phe-Tyr-Gly-Leu-Met-NB2• had a score of
0.83. This Is another instance where there are a number of s~quences
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with similar scores.
In summary, there were only two instances in these twenty cases
where neither prog~am contained the correct sequence in the output -
entries 15 and 17. In the former case, sequence ions indicating cleavage
between two of the amino acids (-Ala-Gly-) were missing from the eIO
spectrum, and it was therefore impossible to correctly determine the
structure. Despite this, a large part of the sequence was correctly
deduced. The second case (entry 17> was one of the more complex CID
spectra encountered. Tn general, most of the twenty peptldes selected
did not provide very simple CIO spectra. Despite this success, it should
be emphasized that the output from either of these programs cannot be
accepted blindly. Instead, the sequences provided by these algorithms
should be taken as suggestions, and it remains for the user tc determine
in each case the reliability of these suggested sequences.
IV.6 General rules of interpretation - using SEQPEP and ALTSEQ
Although SEQPBP and ALTSEQ frequently determine the correct sequence
and may even assign it the highest sequence score, it 1s important to
remember that these programs (and computer programs in general) are an
attempt at making large problems seem smaller. Our knowledge of how
protonated peptides fragment upon collisional activation is still
incomplete (witness the fact that none of the sequences in Tables IV.2
and IV.3 were assigned a score of 1.0). Furthermore, there are still
some CIO spectra of peptides for which neit~er of,these programs viII
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correctly determine the sequence, and in some cases the correct sequ~nce
1s not assigned the highest sequence score. Nevertheless, peptides and
proteins (see Sections V-VIII) can be sequenced from CIO mass spectral
data and these programs provide a semi-automated method for their
interpretat1ono There is still a need for a skilled interpreter capable
of making judgements concerning the computer output and to assemble the
pieces into a completed protein sequence. The remainder of this section
is a discussion of some of these judgments.
Vhen deciding whether a sequcnce adequately accounts for the product
ions observed in a eIn spectrum of a peptide, there are a few general
considerations to keep in mind. It nov appears as though the main
determinant of the types of ions observed In CID spectra of protonated
peptid~s is the presence and location of basic sites (Section III).
Collisional activation of peptides containing arginine result
predominantly in remote site fragmentations where the proton resides
largely on the guanidino group of the arginine side chain. Cleavages
C-terminal to arginine therefore result almost exclusively in an and do
ions, where aD forms a continuous series. Cleavages N-t~'rminal to
arginine result 1n a wide variety of C-termlnal fragment ivns including
va and va' with very few N-terminal Ions. Typically, Yo ions will form a
continuous series in this case, although there may be considerable
variablility in the abundance of these Ions. The other C-terminal ions
may not necessarily form a complete series, and there may also be wide
variability in the abundance within each 10n series.
..:?J
Histidine and lysine are of approximately the same moderate gas
phase basicity <93>, and seem to allow both remote s~te and charge
induced cleavages. If either of these amino acids are at the N-terminu~,
ions of types aD (plus dQ ) and ba are usually prGminent and generally one
or both viII form a complete series. Some C-term1nal ions may also be
observed, usually only Yn , but m4y not necessarily form a complete
series. As with arginine, 1f these two amino acids are at the
~·term1nus, a wide variety of C-term1nal ions are often observed
including va and vD- Ions of type Ya usually form a continuous series,
but not necessarily with the same abundancp throughout. !he other
C-terminal ions may not form a continuous series and the abundances
within each series may vary. N-terminal 10ns are also observed if
histidine or lysine 1s at the C-termlnus. Although aD' Ca' and do may
not be abundant (and are usually absent), bD ions may be fairly prominent
and often form a completed series (except, as is always the case, hi Is
not observed).
Peptldes that lack basic sites yield fairly simple eIn spectra.
Usually bD Ions are the most abundant series, and occasionally a bn Ion
is accompanied by an a4 ion of much less abundance. Ions of type Yo are
also fairly prominent. Both bn and Ya are likely to form continuous
series.
Two other amino acids have localIzed effects on the fragmentations
observed in CID spectra. If glycln~ 1s at the C-terminus of an aD lon,
that ion is usually of much reduced abundance and may be absent. Ions of
2~4
type Ya with proline at the N-teralnus are almost always of high
abunance. On the other hand, Yo ions resulting from cleavage on the
C-termlnal side of proline are often absent. Additionally, proline at
the C-termlnus of a ba ion often seems to induce eliMination of CO to
form preferentially the aa lone
Low mass amino acid tmmonium ions often provide useful information.
There ere tvo types of conclusions that can be drawn fro. these ions,
namely that certain amino acids are present in a peptide or that they are
absent. Table IV.6 lists the conclusions that can safely be made from
the presence of these ions. This information differs fl"O. that shown in
Table 111.10 in that Table IV.6 Is an abbreviated list containing the
more abundant low mass ions, which If present strongly suggests the
presence of particular amlno acids. Table 111.10 lists all possible low
mass 10ns that may result fro. each amino acid. For instance, the
presence of methionine in a sequence Is strongly suggested by the
presence of an ion at m/z 104; if m/z 61 is also present at low
abundance one would conclude that this ion is also du~ to methionine.
Alternatively, an Ion at _/z 61 without an ion at m/z 104 does not
indicate the presence of methionine. It is more difficult to conclude
that an amino acid Is not present based on the absence of Immonlum ions.
However, if the immonlum ion of histidine at m/z 110 <which if present is
quite pro.lnent) is not observed and other immonium ions are found in the
spectrum, then its safe to conclude that histidine 1s absent from the
sequence.
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Table IV.6: The following low mass ions indicate the presence of
particular amino acids. The amino acids in parentheses indicate amino
acids that may give rise to a loy ~ss ion
W
70, 87, 100, 112
70 (w/o 87, 100, and 112)
72
84 (v/o 101>
86
101 (via 84)
102
104
110
120
133
134
136
159
Alino Acid PreslD1
Arginine
Proline
Valine
Lysine
Leucine or Isoleucine
Glutamine
Glutamic acid
Methionine
Histidine
Phenylalanine
carbamldoBethylated Cysteine
C8rboxymethylated Cysteine
Tyrosine
Tryptophan
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These general principles are helpful In determining which, if any,
of the sequences suggested by the algorithms is correct. Not only is it
important to account for as many product ions as possible in aCID
spectrum, but to also be sure that the ion types assigned by a sequence
are reasonable with regards to the presence and locatio" of basic amino
acids. Furthermore, while carrying out structural studies on proteins,
CIO spectra of 2everal pept1des encompassing th~ same regions are often
acquired. In such cases the deduced sequence of this region should
account for as many product ions 1n a reasonable aanner as possible for
a~l of the peptides.
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Section V
Primary Structure of the Thloredoxin Isolated From ChlorobiulD
thiosulfatophilu!D Using a Combination of Mass Spectrometric Methods
V.I Introduction
Th1oredoxlns are relatively 8..11 proteins (typically 12 K daltGDs)
that are involved as cofactors in a variety of important
oxidat.ion-reduction reactions including ribonucleotide reduction,
reduction of sulfur containing co_pounds and regulation of photosynthesis
(108-110). While initially studied ..inly 1n B. coli (111), this
ubiquitous protein has since been isolated from a variety of procaryotic
as well as several eucaryotlc systeBS (lOS-109). Six thloredoxins have
been sequenced to date, those fro. the bacteria ~ coli (112-113), Cl
and C2 types from Coryn~b.cteriun2 nephridil (114-115), the cyanobacterium
Anabaena 7119 (116), bacteriophage T4 (117), and mrtype thloredoxins from
spinach chloroplasts(llS). Bxcept for T4 thioredoxin, these proteins
show considerable homology. The three-dimensional structures of T4 and
£ coli thioredoxins have been determined (119-120) and found to be very
similar In spite of large differences in their amino acid sequences.
Thloredoxins also show similar functional activity and those from
different species are often able to substitute for each other in in vitro
assay systems (108-110). These findings suggest that thloredoxlns from
different sources are very similar and that they were derived from a
common ancestor. The importance as well as the vide occurrence of these
proteins make them peomising tools for studying the evolutionary process
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by investigating their primary structures.
The functional similarities of the thloredoxlns, as vell as the
considerable homology between the bacterial and spinach proteins
suggested the use of FABHS as a means of sequencing these proteins. The
goal at the outset was to determine the masses of proteolytic or
chemically cleaved peptldes derived from th1oredoxlns of unknown
structure, and compare these values with those from thloredoxlns of known
sequence. Peptldes of the same mass would presumably have the same
sequence, although in Section VIr a case Is presented where the masses of
two relatively small tryptic pept1des derived from the thloredoxins of R.
rubrulD (of previously unknown structure) and E. coli are ot equal mass
and encompa~s the same region of the protein, but have different
sequences. However, initial experiments comparing the molecular weights
of the tryptic peptides from the thioredoxln isolated from ChlorobiulD
thiosulfalophiluln, a photosynthetic green sulfur bacterium, with those
from E. coli showed that none of them matched, thus indicating that the
tvo sequences were not as homologous as was hoped. Thus, it vas
necessary to determine the, sequence of Chlorobiuln thioredoxin dlrectly~
This involved the determination of the molecular weights, using FABHS, of
the pept1des generated from thloredox1n by digestion with various
proteolytic enzymes or by chemical cleavage. These data, when combined
with manual Edman degradation followed by molecular weight determination
of the truncated peptides by FABMS revealed a portion of each peptide
sequence. These partially sequenced peptides were aligned with the £
coli se~uence so that homology between the two thioredoxlns vas
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maximized, which led to a tentative ChlorobiulD sequence (121)~
Additional infor28tlon obtained from CID mass spectra of tryptic peptldes
led to the final primary structure of this thlored~xin <122>.
V.2 Materials and Methods
ChlorobiuJD thloredoxln vas denatured in 6 Mguanld1nlum
hydrochloride, and reduced with a fifty fold molar excess of
dithiothreitol. The reduced thioredoxin vas alkyl.ted with a 2.6 fold
molar excess over dlthlothreitol of iodoacetic acid to form the
S-carboxymethyl cysteine derivative, and desalted on a polyacrylamide gel
column with a molecular weight cutoff of 6,000. In amounts ranging
between 120 and 600 ug, the carboxymethylated thioredoxin vas digested
wi th Staphylococcus aureus (strain va> protease, trypsin, chymotrypsin,
or thermolys1n <50-100:1 substrate/enzyme) for two to twelve hours at
37 OC in a volatile buffer (87mM NB40Ac, O.lmM caCIJ~ pB 8.3). The
progress of the digestion was monitored by reversed phase high
performance liquid chromatography (BPLC) as described in Section I.
After completion of the digest, as indicated by a stable BPLC pattern,
the digests were separated into five to eight HPLC fractions which were
then taken to dryness 1n a vacuum centrifuge. For some experiments,
tryptic digests were used directly, without fractionation.
The manual Edman degradation procedure has been dlscu~sed in Section
II. Automated gas phase Bdman degradation was carried out for twelve
cycles by Dr. Nancy Royal, Creative Biomolecules, Hopkinton, HA.
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Tvo nano.ales of ChlorobiulD thioredoxln vas hydrolyzed at 110 OC for
24 h in an evacuated 10 x 70 .. ignition tube containing 0.1 ml uf
constant-boiling HClo Amino acid analysis vas performed on a Dionex
0-500 amino acid analyzer.
The ChJorobiulD thloredoxin vas isolated i" the laboratory of Prof.
Bob B. Buchanan at the University of california, Berkeley (122). The
FABHS/Bdaan experiments were carried out by Dr. V. R. Mathews»
currently of Upjohn Company, us1n, the Varian-KAT 731 mass spectrometer
de~crlbed in Section II. The CID mass spectra were acquired un the JBOL
BX1IO/BX110 as discussed in Section I.
Trypsin (dlphenylcarbamyl chloride treated>, chymotrypsin, and other
biochemicals were obtained from Sigma Chemical Co., St. Louis, MO.
Ther.olysln vas ob~alned fro. calbiochem-Behring Corp., La Jolla, CA, and
Staphlococcal protease strain va fro. Hiles Scientific Inc., Blkhart, IN.
P-6DG gel matrix vas purchased from Bia-R&d Ltd., Richmond, CA.
Trlfluoroacetlc acid, cyanogen bromide, phenyllsoth1ocyanate, heptane,
heptafluoroisopropanol, dimethylamine, pyridine, dithiothreitol,
dithloerythritol, and ethyl acetate were from Pierce Chemical Company,
Rockford, IL. All other reagents were the highest grade available and
were obtained from local suppliers.
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V.3 Results and Discussion
As previously mentioned, none of the tryptic peptidea from
ChlorobiulD thloredoxln matched those fro. the E. coli protein;
therefore, additional sequence information vas required. Initially, such
information vas obtained by manual Bdman degradation followed by PABMS
after each step. The difference In molecular weight of each peptide in
the mixture before and after each step of Bdman degradation indicates the
successive N-termlnal amino acids in each peptide present in the mixturee
The ~~ly am~iguities are due to tvo pairs of amino acids:
leucine/isoleucine and lysine/glutamine. The latter pair is not a
problem when found in tryptic peptldes because lysine is a tryptic
cleavage site. Furthermore, the presence of lysine manifests itself by
the addition of 135 u, due to the reaction of the £-amino group with
phenyl1soth1ocyanate during the first Edman step. The information thus
generated will hereafter be refered to as FABMS/Edman data.
In order to obtain further sequence information for those portions
of the protein not covered by the tryptic peptldes as well as to provide
the overlap necessary to establish the order of the tryptic peptides,
several other enzymatic and chemical methods were used to produce
additional peptide mixtures. These were then subjected to Edman
degradation co.bined with FABMS, but usually for fever cycles~ The
results of these experiments are summarized in Table V.I. These
peptldes, are also shown in Pig. V.I aligned under the Chlorobiuln
thioredoxin sequence arrived at on the basis of the work described here.
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Table V.I: Summary of FABHS/Bdman data. The m/z value of the <H+8)+ ion
is followed by the N-terminal amino acids (in parenthesis); the number
of asterisks indicate the nu.ber of lys1nes in the re-a1ning unsequenced
portion of each peptide as deduced fro. the addition of 135 u to each
lysine. lIe indicates leucine or isoleucine, which cannot be
differentiated using this technique.
Tryptic peptides
S15(Ala-Xle)'; 576(Asn-Met)'; 811(Lys-Xle-Asp-Glu); l015(Ser)';
1156(Val-Val-~~p-Gln-"et-Val-Gly-Ala)'; 1309(Asn-Phe-Gln-Thr-Glu-Xle)I;
1446(Xle-Asn-Val-Asp-Glu-Asn-Pro-Asn); 1646; 1772; 1931
Cyanogen bromide/Tryptic peptides
380(Val>; 486; SOO<Ser); 515; 584(Val)e; 683;
873; lOlS(Ser)'; 1048; 1156(Val)'; 1309(Asn)';
1646(Xle)'; 1777(Het)'
774; 811(Lys); 849;
1446(Xle); 1533;
ThermolYJic Peptides
683(Xle-Asp-Glu); 686(Xle-Arg-Ser); 755(Xle-Gly-Pro); 817(Xle-Arg>;
860<Xle)'; 136S(Phe-Gln-Thr)'; 1478(Phe)'; 1717(Xle-Gly>'
Staph Protease Peptide,
853(Gln)i l053(Ala-Thr-Asp)'; 1187(Xle)'
Table V.I (continued>
~Chymotryptic PeDt1d"
584; 743(Gly-Xle); 75S(Gly-Pro); 868(Xle-Gly); 987<Gly-Xle);
999(Het-Xle); 1123; 1332(Xle-Gly)
o-Chylotryptlc/TryDtic Peptide,
51S(Ala-Xle)'; 576; 661(Ser-Xle-Pro); 811; 873<Tyr)'; l015<Ser)'j
l04S(Gln-Thr-Glu)'; 1134(Tyr-Phe-Glu)'; 1156; 1219(Gly-Pro);
1309(Asn-Phe)'; 1446(Xl~-Asn-V~1-Asp-Glu)i 1533(Gly)'
Cyanogen bromide Peptides
781(Val-Gly-Ala)·; 1123(Xle-Ala)"; 1252(Xle-Xle)··
Staph Protease/Tryptic/Cyanogen bromide Peptides
51S(Ala-Xle)'; 576(Asn-Met)'; 584; 627(Xle); 700(Gly-Lys)';
758(Het>; 781(Val)'; 811(Lys-Xle); 816; 1015; 1123(Xle)'t; 1156;
1187; 1252(Xle)"; 1398; 1461CXle); 1772<Xle-Asn-Val-Asp)
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Figure V.I: The ..ino acid sequence of CA/orobiulD thioredcxln &s compar@d
to ~ coli thloredoxln. 'I' stands for either leucine or isoleucine.
Solid lines are placed under peptide. observed by PAlMS. Balf arrows
immediately beneath the solid lines indicate am1no acids identified by the
mass dlffe~ences deter.1ned after shortening the peptide by consecutive
manual BdBBn degradations. Identifications A through I refer to the type
of data: (A) the heavy markings laid over the solid lines show regions
where the sequence of tryptic peptide. vas deteralned fro. CID mass
spectra; (8) FABM5/Bdaan of tryptic peptides; (e) PABMS/Bdaan of cyanogen
bro.ide/ tryptic peptldes; (D) PABMS/ldaan of thermolytic peptide.; (I)
PABMS/Bdlll8l1 of S. aureul (strain V8) protease peptides; <P) PAlMS/Edman
of m-chymotryptic peptides; (G) vABMS/ld.-n of .-chymotryptlc/tryptic
p~ptldes; (8) FABMS/Bdman of cyanolen bromide peptldes; (I) PABHS/Bdma..
of S. aureus protease/tryptic/cyanogen bromide peptldes. Underllnings B
through I i.ply peptldes the .olecular weights of which corresponds to that
region. Balf arrovs beneath the first twelve aaino acids indicate data
obtained by autoaated Bdaan degradation. AMino acids in parenthesis are
assigned on the basis of hOllOlogy and total mass.
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Subsequent to the FABMS/Edman experiments, a JEOL HXIIO/BXIIO tandem
high resolution mass spectrom~ter vas installed in the laboratory at HIT.
Thus, it was possible to acquire CID spectra of a number of the tryptic
pept1des from ChJorobiuLD thioredoxin, including some not presented
previously (121), and thus obtain independent sequence information. For
this purpose, a tryptic digest of the remaining 120 ug of
carboxymethylated thioredoxln was partially fractionated using reversed
phase HPLC (Fig. V.2). Figures V.3-V.5 represent examples of tbe eID
spectra obtained from these tryptic pept1des. The ion types have been
dlscus~@d in Section III, and the nomenclature is summarized in Scheme
111.2. Product ion assignments were always within 0.4 u of the
calculated values.
At this stage of the investigation we had not yet worked out the
conditions for optimizing the sensitivity of the mass spectrometer in the
four-sector mode for peptides of higher molecular weights (96).
Therefore 9 for some samples recourse was taken to operating the first two
sectors (MS-l) in the "linked scan" mode (chapter 9 of reference 42).
After fragmentation of the ("+8)+ ion in the first field free region
(directly after the 10n source) the product ions are brought into focus
by scanning both the electric sector voltage (E) and the magnetic field
<B> simultaneously while keeping the BIB ratio constant. The resulting
spectra, compared to the fou~ sector mode, have higher product ion
abundances, but lover precursor ion resolution. Figure V.6 demonstrates
the utility of two-sector BIE linked scans. The data obtained from the
CID ~ss spectra of tryptic pept1des is summarized in Table V.2, and the
~37
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P~lUre V.2: BPLC cbroaatolram of a tryptic diseat of S-carboxyaethylated
CAlorobiulD tb1oredox1n. The aarkinls indicAte collected fractions.
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sequences that were deduced from this data are shown as heavy markings
laid over the solid lines labeled A in Fig. V.I.
The sequence of the thioredoxin from ChJorobiulD v~s deduced from the
large set of data summarized in Figure Vol, Tables V.I, and V.2 in the
following way. The first twelve N-terminal amino acids were determined
by gas phase Edman sequencing, indicating a Lys in position 10 followed
by Asn and Phe. Thus, a tryptic peptide with a N-terminal sequence
Asn-Phe would begin at position 11. This Is the case for the tryptic
peptide of ("+8)+ ~ m/z 1309, the sequence of which was determined from
its CID mass spectrum (Pig. V.4). Thus, the sequence vas extended to
position 21.
A tvo sector B/I linked scan of the peptide derived from a tryptic
digest of <M+B)+ a m/z 1931 revealed a portion of its sequence,
-Phe-Trp-Ala-Ser-Trp-Cys(cm)-Gly-, where Cys(cm) is carboxymethylated
cysteine, which by ho.ology with ~ coli thloredoxin was assigned
positions 21-33. Prom this spectru. the N-terminal residue mass (the
mass corresponding to -BNCBRICo---BNCBR.~, i.e., positions 22 - 26,
assuming no deletions of aaino acids compared to E. col~ vas found to be
497 u, and the C-termlnal residue mass was found to be 520 u. The
N-termlnus vas deduced fro. the presence of tvo thermolytic peptides of
("+8)+ = m/z 1365 and m/z 1478. The first of these begins with
Phe-Gln-Thr and its molecular weight indicated that it extends 170 u
beyond the tryptic peptide of <M+8)+ • ./z 1309. The second thermolytic
peptide begins with Phe and is 113 u larger than the first. These mass
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differences correspond to Ala plus Val (71 u + 99 u), or Gly plus Xle <57
u + 113 u), respectively, followed by Xle (113 u>, where Xle is either
Leu or lIe. Ve chose Aia-Val-Xle as the most likely sequence, as this
provides for the maximum homology with the thioredoxins from E. coli
(112-113>, the cyanobacterium Anabaena (116), and C. nephridil (114).
Since the sequence Ala-Val-Xle was assigned positions 22-24, this left
214 u for positions 25-26.
A peptide derived from a CNBr/tryptlc cleavage of <"+8)+ = m/z 380
was found by subtractive Edman degradation to have an N-term1nal Val
(Table V.l>, which in the final Ch/orobiulD thioredoxln sequence could
only be placed 1n postions 25-27. Since position 27 is known from the
CID mass spectrum of (M+8)+ = m/z 1931 (Table V.2) to be Phe, position 26
must be Asp. Thus the sequence has been extended to position 33. The
C-terminus of the tryptic peptide of <H+8)+ = m/z 1931 vas deduced from
the presence of a peptide derived from a CNBr/tryptic cleavage of
<"+8)+ ~ m/z 1777, which vas found to have an N-termlnal Met. This
peptide 1s 131 u (which corresponds to the residue mass of Met) larger
than the peptide of ("+8)+ • m/z 1646 derived from a tryptic digest,
which encompasses positions 38-52 (to be discussed below). Bence, this
peptide provides overlap between the pept1des of ("+B)+ • m/z 1931 and
m/z 1646. It also reveals that the C-terainus of the peptide of
<H+8)+ 3 m/z 1931 Is Met. Furthermore, since the peptide of
("+8)+ = m/z 1177 was derived frOB a CNBr/tryptlc cleavage, and since
there is no evidence that trypsin alone cleaves at this position, it is
concluded that there must be a second Met preceedlng the N-ter.lnal Met
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of the peptide of ("+8)+ ~ m/z 1777. Thus the peptide of
<"+8)+ = m/z 1931 ends with Met-Met (positions 36-37). The original
C-terminal residue mass of 520 u minus the residue mass of tvo
methion1nes leaves 258 u for positions 34 - 35, which could have the
following amino acid compositions: Pro, Cys(cm) <carboxymethylated
cysteine); Glu, Glu; GIy, Serf Asn; or Gly, GIy, Gly, Sere Since
these positions make up part of the highly conserved active site region,
it is likely that the sequence at positions 34 - 35 is Pro-Cys(cm).
The peptide of ("+8)+ = m/z 1646 was derived from a tryptic digest
and the HS/MS spectrum indicated the partial sequence
-Val-Ile-Glu-Gln-Leu-Ala-Asp-Asp- with an N-termlnal residue mass of 267
u and a C-terminal residue mass of 477 u. A thermolytic peptide of
<"+8)+ = m/z 755 had an N-terminal Xle-Gly-Pro sequence, which
corresponds to a residue mass of 267 U; the remaining mass corresponds
to the Val-Ile-Glu-Gln portion of the sequence discussed above. This and
other information shown in Table V.I and Flg. V.I confirm that the
N-terminal sequence of the tryptic peptide of (H+8)+ = m/z 1646 Is
Xle-Gly-Pro. The C-terminal portion of this peptide is deduced as
follows: a chymotryptlc peptide of (Ht8)+ ~ m/z 1332 with an N-terminal
Xle-Gly encompasses the mass of the nov known part of (M~B)+ m m/z 1646
plus 163 u, which extends the sequence by Tyr. Similarly, a pept1~e
derived from a SPV8/tryptic/CNBr cleavage of ("+8)+ • m/z 1461 with an
N-term1nal Xle is 129 u heavier than the aforementioned (H+8)+ • m/z 1332
and extends the sequence to include Glu. The nature of the re~in1ng
residue mass of 185 u, as veIl as overlap with the next tryptic peptide
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was deduced from the SPVS/tryptic/CNBr peptide of <H+8)+ a m/z 700 0 which
vas found to have an N-terminal Gly-Lys. This mass corresponds to
Gly-Lys plus Ala-Ile-Ile-Ala-Lysp a tryptic peptide of (H+8)+ • m/z 515,
which was completely sequenced from its CID mass spectrum. This
establishes the sequence to position 57.
There is no overlap leading 1nto the next tryptic pept~de, which had
to be placed by homology alone. Part of the sequence of the tryptic
peptide of (H+8)+ = m/z 1772 was deduced from a two-sector B/E linked
scan (Fig. V.6> to be -Glu-Asn-Pro-Asn-Ile-Ala-Gly-Gln-Tyr-, which fits
best the region of positions 62-71 of the E coli product. Subtractive
Edman degradation of a related peptide of <H+B)+ = m/z 1446 that had
undergone a chymotryptic cleavage at the C-terminus indicated an
N-term1nal sequence of Xle-Asn-Val-Asp-Glu-Asn-Pro-Asn. The first four
amino acids match the mass of the undefined N-term1nus of the tryptic
peptide of <M+8)+ = m/z 1772 (Table V.2). The remaining C-terminal
sequence vas deduced from the chymotryptlc peptide of <H+8)+ = m/z 987
with Gly-Xle at the N-term1nus, and a thermolytic peptide of
<"+8)+ = m/z 686 with an N-terminal Xle-Arg-Ser. The next tryptic
peptide thus begins with Ser and must therefore be that with
<"+8)+ • m/z 1015, which vas completely sequenced from its CID mass
spectrum (Fig. V.S). Thus, the sequence 1s extended to position 82.
There Is no FABHS/Edman or CID mass spectral data in direct support
of the sequence assigned to positions 83 - 85. However, a cyanogen
bromide peptide of <M+8)+ M m/z 1252 and encompassing positions 79 -- 90
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was shown to have an N-:erm1nal sequence of XIe-Xle upon two Edman
degradation steps CTable V.I)o Also, the presence of two lysines in this
peptide was deduced from the observation of an addition of 2 x 135 u (due
to the re~ction of phenylisothlocyanate with the £-amino groups of t~o
lysines> to the truncated peptide after the first Edman stepv Since the
sequences of positions 79 - 82 and 86 - 90 are known from Edman/FABMS ano
HS/MS data of tryptic peptides encompassing these regions, the remaining
mass for amino acids 83 - 85 (-NB-CHRI3-CO-NH-CHRC4-CO-NB-CHRls-CO-) is
242 u. Furthermore, part of that must include the second lysine of this
cyanogen bromide peptide, because the first one is already known to be at
position 82. This leaves 114 u which must be either tvo glyclnes or one
asparagine. Under the assumption that there was no amino acid deletion,
the sequence of amino acids 83 -85 must be Gly-Gly-Lys.
Many overlapping peptides require that the next tryptic peptide is
that of <"+8)+ = m/z 1156, which was sequenced up to position 94 from its
ern spectrum and subtractive Edman degradations, leaving 225 u for the
remaining C-termlnal residue mass. Since Lys ~ust be the C-term1nal
amino acid of this tryptic peptide, because it adds 135 u during the
first Edman step, positions 95 - 96 must represent Pro-Lyse The last two
tryptic pept1des of (M+B)+ • m/z 576 and m/z 811 (Pig. V.3) were
sequenced entirely from their CID mass spectrum, and their relative
positions are unambiguously defined by redundant and overlapping data.
In particular, the CNBr peptide of (H+8)+ • m/z 1123, which begins with
Xie-Ala and was found to contain two lysines by the addition of 2 x 135 u
after the first Edman step, fits only positions 99 -108u Furthermore,
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the tryptic peptide of <"+8)+ • ~/z 811 does not end in a basic amino
acid, and thus most likely represents the C-terminus of the ChlorobiulD
thioredoxin.
The data obtained by tande. mass spectrometry led to a few
corrections in the earlier tentative sequence (121). Positions 17-20 had
been assigned Phe-Pro-Ala-Asp primarily by maximizing homology with E.
coli thioredoxin; however, the tandem mass spectra of the tryptic
peptide encompassing positions 11-21 (Fig. V.4) indicated
Leu-As~-S£r-Asp instead. Likewise, a tvo-sector B/E linked scan of the
tryptic peptide ranging from position 22 to 31 gave a partial sequence of
Phe-Trp-Ala-Ser-Trp··Cys-Gly, which covers the middle portion of the
peptide. From this spectrum one can also deduce that the remaining
portions of this peptide (preceedlng Phe and following Gly> have the
expected masses as predicted by the tentative sequence. Thus, this
spectrum indicated only one error - serine rather than glutamic acid at
position 30. Similarly, a two sector BIB linked scan of the peptide of
<"+8)+ = m/z 1646 gave a partial sequence of
Val-Ile-Glu-Gln-Leu-Ala-Asp-Asp for positions 41 - 48, rather than
Xle-Xle-Asp-Gln-Xle-Gly-Asp-G1u. Finally, a tvo-sector linked scan of
the tryptic peptide covering positions 58 through 73 (F1g. V.6) provided
sufficient data to assign residues 66-70 to be Ile-Ala-Gly-Gln-Tyr,
rather than Phe-Ser-Gly-Xle-Lys.
For the most part, the sequence Is supported by the large amount of
data sumgar1zed in Fig. V.I. Nevertheless, there are regions of the
249
sequence - positions 22-23, 34-35, and 83-85 - that cannot be directly
deduced from the data. However, the masses of these unsequenced regions
are known, thus limiting the amino acid compositions for these positions.
These positions were then assigned so as to maximize homology with £
coli and other bacterial thloredoxins t under the constraint that the
amino acids added up to the known mass.
Table V.3 compares the amino acid composition predicted from the
sequence v1th that determined by amino acid analysis. The only major
discrepancy is t:~~ lower value <84%) for the sum of leucine and
isoleucine in the analysis. This may be due to incomplete hydrolysis of
sterically hindered Ile(or Va!)-Ile(or Val) bonds.
V.4 Conclusion
In summary, the amino acid sequence of ChlorobiulD thiosulfatophilulD
thioredoxin has been determined using a combination of mass spectrometric
methods, including FABMS in conjunction with subtractive Edman
degradation, and tandem mass spectrometry. Sequence information obtained
from CID mass spectra in the final stages of the work proved particularly
useful and efficient. The data available did not permit the unambiguous
assignment of positions 22 - 23, 34 - 35, and 83 - 85; however, the
masses of these segments were known, and the most homologous sequences
were chosen under these constraints. The only unresolved question is the
differentiation of leucine from isoleucine at positions 24, 38, 58, 72,
and 81. At the 14 other positions do and va ions present in the CID
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Table V.3: Comparison of amino acid compositions of ChlorohiYm
thioredoxin calculated from the sequence shown in Fig. V.I, and amino
acid analysis (tryptophan vas not determined).
Amino Acid Analysis Sequence
Ala 11 10
Arg 1 1
Asp/Asn 13 14(915)
Cys 2 2
GIu/GIn 10 10(6/4)
Gly 9 10
His 1 1
Leu/lIe 16(719) 19
LY3 9 10
Met 5 5
·Phe 3 3
Pro 5 5
Ser 4 3
Thr 3 3 It
b
Tyr 3 3
Val S 7
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spectra permitted the differentiation of these two isomeric amino acids
(see Section III). It should be stated that FABMS in conjunction with
subtractive Edman degradation is not a recommended procedure for protein
sequencing. This study was initiated vith the intent of quickly locating
a feY non-homologous regions by FABMS; however, it eventually became
apparent that ChlorobiulD thioredox1n was quite different from that of E.
coli. The following sections (Sections VI-VIII) describe the sequencing
of three other th1oredoxins predominantly by tandem mass spectrometry,
which proved to be much simpler, faster, and more sensitive.
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Section VI
Primary structure of the th1oredoxln isolated from Chromat;um "inosum
determined by high performance tandem mass spectrometry
VI.l Introduction
In the recent past, the vast majority of primary structures of
proteins have been determined either by the stepwise, automated Edman
degradation or, indirectly, by the translation of the DNA sequence of the
gene coding for the protein. Alternatives b~~~d on entir~ly different
methods are always useful, if only to provide at least a yay to overcome
obstacles in the course of the conventional appLoach. Mass spectrometric
peptide sequencing has been such an alternative, and with the
availability of high performance tandem mass spectrometry, viII likely
become an increasingly important methodology for the more difficult
sequencing problems.
The strategy developed for the deter.1nation of the primary sequence
of a protein by tandem mass spectrometry 1s as follows: The reduced,
S-carboxymethylated (or S-carbaaidomethylated> protein is digested vith a
protease of h11h specificity, such as trypsin, the digest Is free~ of
remaining enzyme, buffer, etc., by reversed-phase HPLC and, at the same
time, separated into fractions containing preferably one to three, but
sometimes as many as ten peptides depending on the size of the protein
and the complexity of the d1gestG A second set of overlappln, peptldes
Is generated by cleavage with an enzy.e of different specificity (such as
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chymotrypsin or S~phloCOCCU3 aureus (strain Va) protease) or with
cyanogen bromide to allow the proper arrangement of the tryptic peptides.
We have used this approach to determine the primary structure of the
thloredoxin from ChrolDatiulD V;DOfUlD which is, to our knowledge, the first
example of the sequencing of a protein entirely by tandem mass
spectrometry (123). Finally, the molecular weight of the original
molecule was determined to within t2 dalton using the high mass
capability of the first stage of the tandem mass spectrometer. This
result confirms that none of the tryptic peptides have ~~caped detection.
VI.2 Materials and Methods
Preparation of peptides-- Approximately 100 nmol of thioredoxin
isolated from CbrolDatiulD was denatured in 6 H guanidinium chloride, 0.1 H
trls<hydroxymethyl)am1no methane (Tr1s) and 1 mM
ethylenediam1netetraacetic acid (EDTA) at pH 8.5, and ~educed with a 50
fold molar excess of dlthiothre1tol for one hour under nitrogen at 37 oc.
The reduced thioredoxln vas treated with a 2.6 fold molar excess of
iodoacetamide over dithiothreitol at pH 8.5 and 37 OC for one hour. The
reaction mixture vas desalted on a polyacrylamide gel column of molecular
weight cutoff 6,000, and ~vaporated to dryness on a Savant Speed Vac
Concentrator. One half of the product (corresponding to 50 nmoles
starting protein) of the S-carbamidomethylated protein vas digested with
trypsin (50:1 substrate/enzyae) for tvo hours in 0.1 H NB4BCO) and 0.1 mH
CaC12 at pH 8.5 and 37 oc. The tryptic digest vas part~ally fractionated
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into ten fractions by reversed-phase high performance liquid
chromatography capLe) as described In Section I (Fig. VI.I). A portion
of tryptic fraction 10 vas treated vith ~-chymotrypsin (100:1
substrate/enzyme) for 45 min in the tryptic buffer at 37 OC and pH 8.5
and then fractionated by reversed-phase BPLC. Part of fraction 6 was
digested further with S aureus (strain VB) protease (50:1
substrate/enzyme) in 0.1 K NB4HCOJ at 31 OC and pH 8.C for seven hours
and fractionated by HPLC. One quarter of the intact
S-carbamidomethylated thioredoxin was also digested with this enzyme and
was separated into five fractiods by reversed-phase HPLC. The m~n~l
Edman degradation procedure has been described in Section II~
Both FAB and CIO mass spectra vere acquired on the JEOL BXIIO/BXIIO
mass spectrometer (see Section I for details). For the determination of
the molecular weight ef the thloredoxin, the mass spectrometer (MS-}) vas
calibrated with (CsI)DCs+ cluster ions (n-44-47) to cover the mass range
from m/z 11,300 to 12,000. Approximately 0.8 nmol of the protein sample
was deposited onto the sample probe and mixed with 1.5 ~l thioglycerol.
The range from m/z 11,600 to 11,800 vas scanned in 10 sec at a resolution
of 1:500 and nine such scans summed.
VI.3 Results and Discussion
As a first step in the sequencing of the thloredoxin from
ChrolDauulD, a tryptic digest of the S-carbamldomethylated protein was
partially separated by reversed-phase HPLC into ten fractions CPig.
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VI.I). (The modification of the cystelnes is necessary to make the
protein susceptible to tryptic digest1oDg) The 'ABMS spectra of these
ten fractions shoved a total of sixteen different protonated molecules,
<H+8)+, indicating the presence of sixteen peptides (Table VI.}). The
<H+8)+ ion at m/z 1047 vas found mostly in fraction 9, hut a smaller
signal vas also found in fraction 10. The ("+8)+ Ions of each of these
were then subjected to collision with He as described in Section I, and
the resulting CID BaSS spectra recorded. Five of these spectra could not
be recovered from ~et1c tape and the data is therefore listed in
tabular form (Tables VI.2-VI.6). Nine of these CID spectra are depicted
in Figs. VI.2-VI.IO, and the remaining tvo «"+8)+ • m/z 1209.2 and
m/z 2164.7) have been published (123-124). The accuracy of all mass
assignments vas within 0.3 u. At the ti.e these spectra were acquired,
the computer prograas SEQPBP and ALTSEQ were not available, hence these
were all interpreted manually using the same subsequence ~pproach, except
at a much mora limited scale. Since then these spectra have been
interpreted by SRQPBP and the results are presented in each table or
figure; the score Is based on the fraction of ions accounted for and not
on product ion abundance (see Section IV).
The low abundance of sequence specific fragaent Ions In conventional
FAS mass spectra beco.es a more severe proble. at low -ass where matrix
ions are most abundant. However, in tande. mass spectro.etry these
contributions are filtered out by M5-1 and only fr.,.ent 10ns derived
from the selected precursor are observed. For instance, the sequence
Val-Lys vas deduced frOB the collision spectrua of a/z 246.2 found in
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Table VI.l: (H+8)+ ions of tryptic peptides from Chromatium tllioredox1n.
HPLC
Fraction
1
2
3
3
4
4
5
6
6
7
8
8
9
9
10
10
10
(H+8)+
246.2
331.2
560.3
790.3
435.3
508.3
1379.7
531.3
2049.0
999.5
744.6
1063.9
1047.4
1208.2
1047.8
1762.7
2164.7
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Table VI.2: Product ion aasses, relative mbundance, and 10n assignments
for the CID .ass spectrum of the tryptic peptide of (M+Dj+ • m/z 331~2~
Only those ions of relative abundance greater than 8.0% are listed. The
sequence Ile-Ala-Lys vas the highest scoring structure detera11\ed by
SEQPIP (s~ore • 0.867). The ion noaenclature is depicted in Schem~
111.2.
Relative Ion
!!Ll Ahundance Assignment
84.1 20.1 R
86.1 57.8 X
12800 8.8 K
129.1 12.0 It
130.0 9.9 z.
147.0 50.7 y.
157.1 13.5 a l
185.1 17.0 bz
202.1 16.4 zIti
218.1 100.0 Yz
274.1 23.2 -I
286.1 9.2
331.2 ("+8) +
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Table VI.3: Product 10n masses, relative abundance, and ion assignments
for the CID mass spectrum of the tryptic p~pt1de of <K+B)+ = m/z 790Q3a
Only those ions of relative abundance greater than 7.9% are listed. The
sequence Gly-Gly-Glu-Val-Glu-Ala-Thr-Lys vas the highest scoring
stru~ture determined by SEQPEP (score = O~878). The ion nomenclature 1s
depicted in Scheme III.2.
72.0
84.0
102.0
115.0
147.1
201.1
229.0
244.0
248.0
300.0
303.1
315.1
319.1
343.0
373.1
444.1
448.1
472.2
503.1
515.1
516.2
531.1
543.1
547.3
601.2
644.1
658.2
660.2
688.0
700.0
702.1
716.1
717.2
718.1
730.1
731.1
732.1
733.1
744.1
745.1
747.0
759.0
772.2
774.0
775.0
790.3
Relative
Abundance
16.8
7.9
25.4
11.7
14.9
13.4
17.2
92.9
28.5
8.2
21.9
21.2
25.9
39.6
47.8
17.1
22.5
31.8
11.5
8.1
30.3
14.2
21.3
12.3
27.4
12.9
12.2
10.8
23.1
16.7
20.7
11.2
100.0
1487
29.2
17.5
11.8
8.6
13.5
93.2
32.4
16.5
32.8
19.8
23.0
Ion
As.s,.ig,nmen t
ZJ+ 1
8 4
YJ
b4
W4
as
Y4
bs
Vs
a6
Ws
zs+ 1
b6
Y5
w6
b7
v7S
Z6+ 1
X~
2: ,
-E
-8
-K
-K
.roV
-HIO
-NOJ
-NB or -CB)
("+8)+
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Table VI.4: Product ion masses, relative abundance, and ion assignments
for the eID mass spectrum of the tryptic peptide of ("+8)+ ~ m/z 560.3.
Only those ions of relative abundance greater than 7.8% are listed. The
sequence Val-Gly-Ala-Val-Ser-Lys vas the highest scoring structure
determined by SRQPBP (score = 0.892). The ion nomenclature is depicted
In Scheme 111.2.
Relative Ion
m/z Abundance Assignment
72.0 32.5 V
04.0 7.9 K
129.1 13.2 az
147.1 12.4 YI
157.1 39.7 b2
201.0 7.8 w2
228.0 72.2 b)
234.1 58.3 Y1
299.2 18.6 a 4
300.2 8.3 a4+1
302.1 17.9 w)
315.1 8.1 GAVS
317.1 13.8 zJ+ 1
327.1 12.5 b4
333.1 16.1 Y3
388.1 15.8 z4+ 1
404.1 9.9 Y4
430.2 984 x4
445.1 8.0 zs+ 1
461.2 29.3 Ys
487.1 8.9 x5
488.1 10.3 -K
515.2 17.8 -K
516.1 10.9 -44
517.1 100.0 -v
529.1 19.2 -5
542.2 11.7 -H2O
543.1 11. 1 -NBJ or -08
544.1 12.7 -NB2
545.2 11.4 -NB or -CBl
560.3 (H+8) +
.- ..':'
261
Table VI.5: Product ion masses, relative abundance, and 10n assignments
for the CIO mass spectrum of the tryptic peptide of <H+8)+ • m/z 435.3.
Only those ions of relative abundance greater than 10.0% are listed. The
sequence Xle-Phe-Arg was the highest scoring structure determined by
SEQPEP (score K 0.758). The ion nomenclature is depicted in Scheme
III.2.
Relative Ion
m/z Abundance AsJl19ruaen t
70.0 18.1 R
86.1 48.5 X
87.1 32.0 R
100.1 20.4 R
112.1 15.8 R
120.1 70.9 F
158.0 16.2 z.
159.0 22.3 zl+l
1:'5.1 51.5 Y.
201.0 23.7 XI
230.1 32.7 v2
233.2 18.6 8 2
261.2 10.7 b2
305.1 35.8 Z2
306.1 32.1 Z2+ 1
322.2 23.7 Yz
348.1 27.0 Xl
376.1 1982
377.2 29.6
378.1 65.0 -x
390.2 22.4
391.1 62.9 -44
418.2 29.1 -NB) or -08
1.19. 1 17.0 -MHJ
435.3 <"+8)+
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Table VI.6: Product ion masses, relative abundance, and ion assignments
for the eIe mass spectrum of the tryptic peptide of (M+8)+ a m/z 50803.
Only those ions of relative abundance greater than 10.0% are listed. The
sequence Tyr-Gly-Ile-Arg vas the highest scoring structure determined by
SEQPBP (score = 0.897). The ion nomenclature is depicted in Scheme
lII.2.
70.0
86.0
87.0
100.1
112.1
136.1
143.1
158.1
159.1
175.0
200.9
221.0
230.1
243.1
271.1
272.2
300.1
314.1
328.2
345.2
371.1
400.2
401.2
451.1
462.1
463.2
478.1
479.1
491.2
492.1
508.3
Relative
Abundance
13.5
41.9
24.1
18.4
12.5
6603
17.4
19.9
25.3
29.7
16.1
13.5
21.1
34.1
14.3
15.8
10.a
21.4
14.0
21.7
20.0
73.4
67c.8
60.1
13.5
28.1
26.8
10.6
55.9
18.0
Ion
Assignment
R
I
R
R
R
Y
ZI
2 1+1
YI
XI
b2
V2
V1
Zl
z2+ 1
"'31
Xl
Zl
Yl
X J
-y
-y
-1
-NHl or -08
-Na1("+8)+
Va
l-L
ys
K
v
N 0
\
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BPLC fraction 1 (Pig. VIo2).
The pept1des represented by Figs VI.7 and VI.S and Table VI.5 are
derived from chymotryptic cleavages (such cleavages are frequently
encountered even in TPCK treated trypsin> and contain portions of the
peptide shown in Fig. VI.3. This situation can be unambiguously
identified from their CID spectra. Note that the absence of arginine
precludes the formation of va ions in the chymotryptic cleavage peptides
and leucine/isoleucine cannot be differentiated, which Is in contrast to
the int~ct tryptic peptide of Fig. VI.3. Furth~r complications
involving the peptide of Fig. VI.3 were identified from the CID mass
spectrum of Figs. VI.9 and VIoIO. In the former case, the difference in
mass between y, and YJ is consistent vith having an oxidized mEthionine
at position four. Such oxidations may be troublesome since the mass of
Het(S-O> is nominally equal to that of phenylalanlnes However, in this
case the oxidized methionine was a minor component and there was no
confusion. In Pig. VI. 10, an apparent ~-ellminatlon of either HSCB)
from methionine or B(SO)CBJ from the oxidized methionine of Fig. VI.9
had occurred, probably during the peptide workup. In comparison with
Fig. VI.3 the w4 ion is absent, and the mass difference between Z4-Z)
and x.-xJ (Fig. VI.IO) conclusively demonstrates that this elimination
had occurred.
Y1th few exceptions, the ion series shown in Figs VI.2-VI.IO and
Tables VI.2-VI.6 define the entire sequence of each peptide. However,
when glycine 1s at the N-terminus of a peptide the corresponding
273
N-term1nal ions are not observed, and the C-terminal ion, Yo 1 which would
reveal the loss of the glycine <57 mass units>, 1s not only of very low
abundance, but is also indistinguishable from the loss of the side chain
of leucine or lso1euc1nee Such an N-terminal glycine can be identified
conclusively by subjecting the peptide to a single Edman cleavage and
determining the mass of the shortened peptide. The peptides of Table
VI.3 and Fig. VI.3 were therefore subjected to an Edman degradation
cycle and were found to each contain a N-terminal glycine.
Although the CID mass spectr~m of Fig. VI.6 contains suff1~1ent
information to define the entire sequence, the complexity of the observed
fragmentations made it desirable to cleave this peptide further with S
aureous (strain va> protease and examine the fr&gmentations of the
resulting smaller peptides. This enzyme cleaved at position 15. The
smaller peptide (Val-Xle-Lys) was not observed by FABHS; however, the
larger peptide (1-15> gave the CID mass spectrum shown in Fig. VI. II,
the fragmentations of which are consistent with the sequence deduced from
the larger tryptic peptide (Fig.VI.6). A single manual Edman cycle
carried out on this tryptic/S. aureous protease peptide confirmed the
presence of an N-terminal serine.
Another problem arose in sequencing the peptide of ("+8)+=2165.0.
The two N-terminal and two C-termlnal amino acids could not be determined
from this spectrum, which has been reproduced in a recent review (124).
The b2 ion of m/z 185, reveals that the N-terminus could only contain Ser
and Pro, or Ala and Xle. This question was resolved by digestion of
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tryptic HPLC fraction 110 with a-chymotrypsin and fractionation by
reversed-phase BPLC. The FAB aass spectrua of these fractions indicated
seven (K+B)+ ions - m/z 620.9, ./z 631.0, m/z 1004.1. m/z 1190.4, ~/z
1478.3, m/z 1562.1, and m/z 1708,2. The CID mass spectrum of
(H+8)+· m/z 620.9 (Plg. VI.12) indicated the sequence
Cys·-Gly-Pro-Cys·-Lys, where Cys' is carbam1domethylated cysteine, thus
confirming the C-terminal sequence of the original peptide of
<"+8)+=2165.0 which exhibited only a weak Y2 ion. The CID mass spectrum
of (M+8)+=loo4.5 (Fig. VIe 1) has the sequence (Ser,Pro or
Ala,Xle)-Asp-Pro-Val-Leu-Val-Asp-Tyr. ~.dentifying it as the peptide
containing the nine N-terminal amino acids of (H+H)+z216S.0, but again
did not define the sequence of the two N-terminal amino acids. A single
Edman cycle on this fraction indicated the loss of 87 daltons, which
reveals that Ser is at the N-ter.1nus. The complete sequence of this
peptide is as shown in Pig. VI.14~
At this point, the sequences of all of the tryptic peptides ~ere
known and they could be aligned by aax1.izlng ho.ology with £ coli
thioredoxin <112-113). Vlthout such a template the order of tryptic
peptides can be established from the .olecular weights of the peptides
generated by another enzyme or chemical cleavage. The FABHS of BPLC
fractions fro. a S. aureus protease digest of S-carbamidoaethylated
ChrolDaUuLD thloredoxln indicated the presence of seven peptldes of
molecular weights 1180.8, 1559.1, 1707.9, 1787.2, 2049.3, 2585.5 and
3372.9. This makes it possible to order the tryptic peptides correctly
as shown in Figure VI.14 where the .~ aur~U$ pept1des correspond to the
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F1gure VI.14: Amino acid sequence of the th1oredox1n from ChrOl.DaUUlD
vinosulD: (a) tryptic peptides (positions 74-78, 74-80) and 80-82 are due
to chymotryptic impurity in the trypsin); <b> further digestion of
selected tryptic BPLC fractions with either a-chymotrypsin or S. Qureous
(strain va> protease; (e) S. aur~ous (strain VB) protease pept1des.
Half arrows: amino acids removed by manual Edman steps.
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regions 16-26, 72-85, 1-15, 72-87, 88-107, 49-71 and 16-44. One
exception is the region covered by (H+8)+·2586.5 (positions 49-71).
Given only the molecular weight of this peptide, the three complete
tryptic peptides encompassed could be arranged six different ways.
However, the FABHS/HS spectrum of <H+B)+-2586.5 (Fig. VI. IS) is
compatible only with the sequence shown in that figure. The FABHS/HS
spectra of most of the other S. aureus protease peptides were obtained,
and, although of poor quality (lov signal to noise ratio). were in
agreement with the sequence determined from the tryptic peptides. The
relatively high degree of homology with the £ coli thioredoxin increases
the confidence in the structure of the ChrolnatiuJ.n vinoJulD protein even
though the mass spectra of the tryptic pept1des were sufficiently
different (with the exception of 70-73, which 1s identical) that they had
to be interpreted independently before the homologies could be
recognized.
A comment about the sample requirement is in order. While 100 nmol
of thioredoxin was used as the starting material, the products were split
at two points and only about 0.5-1.0 nmol of peptide vas used to obtain a
FABHS/HS spectrum. V1th proper care in sample handling, much less
material would suffice than what was used in the-york described here.
The amino acids composing thic sequence agree with the amino acid
analysis, except that the latter showed 9 Pro and 6 Ser instead of 8 and
7. It also indicated 8 Leu and 8 lIe in agreement with the total of 16
required by the sequence. While this 1s generally considered adequate,
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we made use of the high mass range of the JEOL HXIIO mass spectrometer
(to mass 14,500 at 10 KV accelerating voltage) to determine th~ molecular
weight of the thioredoxln from ChroInatiulD directly. The value of
11,749~O obtain~d for the ve1g~ted average of the isotope cluster of the
<H+8)+ ion agreed well with that calculated, 11,751.2 (Fig. VI.16>,
lending further support to the correctness and completeness of the
primary structure s~own in Figure VI.14.
VI.4 Conclusion
The sequence of ChronJatiulD vinosulD thioredoxin, a protein of
",-11,750, vas determined entirely by mass spectrometric methods,
predominantly by tandem mass spectrometry. Six leucines and six
isoleucines were positively identified and only two of each remained
undifferentiated. This technique is efficient, fast and 1n contrast to
conventional Edman methodology, does not require complete separation of
proteolytic or chemically cleaved peptides. Although not a factor in the
present case, N-terminally blocked peptld~s are equally suitable for mass
spectrometric sequencing as demonstrated by Crabb et al,. (125) on a
blocked tetradecapeptide from prostatropin. The capability of measuring
the molecular weight of large peptides or the protein itself facilitates
the alignment of proteolytic peptides and provides a check on the primary
structure deduced from the sequence ~ata.
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11600 m/z 11700 11800
P1aure VI.16: Unresolved isotopic
multiplet of the ("+8)+ ion of
thioredox1n fro. C. "iQosum. The BlaSS
value shown corresponds to the center of
the peak.
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Section VII
Primary structure of the thioredoxin isolated from RhodospirilJulD
rubrum determined by high perforaance tandem mass spectrometry
VII.! Introduction
The thloredoxln sequences for the green sulfur bacter1ua ChlorobiulD
thio$ullatophilum (Section V) and the purple sulfur bacterium CbroDJlltium
~inosulD (Section VI) are definitely related, but they nevertheless show
slgnlf1~ant structural differences. The thloredoxin of ChrolD~tiUJD
r;lJo$um is much more similar to 1 ts Escherichia coli (112-113)
counterpart than that of the .ore distantly related CbJorobiulD
thiosullatophilul.D. In view of the structural differences in the
thloredoxlns fro. the tvo photosynthetic bacteria studied thus far. it
vas of interest to examine the amino acid sequence of the thioredoxin
produced by a third major g~oup of these organisms - the purple nonsulfur
bacteria. For this purpose, tand~m mass spectrometry was again utilized
to determine the primary structure of the thloredoxin isolated from
RhodospirilluIn rubrum.
VII.2 Materials and Methods
Approximately 30 n.ol of thioredoxln isolated fro. R. rubruAD vas
S-carbamidomethylated as described in Section VI, and digested with
trypsin (50:1 substrate:enz~e) for tvo hours in 0.1 H NB4BCO) and 0.1 mM
Cael} at pH 8.5 and 37 oc. The tryptic digest vas separated into seven
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fractions by BPLC as described 1n Section I (Fig. VII.I). One third of
fraction 4 vas dissolved in 100 ~l of the tryptic buffer and 1 ~l of 2097
IU/ml carboxypeptidase B (Calbiochem) vas added and the digestion
proceeded ot room temperature for 1 hr. HPLC fractions 5, 6 p and 7 of
the tryptic digest were treated further with ~~ aureous (strain va>
protease (50:1 substrate:enzyme) In 0.1 H NH4HCO] at 31 OC and pH 800 for
seven hours and fractionated by HPLC. Twenty nanomoles of undenatured
and uncarbamidomethylated thioredoxln vas digested with S aureous
protease in 0.1 H NB.BCO) and 4 Murea at pH 8.0 and 37 OC for 24 hours.
An S aureous pr~~~ase peptide of appoximate molecular weight 6070 was
digested further with a-chymotrypsin in the tryptic buffer at pH 8.5 and
37 OC for 2 hours. The manual Edman degradati~n procedure has been
described 1n Section II, and the automated gas phase Edman degradation
was carried out at the Whitehead Institute Protein Sequencing Facility.
For amino acid analysis, samples were hydrolyzed at 110 OC for 24 hr 1n
an evacuated 10 x 70 ignition tube containing 0.1 ml of constant-boiling
Bel; the analysis vas performed on a Dionex 0-500 amino acid analyzer.
Both FAD and CIO mass spectra were acquired on a JEOL BXIIO/HXIIO mass
spectrometer (see Section I for details).
VII.3 Results and Discussion
The S-carbamldomethylat~d R. rubruln thloredonin was digested with
trypsin and the resulting pe~t1des were separated into seven fractions by
HPLC (Fig. VII.I). The molecular weights of the tryptic peptides 1n
each fraction were determlne~ by FASKS CTable VII.l), and eIO mass
286
Figure VII.I: BPLC chro.oatogram of a tryptic digest of RhodospirilJulD
rubrUlD thioredoxln. The markings indicate fractions coll~cted.
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spectra were obtained for nine of the ("+8)+ ions observed (Table VII.2).
Of particular interest is the CID mass spectrum of the tryptic peptide of
<H+8)+ = m/z 789.4. A tryptic digest of E coli thioredoxin resulted in
a peptide of the same mass with the sequence
Asn-Gly-Glu-Val-Ala-Ala-Thr-Lys, which, as was later found, encompas~es
the same sequence region as the R. rubrulD tryptic peptide. The
reasonable assumption would be that these two peptides have the same
sequence; however, the sequence deduced from the CID mass spectrum of
the R. rubrulD peptide (Asp-Gly-Gln-Val-Ala-Ala-Thr-Lys) revealed that
tvo amino acids were different, even though their molecular weights were
identical. The CID mass spectra of these two peptides are shown in Figs.
VII.2a-b and at first glance appear to be quite similar. However, the b2
ions differ by one ~ass unit (m/z 173.0 and m/z 172.0 for the R. rubrulD
and E. coli peptides, respectively>, as do the Y7 ions Cm/z 674.5 and
m/z 675.5>. This example demonstrates the need for unit resolution of
CID spectra of peptides.
The CID mass spectrum of the tryptic peptide of <H+8)+ = m/z 1355.7
did not clearly identify the two C-terminal amino acids, although the
mass of this region plus the fact that trypsin cleaves at arginine or
lysine strongly suggested the sequence -Ser-Lys. Nevertheless, this
peptide may have been the C-terminal tryptic peptide or have been derived
from cleavage resulting from chymotryptic impurities. To make an
unambiguous distiction, BPLC fraction 4 vas digested with
carboxypeptidase B, and analyzed by FABMS. The truncated peptide had a
mass corresponding to the loss of lysine (this enzyme removes only
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Table VII.I: <M+8)+ ion masses of tryptic peptldes from
S-carbamldomethylated Rbodo$pirilJulD rubruJD thloredoxln. Asterisks
indicate ions for which CIO mass spectra were obtained. The poo1tlons
were determined f~o. the final structure.
<"+B)+
494.3'
517.3'
598.3'
789.4'
1019.6'
1079.1'
1355. 7-
1466.8'
1640.0'
2135.1
2138.3
BPLC
Fraction
2
2
3
1
6
6
4
5
7
7
7
POlition
67-70
50-54
88-93
80-87
96-104
71-79
55-66
3-15
34-49
16-33
34-54
Table VII.2: CID aass spectral data for the tryptic peptides of
S-carbaaldomethylated RhodospirilJulD rubru1.D th1oredoxln~
iM+Bi+ • lIz 494.J
v 230.1
v 243.0
x 3'57.2 300.1 201.0
y 331.1 175.0
z 314.2 257.2
z+l 315.2 258.2
4 3 2 1
Tyr - Gly - Val - Arg
1 2 3 4
b 221.0
("+8)+ • lIz 5J7..3
v 372.3
v 385.3 286.2
x 343.3 173.1
y 418.4 311.2 218.2 147.1
z 300.2 201.1
z+l 402.4
5 4 3 2 1
Val - Thr - Val - Ala - Lys
1 2 3 4 5
a 113.1 272.2 343.3
b 201.1 300.2 371.3
<M+B)+ = m/z 598.3
v 298.2
x 511.4 454.4 383.2
y 485.5 428.4 351.2 244.1 147.0
z+l 469.4 412.3 341.2
6 5 4 3 2 1
Ile l - Gly - Ala - Leu- Pro - Lys
1 2 3 4 5 6
a 321.2 424.4
b 171.1 242.1 355.2 452.2
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Table VII.2 <continued)
("+8)+ s m/z 78904
v 445.1
w 543.4 458.3
x 643.5 515.5 416.3 113.0
Y 674.5 489.2 390.1 319.2 248.1 147.1
z 600.3
z+1 658.5 601.4 473.2 374.2 303.2
8 7 6 5 4 3 2 1
Asp - Gly - GIn - Val - Ala - Ala - Thr - Lys
1 2 3 4 5 6 7 8
a 372.2 443.2 615.5
b 173.0 301.1 400.2 411.2 542.3 643.5
(H+8)+ • ./z 1019.6
v 917.9 806.7 719.6 592.4 461.4 362.3
x 778.7 677.4
y 962.9 849.7 651.6 538~4 407.4 29402 141.1
z 735.6
ztl 136.6
9 8 7 6 5 4 3 2 1
Gly - lIe - Pro - Thr - Leu- Met - !le - Phe - Lys
1 2 :\ 4 5 6 1 8 9
a 143.1 454.4 585.2
b 171.1 268.2 369.2 482.3 613.4 726.6 873.8
("+8)+ = m/z 1019.7
y 819.3 690.5 504.2
z 949.8
9 8 7 6 5 4 3 2 1
Leu· - Phe - Giu - Trp - Val - Glu - Ala - Ser - Val
1 2 3 4 5 6 7 8 9
a 548.3 647.5 776.6
b 390.2 576.3 675.3 804.6 875.8 962.7
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Table VlI.2 (continued>
(H+92+ B lIz 1155.7
v 1071.0
v 1182.8 1083.7 825.4 111.6 614.6 486.4
x 1269.1 1154.8 586.4
y 1243.0 900.8 771.5 6S7.3
z+l 1\12.7 755.2
12 11 10 9 8 7 6 5
Ilel - Aso- Ile - Asp- Glu - Asn- Pro - GIn -
1 2 3 4 5 6 , 8
a 200.0 896.4
b 228.2 45682 585.3 699.5 796:.6 924.5
432.5 331.2
4 3 2 1
.-.Thr - Pro - Ser - Lys
9 10 11 12
1094.6
1025.6
~! • ./z 1466.8
v 1294.8 1207.9 934.6 787.3
v 1308.1 657.6 528.4
x 1265.9 1063 .. 9 905.4
y 1338.9 1240.2 1152.8 1037.6 966.7 879.5 732.5 603.5 474.3
z 1223.6 949.6 587.0
z+1 1322.9 1136.9 1021.7 950.4 863.3 716.1
13 12 11 10 9 8 1 6 5 4
GIn - Val - Ser - Asp- Ala - ser- Phe - Glu - Glu - Asp -
1 2 3 4 5 6 7 8 9 10
a 836.3 1080.8
b 430.2 588.5 1108.8
3 2 1
-Val - Leul- Lys
11 12 13
a 1179.7
b 1201.9
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Table VII.2 (continued)
<H+8)+ = m/z 1640.0 (2-sector BIB linked scan)
w 1100.6 971.5 842.3 729~3
y 1399.2 1327.6 1159.3 1046.4 917.5 788.3
z 1383.5
z+ 1 901.3
16 15 14 13 12 11 10 9 8
GIn - Xle - Ala - Pro - Ala - Leu - Glu - Glu - Leu -
1 2 3 4 5 6 7 8 9
a 213.9
b 241.9 313.1
y 675.2 604.2 503.1 432.3
7 6 5 4 3 2 1
- .'\la - Thr - Ala - Leul- Gly - Asp - Lys
10 11 12 13 14 15 16
I Leucine or isoleucine was differentiated based on the masses of do or
Wo ions found in the CID spectra of other peptides that encompass this
position.
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Figure VII.2: (a) CID BaSS spectrum of the tryptic peptide of
(M+8)+ • m/z 709.4 of Elcherichh coli th1oredoxln. <b) CID mass
spectrum of the tryptic peptide of <"+8)+ • ./z 789.4 of RhodoJpiril/unJ
rubrULD thioredoxin.
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C-terminal lysine and arginine), and the sequence deduced from its CID
mass spectrum was in agreement with that determined from the original
tryptic peptide.
In order to more clearly delineate the sequences of some of the
larger tryptic peptides, BPLC fractions 5-7 were each digested further
v1th S aureous protease and fractionated by BPLC.. Eight peptides of
<H+8)+ = m/z 408.2, m/z 603.4, m/z 690.3, m/z 7B8~3, m/z 835.5,
m/z 870.6, m/z 882.5, m/z 1318.6 vere observed. The CID mass spectra of
these peptides were acquired and the data are listed in Table VII.3. The
N-termlnal sequence of the peptide of <"+8)+ = m/z 1318.6 was deduced
from a series of internal fragment ions - DGP, DGPV, DGPVX (X = leucine
or lso12ucine), and DGPVXV - which could not be accounted for otherwise.
A ninth tryptic/.~ aureous protease peptide of <"+8)+ ~ m/z 865.4
was also observed; in Fig. VII.3b its CID mass spectrum is compared to
the CID spectrum of <M+8)+ = m/z 882.4 (Fig. VII.3a). It is quite clear
that they have the same C-terminal sequence; however, the bD ions of
Fig. VII.3b are observed 17 u below those of Fig. VII.3a. The most
likely explanation is that the peptide of Pig. VII.3b is the same as
that of Fig. VII.3a except that the N-terminal glutamine has cycllzed
during workup to for. pyro~lutamic acid. Further comparison of these two
spectra reveals that ions corresponding to ba-l1 in Fig. VII.3a are
absent in Fig. VII.3b, suggestiug that collisional activation also
induces this cyclization. However, Ions of type ba-17 have also been
found in CID mass spectra of peptides not containing N-terminal
Table VII.3: CID mass spectral data from peptides resulting from
digestion of tryptic HPLC fractions 5-7 with S aureous (strain Va)
protease. Cys' indicates carbam1domethylated cysteine.
<M+8)+ = m/z 408.2
x 174.0
y 295.0 148.0
2 130.9
2+1 279.0
3 2 1
Leu· - Phe - Glu
1 2 3
a 233.1
b 261.0
<H+H)+ ::II m/z 603.4
v 414.2
w 413.2 328.2 201.0
x 500.3 385.2 286.1
y 474.3 359.2 260.1 146.9
z 457.2
z+1 458.3 244.0
5 4 3 2 1
Glu - Asp - Val - Leu- Lys
1 2 3 4 5
a 217.0 316.1 429.2
b 244.9 344.1 457.2
(M+8)+ ~ m/z 690.3
y 504.1 405.0 276.0 204.9
6 5 4 3 2 1
Trp - Val - Glu - Ala - Ser - Val
1 2 3 4 5 6
a 258.0 387.0 545.1
b 285.9 415.1 486.1 573.1
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Table VII.3 (continued)
<H+8)+ = m/z 788.3
v 558.0
v 570.9 372.9
x 701.2 630.1 528.9 458.0 172.8
Y 675.2 604.0 503.0 432.0 318.9 261.8 146.8
z 587.0
z+ 1 659.1 588.1 487.0 416.0 302.9
8 7 6 5 4 3 2 1
Leul - Ala - Thr - Ala - Leu - Gly - Asp - Lys
1 2 3 4 5 6 7 B
a 156.8 329.0 442.1 614.1
b 184.9 285.9 357.0 470.0 527.0 642.1
<H+6)+ = m/z 835.5
w 543.2 389.2 229.0
x 675.2 515.2 361.2 201.1
y 649.1 499.1 432.3 175. 1
z 632.1 472.1 318.2
zt 1 473.2 159.0
6 5 4 3 2 1
Trp - Cyst - Gly - Pro - Cyst - Arg
1 2 3 4 5 6
a 473.2
b 404.2
(H+8)+ I: m/z 870.6
y 742.5 629.3 558.3 390.2 276.9
8 7 6 5 4 -3 2 1
GIn - Xle - Ala - Pro - Ala - Leu - Glu - Glu
1 2 3 4 5 6 7 8
a 213.8 382.1 453.3 566.1 695.4
b 241.9 312.8 410.1 481.0 594.3 723c4
d 524.3 637.3
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Table VII.3 (continued)
<H+8)+ :II m/z 882~5
y 754.3 655.3 568.3 453.0 382.1 294.9
8 7 6 5 4 3 2 1
GIn - Val - Ser - Asp - Ala - Ser - Phe - Glu
1 2 3 4 5 6 7 8
a 200.0 402.1 473.2 707.1
b 228.0 315.0 430.1 501.2 588.3 735.3
<MtB)+ • m/z 1318.6
x 1273.7
y 1132.3 1075.3 879.1
12 11 10 9 8 7 6 5 4
Ala - Asp - Gly ..- Pro - Val - Xle - Val - Asp - Phe -
1 2 3 4 5 6 7 8 9
a 158.5 411.9 525.1 624.0 739.3 885.9
b 243.7 340.8 439.9 553.0 652.1 76702 914.2
3 2 1
-Trp - Ala - Glu
10 II 12
a 1072.3
b 1100.4 1171.3
I Leucine or isoleucine was differentiated based on the masses of do or
va ions found in the CID spectra of other pept1des that encompass this
position.
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Figure VII.3: (a) CID mass spectrum of the tryptic/S. aureous protease
peptide of <"+8)+ • II/Z 882.5 of Rhodolpirillum rubrum thioredoxin. (b)
CID mass spectrum of the tryptlc/.~ aureous protease peptide of
<"+8)+ d ./z 865.4 of R. rubrulD thloredoxin.
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glutamine, so the origin of these ions in all cases cannot yet be stated
with certainty. These two spectra are important because they de~onstrate
the possibility of identifying postranslational modifications in
proteins, although in this case the transformation occurred during sample
preparation.
In an attempt to avoid sample loss due to the carbamidomethylation
and gel filtration procedures, the undenatured and
non-carbamidomethylated thloredoxin vas digested vith S aureous <strain
VB> protease in 4 H urea. These conditions were apparently not
sufficient to allow complete digestion, since only a few peptides were
found - <H+B)+ = m/z 1141.4, m/z 3456.2, and m/z 690.4. A fou~th peptide
was observed slightly higher in mass than the range that the mass
spectrometer vas calibrated for. However, the doubly charged ion
[(H+2H)~] indicated that this peptide was approximately of mass 6070 ± 4
u.
The eIn mass spectrum of ("+8)+ = m/z 1141.4 (Table VII.4) revealed
that this peptide had the same seque~ce as the tryptic/S aureous
protease peptide of (H+9)+ = m/z 882.5 (Fig. VII.3a) but contained two
additional amino acids (Het-Lys) at the N-term1nus. The mass of the 5~
aureous protease peptide of (H+d)+ • m/z 3456.2 vas sufficient
information to align the tryptic peptides of ("+8)+ : m/~ 1466.8,
m/z 213501, and m/z 164000 (see Fig. VII.4). Only this ~rrangement
would produce a S aureous protease peptide of (H+B)+ = m/z 3456.2,
which then would encompass positions 11-41. The CID mass spectrum of the
300
Table VII.4: CID mass spectral data for the S. aureOU9 protease peptide
of <"+8)+ = m/z 1141.4.
x 1036.1
y 1010.4 882.3 754.6 294.9
10 9 8 7 6 5 4 3 2 1
Het - Lys - GIn - Val - Ser - Asp - Ala - Ser - Phe - Glu
1 2 3 4 5 6 7 8 9 10
a 360.1 459.1 661.3 732.4 819.4 966.4
b 260.0 388.0 487.2 574.0 689.2 760.2 847.4 994.5
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S aureous protease peptide of <H+B)+ = m/z 690.4 vas identical to the
tryptic/S ~ureOU9 protease peptide of <M+H)+ = m/z 690.4 (Table VII.3)D
Although the mass spectrometer could have been recalibrated for a
slightly higher mass range and a more precise measurement made of the
peptide of approximate mass 6010 u, this would not have provided the
required overlap information and would have consumed more of the sample.
Instead, this peptide was digested further with u-chymotrypsln,
fractionated by HPLC, and analyzed by FAB (Table VII.S> and CID mass
spectrometry. The CIO mass spectra for eleven peptides were recorded;
of particular interest were those of <M+8)+ = m/z 726.3, m/z 943.5,
m/z 1158.7, m/z 1177.5, m/z 1216.7, and m/z 1646.7, the data for which is
listed in Table VII.6. From these spectra, the tryptic pept1des could be
arranged as shovn in Fig. VII.4; the S aureous protease peptide of
mass 6070 u apparently encompasses positions 42-98.
At this point of the york, nearly the entire structure was
established. Both tryptic and ~~ aureous protease digestion resulted in
peptides with the C-term1nal sequence -Glu-Ala-Ser-Val, demonstrating
that the C-terminus of the thioredoxin had been determined. However, the
N-termlnus seemed to be shortened relative to the ~ coli sequence. In
order to independently confirm this finding, the intact thloredoxin was
subjected to 10 cylces of automated gas phase Edman seq~encing. The
results supported the data obtained from tandem mass spectrometry.
Lysine and glutamine were differentiated based on the specificity of
trypsin. Only one glutamine (position 34) remained uncertain, since
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Table VII.S: (Ht8)+ ions of peptides resulting from an «-chymotryptic
digest of the S. aureous protease peptide of mass 6070 u. CID mass
spectra were acquired for all of these ("+8)+ ions confirming the
sequences of the positions indicated.
(H+8)+
488.1
637.2
726.3
943.5
988.4
1049;)3
1158.7
1177.5
1216.7
1344.8
1646.7
HPLC
Fraction
3
3
1
8
3
2
5
1
7
6
4
Position
42-46
94-98
87-93
68-76
42-51
77-86
42-53
77-87
88-98
87-98
54-67
Table VII.6: CID mass spectral data for selected S. aur~ous
protease/chymotryptic peptides of R. rubruLD thioredoxin.
(H+Bl.+ = m/z 726.3
v 540.3
w 553.3 298.1
x 624.2 511. 1
y 598.3 485.4 428.2 357.3 243.8 147.1
z+ 1 582.2 412.2
7 6 5 4 3 2 1
Lys - lIe - Gly - Ala - Leu - Pro - Lys
1 2 3 4 5 6 7
a 214.1 342.2 455.3 552.3
b 241.9 370.2 483.3 580.4
d 413.3
<H+8)+ :: m/z 943.5
v 842.4
TJ 855.4
x 813.2
y 787.4 461.3
z+l 771.4
9 8 7 6 5 4 3 2 1
Gly - Val - Arg - Gly - lIe - Pro - Thr - Leu - Met
1 2 3 4 5 6 7 8 9
a 285.1 455.3 552.4 653.3 76684
b 157.2 313.2 370.2 483.3
d 427.3 637.4 724.4
(H+8)+ ~ m/z 1158.7
w 743.3
x 1071.4 1000.3 658.2
y 974.3 873.4 689.2 517.3
z 957.4
z+ 1 lU29.4 958.3 501.1
12 11 10 9 8 7 6 5
Leul - Ala - Thr - Ala - Leu - Gly - Asp - Lys -
1 2 3 4 5 6 7 8
a 157.1 328.9 442.1 614.2
b 185.1 286.0 357.1 470.2 642.3 770.5
4 3 2 1
-Val - Thr - Val - Ala
9 10 11 12
a 841.4 942.6 1041.5
b 869.5 970.3 1069.5
d 827.4 1027.5
303
304
Table VII.6 <continued)
<H+B)+ = m/z 1177.5
v 729.5
'W 843.5 543.1 458.0
x 1090.3 943.3 815.2 700.3 643.2
y 1064.1 917.3 789.3 674.3 489.1 390.2 318.9 2/~8 eO
Z 600 .. 1
z+ 1 1048.3 901.5 658.2 374. 1
11 10 9 8 7 6 5 4 3 2 1
lle l - Phe - Lys - Asp - Gly - Cln - Val - Ala - Ala - Thr - Lys
1 2 3 4 5 6 7 8 9 10 11
a 233.0 475.9 661.3 760.3 831.4 902~4 1003.4
b 260.9 504.2 561.5 689.4 788.2 859.5 930.4 1031.3
d 604.3 746.5
(H+B)+ = m/z 12\6.7
v 91Dg5 819.2 691.5
x 1129.4 791.2
y 1103.3 975.3 862.5 637.3 536.1 294.9
z+ 1 1087.2 1030.6 959.2 749.3
11 10 9 8 7 6 5 4 3 2 1
Ile l - Gly - Ala - Leu - Pro - Lys - Thr - Lys - Leu - Phe .. Glu
1 2 3 4 5 6 7 8 9 10 11
a 326.9 653.3 894.6 1041 c 4
b 171.2 242.1 355.2 681.4 809.5 922.5 106907
d 852.4
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Table VII.6 (continued)
<H+8)+ = m/z 1646.7
w 1473.1 1345.1 1246.3 988.4 874.1 649.4
x 1544.7 1431.2
Y 1518.1 1404.9 1063.5 820.2 594Gl
14 13 12 11 10 9 8 7 6 5
Lys - lIe - Asn - lIe - Asp- Glu - Asn - Pro - GIn - Thr -
1 'Z 3 4 5 6 7 8 9 10
a 441.1 685.4 799.4 896.5 1125.2
b 584.1 713.0 827.2 1052.4 1153.2
Y 494.3 310.0
4 3 2 1
-Pro - Ser - Lys - Tyr
11 12 13 14
I L~uc1ne or isoleucine was differentiated based on the masses of do or wn
ions found in the CID spectra of other peptides that encompass this
position.
J06
Figure VII. 4: A~~ino acid sequence of Rhodospiri//um rubium thioredoxin:
(a) trypt\c peptides; <b) _~ aureous protease digestion of selected
tryptic pep'l1~~S; (c) ...(). aureous protease pept1des; (d) further
digestion of \.l~~"; ..C;. aureous prott!ase peptide of m/z 6090 vi th
(X-chymotI"ypsin. Heavy underlining: sequence derived from ern mass
spectra. Solid lin€3 with~ut heavy markings indicate regions that match
observed molecular veights of unsequenced peptides. Balf a~rows pointing
to the right indicate N-terminal amino acids removed by manual Edman
degradation; the half arrow pointing to the left indicates r~noval of
lysine by carboxypeptidase B. Xle denotes positions where leHcjn~ could
not be distinguished f~om isoleucine. The first ten amino acids were
also identified by automat~i gas phase Edman degradation of tht~ intact
protein.
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The sequence of Rhodospiril/um rubrum was determined predominantly
by tandem mass spectrometry; only at two positions (21 and 35> leucine
could not be differentiated from isoleucine.
cleavage at arginine at the preceeding position may prevent cleavage at
positiun 34 even it the amino acid at position 34 were lysine. To
differentiate between these two possibilities, the tryptic/S aureous
protease peptide of <H+8)+ = m/z 870.6 was treated with
phenylisothiocyanate, but was not cleaved with TFA. The FAB mass
spectrum showed that 135 u had been added to the mass of the peptide
demonstrating that there was only one free amino group <the N-terminus),
therefore, position 34 must be glutamine. Some of the derivatlzed
peptide still had undergone cleavage, and the truncated peptide of
molecular veight 128 u <the residue mass of glutamine and lysine) less
than t~e original peptide was observed. A few other manual Edman
degradcltions were carried out on other peptides to confirm their
N-terminal amino acids; these are indicated by half arrows in Fig.
VII.4. Finally, the amino acid composition of this sequence was in good
agreement with that determined by amino acid analysis (Table VII.7).
•
ConclusionVII.4
•
•
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Table VII.7: ComparIson of the amino acid composition of R. rubrUlD
thloredoxln as determined from the sequence shown in Pig. VII.4 and amino
acid analysis. Cysteine and tryptophan were not determined by amino acid
analysis.
Ala
Asp/Asn
Arg
Glu/Gln
Gly
His
Leu/lIe
Lys
Met
Phe
Pro
Ser
Thr
Tyr
Val
Sequence
12
9
2
12
7
o
14
9
2
4
7
I~.
6
1
10
Amino Acid
Analysis
llca9
9.5
2.4
12.3
7.7
0.0
8.1/5.4
7.8
2.0
3.,6
6.8
4.1
5.9
1.0
9~3
I
L
•
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L
-
·I!Il
III'
II
I
·I
I
•
•
·
·
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Section VIII
Amino Acid Sequence of Thioredoxin Isolated From Rabbit Bone
Harrow Determined by H1gh Performance Tandem Mass Spectrometry
I
I
I
r
..
t
VIII.! Introduction
The primary structures have been determined for thioredoxlns from a
wide variety of prokaryotic organisms including the bacteria Escherichn
coli (112-113) and Corynebacterium nephridii (114-115), the bacteriophage
T4 (117), the cyanobacterium J1nabaena spheroides7119 (116), and the
photosynthetic bacteria ChJorobium thiosulfatophiJum (Section V),
Chromatium vinosum (Section VI) and Rhodospiril/um rubrum (Section VII).
However, only in the case of the m-type of thioredoxlns from spinach
leaves (118) is the complete amino acid sequence known for a eukaryotic
th1oredox1n, and even here the thioredoxin was isolated from chloroplasts
(intracellular organelles of bacterial origin). Thus it was of interest
to determine the sequence of a mammalian thloredoxin isolated from rabbit
bone marrow.
r-
L
VIII.2 Materials and Methods
Thloredoxln was isolated, purified, and S-carboxymethylated by Dr.
Sarah Hopper of the School of Dental Medicine at the University of
Pittsburgh (126). •
I
I
•
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S-carboxymethylated rabbit bone marrow thioredoxin <360 ~g) was
digested with trypsin <50:1 substrate:enzyme) for 2 hrs in 0.1 H NB4BCO)
and 0.1 mH CaC12 at pH 8.5 and 37 ~c. The tryptic digest was partially
fractionated by HPLC (Pig. VIII.I). Fraction eight was further cleaved
with S~phyJococcus aur~ous (strain VB) protease (50:1 substratc:enzyrne)
for four hours in 0.1 H NB4HCOJ at 37 OC and pH 8.0. Intact
S-carboxymethylated thioredoxin (120 ~g) was cleaved with S. aureous
protease under the same conditions and fractionated by reversed phase
BPLC. Another 120 ~g of the S-carboxymethylated protein was treated with
a-chymotrypsin using the same ·condition~ described for the tryptic
digest. Finally, another 80 ~g of S-carboxymethylated thioredoxin was
again cleaved with trypsin and partially separated by BPLC. The later
eluting fractions were digested further with the endopeptidase from
Bacillus therlDoprotolyticus (50:1 substrate:enzyme) for 1 hr in the
tryptic buffer at 45 oe.
FAB and CID mass spectra were acquired and HPLC was carriea out as
described in Section I. FABMS in conjunction with manual Edman
degradation was performed by Dr. V. R. Mathews as discussed in Section
II. Automated gas phase Edman degradation vas carried out for
twenty-four cycles by Dr. Nancy Royal, Creative Biomolecules, Hopkinton,
KA. For amino acid analysis, samples were hydrolyzed at 110 °C for 24 hr
in an evacuated 10 x 70 mm ignition tube containing 0.1 ml of
constant-boiling Bel, and was performed on a Dionex D-500 amino acid
analyzer.
.
I
~
r
f
VIII.3 Results and Discussion
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Prior to the installation of the JEOL BXIIO/HXIIO tandem mass
spectrometer at HIT, twenty-four cycles of gas phase Edman degradation
were carried out on the intact protein; however, position 14 vas later
shown from eIn mass spectral data to have been incorrectly assigned as
phenylalanine. Additional sequence information vas obtained by
subjecting HPLC fractions of proteolytic peptides to manual Edman
d~gradations followed by FABHS to determine the masses of the truncated
peptldes (FABHS/Edman data), as discussed 1n 5ec~ion II. This data 1s
listed in Table VIII.I.
The same general approach demonstrated in Sections VI and VII for
the sequencing of bacterial thioredoxins was used to determine the
primary structure of the thioredoxin isolated from rabbit bone marrow.
The protein was digested with trypsin and the peptides wer~ separated
into eight fractions by reversed phase HPLC (Figft VIII.I). The
molecular weights Df the peptides in each fraction were deter~1ned by
FABMS (Table VIII.2> , and CID mas~ spectra were measured for nine of the
observed <M+8)+ ions. The sequences summarized in Table VIII.2 were
deduced from these data. Table VIII.3 lists the fragment 10n masses and
assignments for these eIO spectra. The sequence deduced from the CIO
mass spectrum of ("+8)+ = m/z 1366.8 corresponds to cycles 8-20 of the
gas phase Edman data except that leucine rather than phenylalanine vas
found at position 7 of this tryptic peptide. This 1s probably due to the
fact that the retention times for the phenylthlohydantoin derivatives of
Table VIII.I: FABHS/Bdman data.
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NB,-Terminal Number of lysines remaining
<H+8)+ Seguencel in unseguenced RQ£tion
Tryptic Digest
604 Gln/Lys 1
635 Met 1
831 Val-Lys-Gln 1
90a Val-Gly-Glu 1
1015 Xle-Glu-Ala-Thr 0
1206 Cys·-Het-Pro-Thr 1
1272 Glu-Lys-Xle 0
1366 Ser-Ala 1
1447 Het-Xle 2
..~. aucrous (strain VS) protease
547 Ala 0
616 Val-Lys 0
796 Ser-Lys-Ser 0
1109 Gln/Lys 0
1122 Phe-Ser-Gly-Ala-Asn 2
1640 Val 1
~-ChymotryDtlc Digest
978 Phe-Bls-Ala-Xle 1
1020 Gln/Lys-Lyti-Gly 1
I Xle indica tes leucine or isoleucine; Cyst indicates carboxymethylated
cysteine.
314
, ~\ LJ
1 ~~31 ~ 5~8 ~~\ ~J 7 aI I-J
10
Elution Time
20
(min)
P1aure VIII.I: BPLC c~ro..tolr.. of a tryptic digest of
S-carboxyaetbylated rabbit bone aarrov thloredoxin. The markings lndlc&te
thG fractions collected for analysis by PAB and CID -ass spectrom~try
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Table VIII.2: <M+8)+ ions of tryptic peptides.
(M+8) + HPLC Fraction Pas! tionl Sequence2
604.1 2 3-7 a I E S K
635.4 4 36-40 MI K P F
831.5 2 1-7 V K Q I E S K
908.6 3 85-93 V G E F &G A N K
1015.6 6 96-104 LEA TIN ELL
1165.8 3 85-95
1206.7 7 72-80 Ct H P T F a F F K
1272.8 6 94-104 E K LEA TIN ELL
1334.8 6 72-81
1366.8 5 8-20 S A FOE v L D 5 A G D K
1447.9 5 36-47 H I K P F FHA L 5 E K
1740.5 7 21-3j
2162.3 8 85-104
3088.4 8 8-35
I Positions are those corresponding to the final structure.
2 Sequences were determined from CID mass spectral data; CID spectra
were not measured if no sequence is shown. In some instances vhere amino
acids could not be assigned from individual CID spectra they were deduced
from the eIe data of overlapping peptides. C· indicates
carboxymethylated cysteine.
Table VIII.3: CID mass spec~ral data for tryptic peptides. The m/z
values of ions for particular ion series a~e listed by rows. Cys~
corresponds to carboxymethylated cysteine.
<M+H)+ = 604.1
w 431.2 288.3
x 502.3
y 476.3 363.0 234.0 146e9
z+ 1 460.2 347.1
5 4 3 2 1
GIn - lIe - Glu - Ser - Lys
1 2 3 4 5
a 213.9 343.1
b 242.0 371.0 458.2
d 285.3
("+8)+ = 635.4
w 459.1
x 530.3
y 504.3 391.1 263.1
z+1 488.2 375.1
5 4 3 2 1
Met - lIe - Lys - Pro - Phe
1 2 3 4 5
a 216.9 442.1
b 244.9 373.1 470.1
("+8)+ = 831.5
w 658.3 530.1 431.0 287.9
x 758.3 630v3 502.1
y 732.5 604.3 476.1 363.3 233.8 146.8
z 715.3 581.3
z+l 716.3 588.3 460.1
7 6 5 4 3 2 1
Val - Lys - GIn - lIe - Glu - Ser - Lys
1 2 3 4 5 6 7
a 441.1 570.6 657.3
b 227.8 356.3 469.1 598.3 685.3
d 413.0
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Table VIII.3 <continued>
<H+H)+ = 908.6
v 531.2
w 677.2 443.1 200.8
x 835.4 778.2 649;2 502.0
y 809.3 752.4 623.4 476.1 38903 332.2 26088 146.8
z 606.5 459.0 243.8
z+ 1 793 .. 2 736.2 607.5 460.0 373.3 316. 1
9 8 7 6 5 4 3 2 1
Val - Gly - Glu - Phe - Ser - Gly ~ AI? - Asn - Lys
1 2 3 4 5 6 7 8 9
a 549.2 620.3 734.2
b 156.8 285.9 520.2 577.0 648.2 762.2
.uJ+H)+ = 1015.6
y 902.0 773.4 702.0 601.3 244a8
9 8 7 6 5 4 3 2 1
Leul - Glu - Ala - Thr - lle l - Asn .. Glu - Leu· - Leu2
1 2 3 4 5 6 7 8 9
a 214.9 500.1 614.2 743.0 856.4
b 242.8 313.9 415.3 528.1 642.4 771.2 884.4
<"+B)+ = 1206.7
v 771.3
w 968.3 871.3 784.0 495.0
x 1071.3 843.3
y 914.3 716.4 569.1 44103 293.8 146.7
z 800.2 552.0
z+1 1029.3 801.2 700.3 553.0 425.2 277.7
9 8 7 6 5 4 3 2 1
Cyst - Met - Pro - Thr - Phe - GIn - Phe - Phe - Lys
1 2 3 4 5 6 7 8 9
a 264.6 885.2 1032.1
b 292.6 490.8 638.0 766.0 1060.2
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Table VIII.3 <continued)
(H+8)+ = 1272.8
x 1169.3
y 1015.2 773.1
z+ 1 1127.5
11 10 9 8 7 6 5 4 3
Glu - Lys - Leu! - Glu - Ala - Thr - lIe - Asn - Glu-
1 2 3 4 5 6 7 8 9
a 342.8 472.3 542.9 644.2 757.2 871.5 1000.2
b 257.6 371.0 499.9 571.0 672.0 785.2 899.1 1028.4
d 414.3 729.5 828.3 942.5
2 1
-Leu - Leu2
10 11
a 1113.1
b 1141.5
d 1071.3
<"+8)+ = 1366.8
v 1116.6 760.3
w 987.3 858.1 773.2 645.9 444.3
x 1305.5 1234.4 1087.2 959.1 830.1 731.4 618.1
y 933 .. 1 804.2 705.0 591.9 477.2
z 688.2
z+1 1263.5 1192.3 1045.3 788.1 461.2
13 12 11 10 9 8 7 6 5
Ser - Ala - Phe - GIn - Glu - \'a1 - Leu - Asp - Ser -
1 2 3 4 5 6 7 8 9
b 158.5 305.6 562.7 662.0 775.2 890.0 977.3
y 390.0 318.7 261.6 146.7
4 3 2 1
-Ala - Gly - Asp - Lys
10 11 12 13
a 1192.3
b 1105.4 1220.3
318
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Table VIII.3 <continued)
(H+8)+ = 1447.9
v 601.7
w 1271.5 1032.3 417.0
x 1342.5 1229.5 1004.1 857.0
y 1316,,5 1203.3 1075.3 978.2 831.0 684.1 546.8 476.2
z+l 1187.3 962.4 815.1 668.0 530.8 460.2
12 11 10 9 8 7 6 5 4
Met - lie - Lys - Pro - Phe - Phe - His - Ala - Leu -
1 2 3 4 5 6 7 8 9
a 216.6 588.9 736.2 873.2 944.3 1057.3
b 244.5 372.7 4701t3 764.4 901.3 972.3 1085.4
d 1015.4
y 362.8
3 2 1
-Ser - Glu - Lys
10 IJ 12
a 1144.3 1273.5
b 1172.6 1301.8
I Leucine or 1so1euc~.ne vas d::'fferent1ated based on the masses of do or
V o ions found in the CID spectra of other peptides that encompass this
position.
2 Leucine differentiated from isoleucine by amino acid analysis of a
C-~erminal chymotryptic peptide.
leucine and phenr1alanine were similar under the HPLC conditions use~~
FABHS of HPLC fraction 8 revealed only two <H+8)+ 10ns p both of
relatively high mass and neither of which were sufficiently abundant to
obtain their CID spectra. This fraction vas therefore subjected to S
aureous (strain va> protease digestion followed by HPLC fractionation in
order to obtain smaller peptides more amenable to collisional activation.
As a result, eight peptides were observed and are listed in Table VIII.4.
The :IO spectra of the the tryptic / S aureous protease peptldes
of <M+H)+ = m/z 547.1 and m/z 1122.4 led to the conclusion that the
peptide of (H+8)+ = m/z 2162.3 from fraction 8 (Fig. VIII.I) was
composed of the two tryptic peptides of <M+8)+ • m/z 908.6 and m/z 1272.8
(see Table VIII.2> resulting from incomplete cleavage of the
Lys(93)-Glu<94) bond. More specifically, the tryptic I S ~ureous
protease peptide of <M+6)+ = m/z 547.1 upon collisional activation
revealed the sequence Ala-Thr-Xle-Asn-Glu, and that of m/z 1122.4 had the
sequence Phe-Ser-Gly-Ala-Asn-Lys-Glu-Lys-Xle-Glu. The di- and
tri-peptides XIe-XIe and Val-Gly-Glu, which would make up the remainder
of the original peptide of fraction 8 (m/z 2162.3>, were not observed
presumably because of the high matrix background at lower mass in FABHS.
Although these results do not provide additional sequence information in
these regions, the partial cleavage peptide indicates that the tryptic.
peptide of <M+H)+ = m/z 1272.8 is preceeded by that of m/z 908.6.
The tryptic / S. aureous protease peptides of <M+8)+ ~ m/z 581.1,
I
I
r
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Table VIII.4: ("+8)+ ions of tryptic / S. aureous protease peptides.
I Positions are those corresponding to the final structure.
2 The sequences shown were deduced from their CID mass spectra. In som~
instances vhere amino acids could not be assigned from individual CID
spectra they were deduced from the CID data of overlapping peptides. No
CID spectra vas obtained for ("+8)+ • m/z 1350.5, and that of (H+O)+ m
m/z 1640.4 was of too poor of quality (l~v signal to noise ratio) to
determine its sequen~e. CC indicates carboxymethylated cystejne. ,
Sequence}
A TIN B
S A FOE
F N N V V FIE
F S G A N K E K L E
F SAT w C' G P C· K
V L D SAG D K L V V V D
Po§1tlon l
98-102
8-12
48-55
88-97
26-35
13-25
56-67
56-69
1."+8) +
547.1
581.1
981.5
112204
1215.4
1329.6
1350.5
1640.4
I
r
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m/z 1215.4, and m/z 1329.6 (Table VIII.4) ve~@ also sequenced from their
CID spectra and the data is listed In Table VIII.5. From this it vas
determined that the original peptide of fraction 8, <"+8)+ • m/z 3088.4,
was derived from incomplete tryptic cleavage of the Lys(20)-Leu(21) bond,
and vas later shown to encompass positions 8-35 of the protein sequence.
Again, these results provided overlap information, but additional regions
of the protein were also sequenced. The eIO mass spectrum of <"+8)+ •
m/z 1215.4 provided the sequence of the active site re~ion
(-Trp-Cys-Gly-Pro-Cys-Lys>, but the portion N-terminal to the tryptophan
could not be reliably determ1~ed from this spectrum.
Interestingly, the remaining three tryptic / ~~ aurtous protease
peptides of ("+8)+ • m/z 981.5, m/z 1350.5, and ~/z 1640.4 are not
derived from any peptide observed in the FAS mass spectrum of tryptic
HPLC fraction B. The most lik~ly explanation is that fraction 8
contained three peptides, those of <"+8)+ • m/z 2162.3 and m/z 3088.4,
plus an additional one (that vas later found to encompass positions
48-71) of high hydroph111city, which did not readily ionize by FAB in the
presence of the more hydrophobic peptldes (36). The CID mass spectral
data of the tryptic / S aureous protease peptide of <H+B)+ z m/z 981.5
is shown 1n Table VIII.5. That of <H+8)+ a m/z 1350.5 was not
sufficiently abundant for collisional activation, and the CID mass
spectrum of the tryptic / ~~ aureous protease peptide of (H+8)+ =
m/z 1640.4 revealed only partial sequence information.
In order to properly arrange the observed tryptic and tryptic / S
I
I
,
I
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I
a
k
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I
l
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Table VIII.5: CID mass spectral data for selected peptldes resulting Lfrom ..f). aureous (strain VS) protease digestion of HPLC tryptic fraction ,
8. The m/z values of ions for particular ion series are listed by rows; I'J:r
Cyst indicates carboxymethylated cysteine. ~
I
>11+8)+ • a1.1
y 423.1 276.0 147.9
z 406.1 258.9 ~
z+l 407.1 25989 InI
5 4 3 2 1 ..pa
Ser - Ala - Phe - GIn - Glu !
1 2 3 4 5 I"~
a 406.1
b 159.0 306.1 434.1 ~I
I
("+8)+ • 981.5 l
y 606.1 507.2 408~O 260.9 Iz+1 704.3 589.9
8 7 6 5 4 3 2 1
Phe - Asn - Asn - Val - Val - Phe - Ile l - Glu
1 2 3 4 5 6 7 8
a 347.9 447.0 546.2 693.1 806.0
b 261.8 375.9 475.0 574.2 721.1 834.2
8
I
I
•
I
I
L
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Table VIllo5 (continued)
L
(M+Bt+ • 1215.4 Iii·
l
§4
v 516.1
}- 808.7 623. I" 461.8 404.8 307.8
147.0 .
10 9 8 7 6 5 4 3 2 1 II
Phe - Ser - Ala - Thr - Trp - Cys' - Gly - Pro - Cys' - Lys
1 2 3 4 5 6 7 8 9 10
b 234.8
<"+8)+ • 1329.6
w 1171.4
x 1256.2 8J3.0
y 915~4
z 985.3
z+1 1214.4 656.2
13 12 11 10 9 8 7 6
Val - Leu - Asp - Ser - Ala - Gly - Asp - Lys -
1 2 3 4 5 6 7 8
a 184.8
b 212.8 327.8 658.1 786.1
5 4 3 2 1
-Leu - Val - Val - Val - Asp
9 10 11 12 13
a 871.5 970.4 1069.1 1168.1
b 899.2 998.3 1097.6 1196.2
d 829.2 956.1 1055.3 1154.2
I Leucine or isoleucine was differentiated based on the masses of dn or
wn ions found In the CID spectra of other peptldes that encompass this
position.
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aureous protease peptides, as well as to obtain sequence information for
regions not covered by these digests, the S-carboxymethylateo protein was
cleaved with.~ lureous (strain VS) protease, partially fract1cnated by
HPLC, and the molecular weights determined by FABMS (Table VIII.6). The
CID mass spectral data for those peptides that either provide overlap or
additional sequence information are listed in Table VIII.7. CID mass
spectra were not obtained for <"+8)+ • m/z 2515.7 and m/z 3826Q5;
however, the masses alone were sufficient to provide overlap information
demonstrating that Lys<3S) was followed by Met(36) and in the final
structure these peptides encompass positions 26-46 and 13-46,
respectively.
At this point of the work, nearly the entire structure shown in Fig.
VIII.2 had been determined. Since the £-amino group of lysine reacts
with phenyl1sothlocyanate during the first manual Edman degradation
cycle, all of the glutamines and lysines had been differentiated from the
earlier FABHS/Edman data (Table VIII.I). Also, all of the leucines and
isoleucines had been differentiated from the masses of do and va ions,
except for the C-terminal position of the protein. However, there were a
few points that needed clarification. Pl~st, positions 26-29 and 68-69
needed sequencing; second, further overlap covering positions 47-48,
55-56, and 69-70 was required.
For this purpose, a third portion of S-carboxymethylated rabbit bone
marrow thioredoxln was digested with «-chymotrypsin. Again, the
proteolytic fragments were partially fractionated and analyzed by FABMS.
I
.
.
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Table VIII.6: (H+8)+ ions of S. aureous (strain VB> protease peptides.
<"+B)+
547.0
616.1
752.1
796.1
1011.3
1109.3
1122.3
1167.3
1329.6
1350. :1
1640.3
2159.8
2515.7
3826.5
Posi tign l
98-102
1-5
88-94
6-12
70-77
'~7- 55
88-97
78-87
13-:;:5
56-67
56-69
70-87
26-46
13-46
Seguencel
A TIN E
V K 0 I E
F 5 G A N K E
S K S A F Q E
V K C' M P T F Q
K F N N V V FIE
F 5 G A N K E K L B
F F K K G 0 K V G E
V L D SAG D K L V V V D
V D V D D C' K D I A A E
'I D V D D C' K D I A A E C' E
V K C' H P T F Q F F K K G Q K V G E
1 Positions are those corresponding to the final structure.
2 Sequences were determined from CID mass spectral data; eIO spectra
were not measured if no sequence is shown. In some instances where amino
acids could not be assigned from individual CID spectra they were deduced
from the CID data of overlapping pept1des. C' indicates
carboxymethylated cysteine.
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Table VIII.7: CID mass spectral data for selected ..~. ~lUrtoUJ (strain
VS) pro:ease peptides. The m/z values of ions for particular Ion series
arc listed by rows; Cyso indicates carboxymethylated cysteine.
(M+81+ • 126.1
y
z
z+1
a
b
d
7
Ser -
1
709.3 494.3 423~2 276.1
692.4 406.2 259G2
693.3
65432 1
Lys - Ser - Ala - Phe - GIn - Glu
23456 7
346.2 493.4 621.3
21602 303.2 37403 521.3 649.3
564.3
<H+8)+ • 1011.3
a
b
8
Val -
1
921.4 784.4
7 6
Lys - Cys'-
2 3
228.2 389.3
421.3
623.3 492.3 294.3 147.2
5 4 321
Met - Pro - Thr - Phe - GIn
45678
492.3 589~3 690.4 837.3
520.2 718.2 865.3
<M+8)+ = 1109.3
x
y
a
b
d
9
Lys -
1
632.2
261.2
8 7 6 5 4 321
Phe - Asn - Aso - Val - Val - Phe - lIe - Glu
23456 789
248.2 362.2 476.1 575.3 674.2 821.1 934.2
276.2 390.1 504.2 603.2 702.3 849.3 962.4
319.2 433.3 561.3 660.3 906.4
700.3 572.2 443.1
1
Glu
10
2
l:eu -
9
947.4
862.5 975.5
905.4
760.3 646.4 518.2 389.3
629.3 372.2
630.4 502.4
654 3
Asn - Lys - Glu - Lys-
5 6 1 8
706.4
734.3
648.5
942.3
1001.4 914.4
975.5 888.3
959.3
987
Ser - Gly - Ala-
234
235.1 292.2 363.1
10
Phe -
1
w
x
y
z
z+l
a
b
d
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Table VIII.7 (continued>
(M+W.+ • 1161..:1
w 799.3 671.2 486.3
x 1046.3 89905 771.2 586.4
y 1020.6 873.4 745.3 617.4 560.3 432.1 205.2
z· 1004.3 857.4 729.5 601.4
z+ 1 728.3 543.0
10 9 8 7 6 5 4 3 2 1
Phe - Phe - Lys - Lys - Gly - Gln - Lys - Val - Gly - Glu
1 2 3 4 5 6 7 8 9 10
a 708.2 836.2 935.5
b 295.3 608.5 736.5 864.5 963.5 1020.6
d 651.4 779.2 921.5
<"+8)+ :IE 1350.3
x 1277.4 948.2 544.1 429.3
.Y 1136.4 646.4 290.3
12 11 10 9 8 7 6 5 4 3
Val - Asp - Val - Asp - Asp - Cys' - Lys - Asp - lie - Ala -
1 2 ':JI 4 5 6 7 8 9 10.J
a 18763 805.3 920.1 1033.2
b 215.2 314.2 429.3 544.1 705.0 832.9 948.2 1061.1 1132.3
d 1005.2
2 1
-Ala - Glu
11 12
b 1203.5
(M+8)+ = 1640.3
x 1567.8 962.1 606.3
y 1426.6 1097.1 936.4 808.1 693.3 580.3
z 1524.5
z+l 920.3 671.2
14 13 12 11 10 9 8 7 6 5
Val - Asp - Val - Asp - Asp - Cys· - Lys - Asp - Ile l - Ala
1 2 3 4 5 6 7 8 9 10
a 187.3 677.2 920.3 1033.5 1104.5
b 215.3 314.3 429.3 544.4 705.3 833.2 948.5 1061.8 1132.7
y 509.1 309.1
4 3, 2 1
-Ala - Glu - Cyst - Glu
11 12 13 14
b 1203.8 1332.7
Table VIII.7 (continued)
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(H+8)+ • 2159.8
11 1986.5 1695.1 1598.0 1221.6
x 1798.4 1468.6 1192419
Y 1932.8 1771.5 1641.4 1544.0 1442.8 129503 1167.5
z 1755.1 152607 1425.7 1279.4 1150.9
18 17 16 15 14 13 12 II 10
Val - Lys .. Cyst - Met - Pro - Thr - Phe - GIn - Phe -
1 2 3 4 5 6 7 8 9
a 836.9 1112.3
b 228.2 389.3 520.1 616.9 993.7 1140.8
c 882.2 1156.9
v 799.2
x 1045.9 329.9
y 1020.0 873.4 745.1 616 .. 9 432.3
z 728.1
z+1 1004.6
9 8 7 6 5 4 3 2 1
-Phe - Lys - Lys - Gly - GIn - Lys - Val - Gly - Glu
10 11 12 13 14 15 16 17 18
a 125808 1387.3 1516.1 1700.5 1829.0 1928.5
b 1286.9 1415.5 1544.0 1600.4 1729.0(1855.8)1955.9
c 1304.6 1432.4 1617.1 1745.2
d 1329.9 1458.6 1643.8 1771.5
I Leucine or isoleucine was differentiated based on the masses of do or Wo ions
found in the CIO spectra of other peptldes that encompass this position.
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The CIO spectra of thlrtee~ chymotryptlc peptides were obtained and the
results are depicted In Flg~ VIII.2. Host of these peptides covered
regions already sequenced; those that were relevant to the open
questions discussed above are listed in Table VIII.8 and their CID mass
spectral data 1s shown in Table VIII.9. The peptide of <"+8)+ •
m/z 578.2 was shown to have the sequence Val-Val-Val-Asp-Phe, thus
de~onstratlng that phenylalanine Is at position 26. Likewise, the
peptide of ("+8)+ • m/z 464.2 vas shown to have a C-terminal sequence of
Thr-Trp; however, the N-termlnal portion, of residue mass
(-NH-CHR27_CO-NB-CBRzl-CO-) 158 u, could not be confidently sequenced
from this CID mass spectrum. Hence, positions 27-28 could only c~ntain
either Giy + Thr <57 + 101 u) or Ala + Ser <71 +87 u). but still remained
unsequenced. The peptide of (M+B)+ • m/z 978.4 provided overlap for
positions 47-48. Finally, the C-term1nal peptide representing positions
89-104 of <H+8)+ = m/z 1729.9 (which encompasses a previously sequenced
region and therefore is not shown in Tahle VIII.9) vas found to be
present as a single component in the latest eluting HPLC fraction. This
provided an opportunity to differentiate the C-terminal Xle by amino acid
analysis of this fraction (Table VIII.IO>. Not only were the results
consistent with the sequence deduced from the CID mass spectrum, but also
clearly indicated the presence of three leuclnes and one isoleucine.
Since the mass spectral data demonstrated that this peptide contained two
leucines, one isoleucine, and one undifferentiated Xle at the C-terminus,
the latter must be leucinee
The final experiment that completed the sequence involved a second
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Table VIII.a: (M+8)+ ions of chymotryptic pept1des and tryptic /
thermolytic pept1des.
<"+8)+ f2s1tion l ieguenceZ
Chymotryptic peptide,
464.2 27-30 SAT V
578.2 22-26 V V V D F
918.4t 41-48 F 8 A L S B K F
1729.9 89-104 C-termlnal peptide
Tryptic / thermolytic peptides
665.3 22-27 V V V D P S
920.5 64-71 I A A E C~ E V Ie
:208.5 54-63 I E V D V D D C' K D
I Positions are as deduced from the final structure.
2 Sequences were determined from eIO mass spectral data. In some
instances where amino acids could not be assigned from individual CID
spectra they were deduced from the CID data of overlapping peptides. C'
indicates carboxymethylated cysteine.
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Table VIII.9: CID mass spectral data for selected o-chymotryptic
peptldesQ The m/z values of ions for particular ion series are listed by
rows.
(hTO'+ ~ 464.2
x 4.19 .. 0
y 306.0 204.9
z+1 377.0
4 3 2 1
Ser - Ala - Thr - Trp
1 2 3 4
a 131.0
b 158.9 260.0
("+8)+ :II 578.2
Y 479.0 380.0 280.9 165.9
5 4 3 2 1
Val - Val - Val - Asp- Phe
1 2 3 4 5
a 170.9 270.0
b 198.9 298.0 413.0
<"+8)+ =- 978.4
v 749.2
v 564.3
x 857.4 649.3
y 831.2 694.3 623~3 510.2 294.2 166.1
z+l 815.2 678.4 607.4 494.2
8 7 6 5 4 3 2 1
Phe - His - Ala - Leu - Ser - Glu - Lys - Phe
1 2 3 4 5 6 7 8
a 257.1 441.3 528.3 657.3 785.4
b 285.1 356.2 469.2 556.2 685.3 813.5
d 399.1 599.3 728.3
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Table VIll.10: Amino acid analysis of the latest eluting o-chymotryptic
BPLC fraction.
Ser 1.04
Gly 1.14
Ala 2.00
Asn/Asp 2.06
Lys le76
Glu/Gln 3.51
Leu 2.35
lIe 0.89
Thr 0.98
M
r
I
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tryptic digest of the intact protein followed by DPLC fract1onat1onD
From the earlier tryptic digest it was found that the peptide
encompassing positions 48-71, which did not readily ionize by FAa, eluted
late in the chromatogram. Therefore, fractions co~responding to 7 and 8
of Fig. VIII.1 were cleaved further with thermolysin, separated by HPI.C,
and analyzed by FABHS and tandem mass spectrometry. H~ch of the
resulting data covered positions already sequenced, and is not reproduced
here. Three CID mass spectra (Tables VIII.B and VIII. II) contained the
relevant sequence data. The peptide of <H+6)+ z m/z 665.3 vas shown to
be Val-Val-Val-Asp-Phe-Ser, t~us demonstrating that the sequence 27-28 is
Ser-Ala. The CID mass spectra of the peptides of <H+8)+ = m/z 1208.5 and
m/z 920.5 provided overlapping sequences for positions 55-56 and 69-70,
and demonstrated that positions 68-69 had the sequence Cys-Glu.
r
•
P-
.
VIII.4 Summary of the thioredoxin sequences - homology considerations
The complete amino acid sequence of the thioredoxin of rabbit bone
marrow presented here is the first determined for a thioredox1n of
mammalian origin. However, a~ indicated previously by their amino acid
compositions, animal thioredoxins are unique in that they contain
cysteines In addition to the two thlo1s at the active site of all
thioredoxins (126-129). Tvo thioredoxins, C-l and C-2, have been
isolated from Corynebacteriul.D nephridli and the latter which contains
three cysteine residues (115) 1s the only nonmammallan thioredoxin known
to have more than tyO thiols. The sequence da~a presented in Fig.
VIII.2 show that the bone marrow thloredox1n contains five cysteines.
I,
I
~
I
I
~
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Table VIII. II: CID mass spectral data of selected tryptic/thersolytic
peptides. The m/z values of ions for particular ion series are listed by
rows; Cys· indicates carboxymethylated cysteine.
<H+8)+ • 665.3
y Stl603 467.3 368.3 253.3 lz+l 451 .. 36 S 4 3 2 1Val - Val - Val - Asp - Phe - Ser1 2 3 4 5 6 IF
a 171.4 270.4 385.4 532.3 ~b 199.3 298.4 413.4 560.3
(Ht8)+ =
L
920.5
w 590.4 429.2 300.3
~, 833.2 762.2 691.2 562.1 272.3 173.2
Y 807.2 736.1 665.2 536.3 375.3 246.2 147.3
z+l 791.2 720.3 359.3
8 7 6 5 4 3 2 1
lle - Ala - Ala - Glu - Cys' - Glu - Val - Lys
1 2 3 4 5 6 7 a
a 157.3 357.4 518.4 647.3 746.5
b 185.2 256.1 385.2 546.3 675.1 774.0
-
IF
(M+8) + -= 1208.5
y 966.4 752.5 653.1 423.0 [z 735.5 406.1
10 9 8 7 6 5 4 3 2 1 •lIe - Glu - Val - Asp- Val - Asp - Asp - Cys· - Lys - Asp
1 2 3 4 5 6 7 8 9 10 l-s 215.3 314.3 429.3 528.3 643.3 Ib 243.3 342.2 457.3 556.5 671.4 786.3 947r5 1075.2
1'1
I Leucine or isoleucine vas differentiated based on the masses of da or
,
r-.a
VA ions found in the CID spectra of other peptides that encompass this
position.
I
L
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Figure VIII.2: Amino acid sequence of the thioredoxin from rabbit bone
marrow: (a) tryptic peptld~s; <b) peptldes resulting from digestion of
tryptic. BPLC fraction 8 vi th S. aureOU$ (strain VB) protease; (c)
peptides generated by digestion of the intact protein with S 8ureous
protease; (d) .-ehyaotryptic peptldes; (e) peptldes resulting f~om
digestion of late eluting tryptic BPLC fractions with thermolysin. Heavy
underlining: sequence derived froz CID mass spectra. 8alf arrows:
amino acid removed by .-Dual BdBaD step. Over11nlng of the first 24
amino acids indicates sequence dete~lned by automated gas phase Edman
degradation. The gap in the overllnlng at position 14 indicates an error
in the gas phase Edman data that vas corrected by tandem mass
spectrometry.
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Val Lys Gln lIe Glu Ser Lys Ser Ala Ph. GIn Glu Val Leu Asp Ser Ala Gly Asp Lys 20
(a) tL:; I t::::; - .... ...,
(e) L:; I •
(b) • ,...(e) L:; aaao L;
---. ---'7
...
(C) •(d) ., •
Cd) •
-
Leu Val Val Val Aap Phe Sar Ala Thr Trp CyB Gly Pl'O Cye Lys Met lie Lye Pro Phe 40
(8) e
• L:;Ca>
• t:; •(b) • • •
ee)
(e) • •(d) I I • I • I(d) u
-ee)
-
•
Phe His Ala Leu Ser Glu Lyp Phe Asn Asn Val Val Ph~ 11e Glu Val Asp Val Asp Asp 60
&4
-----_1 •.-------~---~----... 010-------... 4t:::;
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-11II.
80
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•
•
•
•
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CyB Lye Asp lIe Ala Ala Glu Cys Glu Val Lye Cye Met Pro Thr Phe Gin Phe Phe Lys
•(a)
Ca)
(e)
(C)
Cd)
(8)
Ca}
(b)
ee)
(e)
(d) .~......_~---.-------~...--••••-----------••
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---~-----~--_ ---_.....-_--_ --_...
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Asn Glu Lau Leu 104
(a) •
(a) •
(a) •(e) •
Cd) •
Lye Gly GIn Lya Val Gly Glu Ph. Ser Gly Ala Asn Lys Glu Lys Leu Glu Ala Thr lIe
( a) --e L:; .-.op --r • t:::;
(a) •
(a) ••----------------------------------
(c)
(c)
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These include the active site disulfide in tile tetrapeptide
-Cysll-Gly-Pro-Cys34_, a single cysteine at posi tion 61, and what may be
an extra disulfide in the pentapeptlde -Cys6LGlu-Val-Lys-Cys72-. The
same active site tetrapeptide sequence has been identified in all
thioredoxins examined with the exception of the phage T4 thioredoxin
(117) and the C-2 thloredoxin of Coryn~bact~rium nephridii (115), which
contain the sequences -Cys-Val-Tyr-Cys- and -Cys-Ala-Pro-Cys-,
respectively. The th101s of glutaredoxins are arranged similarly, i.e.,
the glutaredoxln of £ coli (130) has only the one active site dlthlo1
while the glutaredoxln of calf thymus (131) and the glutaredoxin-like pig
liver thioltransferase (132) contain an additional dithiol. In both of
the latter proteins the two active site cyste1nes are separated by tvo
amino acids and the other half-cystine pair by three. This dithiol
configuration closely resembles that of the bone marrow thioredoxin,
assuming Cys~ and Cys72 form a disulfide bond.
Since prokaryote genealogies are older than those of eukaryotes, the
traditional method of comparing cytochrome c sequences has not been as
useful when applied to bacteria. As a result, comparative analysis of
the much more slowly changing ribosomal RNAs has been used for this
purpose (133). One of the motivations for the study of thioredoxin
sequences has been to provide an additional probe for the determination
of prokaryotic phylogeny. The ubiquity of this protein, and its size.
which provides a sufficient number of traits without requiring a lengthy
sequence analysis p suggest that thloredoxin may be useful for this
purpose.
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There are, however, some problems 1n the comparative analysis of
thioredoxin sequences for the determination of prokaryotic genealogies,
The first relates to the possibility of intergenic transfer between
bacteria mediated by viruses (134). A comparative analysis of sequences
assumes that genes are only transferred from one generation to another
over time. A transfer of genes from one organism to another would make
such an analysis worthless. A second problem is that more than one type
of thioredoxin per organism have been isolated, for example, the C-l and
C-2 thioredoxins of C. nephridil (114-115>. Of course, the difficulty
here is that its not clear which sequences should be compared. A third
problem Is that the biological role of thloredoxln has not been clearly
elucidated, and therefore, different thioredoxins may play different
roles. As a result, comparisons could be made between proteins with
different functions.
One final difficulty has been discussed by Heyer et al. (135). In
this study, a comparison of 18 of the most divergent mitochondrial
cytochromes c with 18 bacterial cytochromes c2 revealed that the
differences between the mitochondrial and bacterial sequences were not
significantly different from that of the mitochondrial cytochromes c
alone. Of course, the conclusion that the eukaryotlc organisms are
therefore equally related to one another as they are to the prokaryotic
organisms Is incorrect. Instead the hypothesis was put forward that
amino acid sequences reach a limit of change, where this limit is
presumably dependent on the protein structure/function relationship.
Bence, in making a phylogenetic tree based on protein sequence
I
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comparisons, it appears necessary to approximately determine this limit,
and make sure that sequence differences between organisms do not approach
this limit. For the purpose of determining the limit of change for
thioredoxins, the sequence of that derived from rabbit bOlle marrow may
prove useful. The relatively low homology between the bacterial
thioredoxins and rabbit bone marrow thioredoxin is probably a good
indication of thi~ structure/function limit of change.
In summary, the four thioredoxlns sequenced by mass spectrometry are
shown in Fig. VIII.3 aligned at their active sites. Homologous regions
for all four sequences are boxed, as are those for only the three
bacterial thioredoxins. Clearly, the active site region for all four
sequences are homologous, as are a few other positions throughout the
sequences. Furthermore, comparison of the bacterial thloredox1ns with
the mammalian one ind1~ates an apparent deletion/addition in the region
55-94 for the latter, as homology is increased if this region of rabbit
bone marrow thioredoxjn Is shifted one position to the C~termlnus. A
complete phylogenetic analysis of these and other thloredoxin sequences
has yet to be made, and further statements would be overly speculative.
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Figure VIII.3: eo.parlson of the amino acid sequences of thioredoxins
isolated froID Chlorobium Ibio8ulfatopbiJuDJ, Chromatium ~ilJosum,
RbodospirilJum rubrulD, and rabbit bone marrow. The nWlberlng on the
right corresponds to the amino acid positions of ChlorobiuJD end
Chromatjam thloredox1ns.
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ChlorobiUll Ala Gly Lys Tyr Phe Glu Ala ThreLys Asn Phe GIn Thr Glu 15
Chromatium Ser Asp Ser lle Val His Val Thr As Asp Ser Phe Glu Glu Glu
R. rubrum Met Lys Gin Val Ser Ala Ser Phe Glu Glu Asp
Rabbi t Val Lys Gin lIe Glu 5er Lys Ser Ala Phe G Glu Val Leu
Chloroblwa
Chroaaatium
R. rubrulD
Rabbit
Phe Trp A Ser 30
Tyr Trp Ala Asp
Phe Tr Ala Glu
Phe Ser Ala Thr____.-..a.
Chlorobium
Chromatlum
Rft rubrUII
Rabbit
45
Chlorobiwa ~ Asp Asp Tyr Glu Gly Lys Ala lIe lIe A a Lys X e Mn Val 60
ChromatlU111 1a Asp Glu Tyr Ala (ily Arg Val Lys lIe Ala Lys Xle Aso lIe
R. rubrum 1. Thr Ala Leu Gly Asp Lys Val Tbr Val Ala L-·s lIe Aso lIe
Rabbi t Ser Glu Lys Phe Asn Asn Val Val Phe Ile Glu, Va Asp Val Asp
ChloroblW1 Asp Glu ABn Pro Asn lIe Ala Gly GIn
Chrou.tl\111 Asp Glu Asn Pro Asn Thr Pro Pro Ara
R. rubrUII Asp Glu Asn Pro GIn Thr Pro 8er Lys
......--..pi!~
Rabbi tAss:ys p lIe Ala Ala Glu Cys
75
Chlorobiwa Pro Thr Met Leu lIe Xle Lys Gly GyLys Va Val Asp GIn Met 90
Chromatiua Pro Thr Leu Met Leu Phe Arg Gly Gly Glu Val Glu Ala Thr Lys
R. rubrull Pro Thr Leu Met Ile Phe Lys Asp Gl GIn Val Ala Ala Thr Lys
Rabbit Thr Phe GIn Phe Phe Lys Lys Gly G D Lys Val Gly Glu Phe Ser
Chlorobium Val y A • Leu Pro Lys Asn Met lIe Ala Lys Lys lIe Asp Glu 105
Chrornatium Val ly Ala Val 5er Lys Ser GIn Leu Thr Ala Phe Leu Asp Set"
R. rubrum lle 1 Ala Leu Pro Lys Thr Lys Leu Phe Glu Trp Val Glu Ala
Rabbit Gly A a Asn Lys Glu L s Leu Glu Ala Thr lie Aso Glu Leu Leu
Chlorobl~ His lIe Gly
Chro..tiUli Asn lIe
R. rubrua 5er Val
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Section IX: Summary
Despite first impressions, it now appears as though the amino acid
sequence of peptid~s of unknown structure can be deduced from their CID
spectra. The computer programs SEQPBP and ALTSBQ, along with the
graphics display approach (104), demonstrate the initial and largely
successful attempts at autoaating CID spectral interpretation. Future
improvements 1n such algorithms viII likely be dependent on an increased
~~erstanding of peptide fragmentations, since unexplained product ions
are still observed. It has been demonstrated that CID spectra can be
simp11fie~ considerably by peptide derivatization. If a generally
applicable and easy peptide derlvatlzat10n procedure could be developed,
most of the ambiguities 1n CID spectra of peptides (e.g., the f['equent
inability to identify the tvo N-term1nal amino acids, and the
differentiation of leucine and isoleucine in peptldes not containing
basic sites) could be resolved. Despite these deficiencies, enough 1s
currently known to allow for the sequence determination of proteins, as
demonstrated here on a number of thioredoxins.
Tandem mass spectro.etr1c sequencing of proteins appears to be
complemetary to the traditional method of Edman degradation. The
advantage of using both techniques is demonstrated In the sequencing of
most of the thioredoxins, where a few steps of automated gas phase Edman
degradation verified the N-termlnal sequence. Although this can be done
mass spectrometrlcally, In these cases it vas simpler to carry out a few
344
Edman cycles.
A comparison of these two techniques for protein sequencing 1s in
order. First, gas phase Edman degradation currently requires 10-20 times
less material than tandem mass spectrometry; however, the need to
isolate peptldes for Edman degradation likely reduces this difference
considerably. The time required for analysis is difficult to compare.
Given an isolated peptide, Edman degradation requires 0.5-1.0 hours for
each amino acid. On the other hand, tandem mass spectrometry requires
only a par~ially fractionatc~ sample where a FAB mass spectrum and
individual CID spectra are each acquired in less than three minutes.
Thus, both FAB and eIO spectra can be obtained for peptides resulting
from a single proteolytic digest in one day. Of course, each CID
spectrum may not unambiguously identify a peptide s2quence, and further
experiments may be called for. Each protein may have features that
create difficulties requiring additional time expenditures using one
method, but not for the other. Purchase and operation costs are always a
factor to consider. A four sector tand2m mass spectrometer currently
costs about 4-5 times as much as a gas phase sequencer. However, the
generaily faster rate of sequencing by tandem mass spectrometry makes
this technique competat1ve with regards to overall cost effectiveness.
Moreover, further developments in instrumentation production may reduce
this price difference.
Perhaps the most significant advantage of mass spectrometric protein
sequencing is the ability to characterize posttranslational
345
modifications. Of course, DNA sequences provide no indication of such
modifications; for N-terminally blocked peptides Edman chemistry fails
completely, and modifications occurring elsewhere yield
phenylthiohydantoin derivatives of unusual retention times or may not be
observed. Although this aspect of protein sequencing vas not addressed
directly here, a few examples of "1n vitro" modifications resulting
during sample handling were presented, e.g., oxidized methionine, and
glutamine cyclizlng to pyroglutamlc acid.
In summarYi tanrlem mass spectrometric sequencing of proteins and
peptides is a viable alternative to Edman degradation. Yet these
techniques each present their own unique advantages and disadvantages
such that use of both methodologies ("in tandemft ) viII likely produce the
optimum configuration for protein sequencing facilities.
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